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ABSTRACT
Women have greater incidence and prevalence of Major Depressive Disorder (MDD)
than men during the reproductive life phase when ovarian hormones fluctuate, suggesting that
ovarian hormones have a significant role in MDD etiology in women. As the core symptoms of
MDD are indicative of alterations in stress responding, emotional processing, and mood
regulation, examining the effects of the estrogen on these processes in women may provide a
better understanding of the role of estrogen in the sex difference in MDD rates. The general aim
of this dissertation was to examine neural, emotional, and attentional processes related to stress
response alterations and cognitive bias in MDD in women.

To examine menstrual phase and estradiol level effects on the neural and mood response
to psychosocial stress, healthy, normally cycling women were examined at either the high or low
estradiol phase of the menstrual cycle. Participants were exposed to the Montreal Imaging Stress
Task (MIST), with brain activity measured through functional magnetic resonance imaging
(fMRI), and behavioral response assessed with subjective mood and stress measures. We found
that women during the high estradiol phase showed significantly less hippocampal deactivation
during psychosocial stress compared to women during the low estradiol phase. Additionally,
women with higher estradiol levels also had less subjective distress in response to the MIST than
women with lower estradiol levels. These results suggest that high estradiol may be protective
against the shifts in brain system activity and negative mood responses associated with
psychosocial stress. Periods of low estradiol may enhance the negative impact of psychosocial
stress on neural activity and mood and thus contribute to MDD risk in vulnerable women.

The relation of cognitive bias to depression history in women was examined in
postmenopausal women with and without a history of major depression using an emotion dot
probe task during fMRI. Women with remitted MDD showed greater attentional facilitation for
negative images than women with no history of MDD that was directly correlated with amygdala
activity for negative images and amygdala-hippocampal connectivity in a resting scan. These
findings provide evidence that differences in activity and functional connectivity in emotional
processing networks may provide a neurobiological basis for continued cognitive bias in remitted
MDD. Preliminary data indicate that estradiol treatment reduces amygdala-hippocampal
connectivity specifically in women with a history of MDD and has interactive effects with MDD
history on the mood response to psychosocial stress following the MIST such that women with a
history of MDD appear to benefit from estradiol treatment while women without such history do
not. Women with a history of or vulnerability to MDD may be particularly sensitive to the
positive effects of estradiol on brain systems important to regulating emotional responses to
psychosocial stress. The findings presented in this dissertation suggest that estrogen fluctuations
across the menstrual cycle and at other reproductive events may contribute to depression risk
through effects on brain systems integral to emotional evaluation and response with potential

cognitive consequences.
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Chapter 1: Comprehensive Literature review
1.1. Introduction
Major depressive disorder (MDD) is a complex disorder that impacts multiple systems in
the brain and periphery and alters emotional and cognitive processes that are integral to healthy
daily functioning and quality of life. The incidence and prevalence of MDD in women is 2-3
times higher than in men (Kessler et al., 2003, 2005). In men new onset rates and 12 month
prevalence of MDD remain fairly constant from puberty to old age, but increase in women at
puberty and remain higher than men until menopause (Kessler et al., 2003, 2005a). Depression
risk for women changes across the lifespan with higher risk corresponding to life stages in which
ovarian hormones fluctuate across the monthly menstrual cycle or with reproductive events such
as parturition and the menopause transition (Gonda et al., 2008; Schiller et al., 2015; Schmidt
and Rubinow, 2010). Ovarian hormones have varied effects in the brain including modulation of
emotional perception, mood regulation, and stress response, as well as effects on cognition. The
concurrence of increased depression risk with the reproductive life phase indicates that ovarian
hormone fluctuations may contribute to mood disruption in women. Naturally occurring periods
of low estrogen (premenstrually and during late perimenopause) may introduce windows of
increased vulnerability for depression through the withdrawal of beneficial modulation of
emotional processing and mood regulation. The research included in this dissertation examined
the role of estrogen in emotional and cognitive processes integral to MDD.
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1.2. Major Depressive
Disorder
1.2.1 MDD Diagnosis and Epidemiology
According to the Diagnostic and Statistical Manual of Mental Disorders 5, MDD is
defined as experiencing one or more major depressive episodes (lasting at least 2 weeks), that are
not better explained by another medical condition or other psychiatric disorder (American
Psychiatric Association, 2013). Major depressive episodes must include at least 5 of 9 symptoms
within the same 2 week period: depressed/ sad mood, anhedonia, change in appetite, insomnia or
hypersomnia, psychomotor agitation or retardation, fatigue, negative feelings of self
(worthlessness, guilt), impaired concentration or decision making, thoughts of death or suicidal
ideation/attempt. These symptoms must cause significant distress and represent a change from
previous functioning (American Psychiatric Association, 2013). The twelve month prevalence of
MDD in the United States is just under 7% (Substance Abuse and Mental Health Services
Administration, 2013) and is predicted to increase in the future (Brundtland, 2001). MDD is the
largest contributor to disability due to mental and behavioral disorders (3.7% of US disabilityadjusted life years and 8.3% of US years lived with disability) (Murray et al., 2013). Although
mood and anxiety disorders are the most prevalent psychiatric disorders in the US, current
strategies for treating MDD fail to induce lasting remission or prevent recurrence in a significant
portion of sufferers.
Current first-line antidepressant medications are ineffective in inducing remission
in almost a third of patients (Adli et al., 2006). If patients do not respond to the first
antidepressant treatment subsequent attempts with other medications are less effective
2

(Oestergaard and Møldrup, 2011). The response rate for the most commonly prescribed antidepressants, selective serotonin reuptake inhibitors (SSRIs) is 30% (Trivedi et al., 2006), and
depressive symptoms often return with SSRI discontinuation (Glue et al., 2010). Because many
individuals with MDD do not experience successful treatment with standard pharmacological
approaches, or have returning depressive symptoms after discontinuing antidepressants,
augmenting current treatments and preventing depression recurrence remains a significant goal
for treatment strategies. Better understanding the role of ovarian hormones in MDD in women
may provide novel targets or better focus prevention strategies.

1.2.2 MDD Recurrence
MDD is often recurrent, with recurrence rates as high as 85% in 15 years in individuals
with past MDD episodes either in specialized mental health or primary care for MDD, and up to
35% in 15 years in the general population (Hardeveld et al., 2010). Most individuals with MDD
have more than one depressive episode, with the response to antidepressant treatments
decreasing with subsequent episodes (Lee et al., 2012). While there are a number of risk factors
that contribute to first onset depression, the primary predictors of recurrence are the number of
previous episodes and residual depressive symptoms that remain during remission (Hardeveld et
al., 2010). The “kindling” hypotheses of depression recurrence suggests that with successive
depressive episodes the threshold for response to stressful life events or depression triggers is
lowered and vulnerability for future depressive episodes increases (Monroe and Harkness, 2005).
Depressive symptoms during remission may indicate trait vulnerability factors that predispose
emotional or cognitive processes towards depressive responding.

3

Hammen and colleagues have proposed a “stress generation” hypothesis of depression
recurrence; individuals who experience recurrent depression are more likely than people with no
medical illness to experience subsequent stressful events (Hammen, 1991), particularly
“dependent” stressful events, meaning generally interpersonal conflict to which the depressed
individual contributes. According to this stress generation hypothesis, recurrence results from a
cycle of psychosocial stress and depression in which stress both contributes to and is a
consequence of depressive episodes (Hammen, 1991). Depressive episodes may leave a “scar”,
such as cognitive bias for negative information which results in maladaptive behavior and
dependent stressful events (Raedt and Koster, 2010). Thus, with each depressive episode the
association between negative cognitive patterns and negative mood may be reinforced and make
the individual more vulnerable to future depressive episodes (Dent and Teasdale, 1988).

1.3 Cognitive Models of MDD
1.3.1 Ventral and Dorsal Systems of Emotion Perception and Regulation
Theories of the neurobiology of MDD have evolved into complex network models that
include cognitive and emotion regulation mechanisms. One useful model that incorporates
emotion processing and cognitive function is the division of stimuli evaluation and emotion
regulation into ventral and dorsal brain systems (Figure 1) (Phillips et al., 2008). Structures in the
ventral system include the amygdala and ventral and orbital prefrontal areas (Drevets et al.,
2008; Mayberg, 1997; Phillips et al., 2008). The dorsal division includes the hippocampus,
dorsal anterior cingulate cortex (dACC), subgenual prefrontal cortex (subgenual PFC) and dorsal
lateral prefrontal cortex (dlPFC) (Drevets et al., 2008; Mayberg, 1997; Phillips et al., 2008). The
4

ventral system allows for the rapid appraisal of emotionally valenced stimuli, while the dorsal
system provides the capacity to modulate the affective, physiological, and cognitive

Figure 1: Ventral and dorsal brain systems for emotional appraisal and regulation.

consequences of ventral output (Phillips et al., 2003).

The overlap in circuits for mood regulation and cognitive function in the ventral-dorsal
model is indicative of an intimate connection between cognition and mood (Fink et al., 1995).
Becks’ cognitive model of depression posits that individuals with MDD experience information
according to mood congruent schemas, and are apt to interpret information as reflecting a
negative self-image, a negative view of external information, and pessimism about the future
(Beck and Haigh, 2014). This predisposition for experiencing and interpreting information such
that negative schemas are reinforced may reflect dysregulated ventral-dorsal interactions in
MDD. Cognitive bias is the predisposition to attend to or remember certain types of information
over others. The cognitive model of MDD posits that emotional processing circuits in the brain
5

are altered in depression such that there is a bias toward negative information, and attenuated
processing of positive information (Disner et al., 2011).

1.3.2 Attention Bias
Attention is the process by which cognitive resources are allocated to processing
information and selecting which information is blocked from further processing (Chun and TurkBrowne, 2007). The focus of attention is determined by interactions between bottom-up
(stimulus-driven) processes in the ventral system and top-down processes in the dorsal system
(Egeth and Yantis, 1997). The interplay between attention and memory is complex and the
pathways and mechanisms involved are not well understood (Chun and Turk-Browne, 2007).
Because memory capacity is limited, attention has a significant role in determining what
information is encoded into memory (Chun and Turk-Browne, 2007). Selective attention, the
process of choosing which stimuli receive attention and which are ignored, is crucial when there
are competing stimuli present (Chun and Turk-Browne, 2007). Memory deficits and bias for
negative information have commonly been found in MDD (Sears et al., 2011; Sheline, 2000). It
may be that altered memory in MDD is largely due to the effects of attention bias on sensory
processing of emotional information and subsequent effects on memory encoding (Raedt and
Koster, 2010). Emotionally-valenced stimuli drive bottom-up attention more than emotionally
neutral stimuli (Holtmann et al., 2013; McHugo et al., 2013; Peers et al., 2013; Stollstorff et al.,
2013). Vuilleumier and colleagues propose a model of attention by which emotional information
is “amplified” and preferentially processed. In this model the amygdala has a significant role in
generating “emotional bias signals”; ventral system processes initiated by the amygdala direct
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attention to emotionally-relevant stimuli and modulate sensory systems such that the processing
of such stimuli is enhanced and maintained (Pourtois et al., 2013).
Ventral and dorsal mechanisms interact to guide attention; the ventral system facilitates
the evaluation of stimuli and directs top-down processes towards emotionally-relevant
information (Chun and Turk-Browne, 2007), while dorsal system processes maintain attention
congruent to endogenous goals and motivational states (Mohanty and Sussman, 2013). Conflict
in top-up and bottom-down attentional processes occur when ventral system evaluation of stimuli
and subsequent emotional responses do not accord with the motivations and goals impacting
dorsal-system activity (Chun and Turk-Browne, 2007; Okon-Singer et al., 2015). Dorsal system
regulation of attention is influenced by endogenous motivational and emotional states.
Depending on these states the dorsal system may respond to attentional conflict by counteracting
amygdala-driven activity and reducing attention to and sensory processing of emotional stimuli,
directing attention to competing stimuli, or directing top-down attention to the stimuli driving
bottom-up attention (Pourtois et al., 2013). Studies demonstrating that acute stress and anxiety
enhances both amygdala response and subsequent sensory systems activity to negative emotional
stimuli (Bishop et al., 2004; Cornwell et al., 2011; van Marle et al., 2009; Shackman et al., 2011;
Vogel and Luck, 2000) provide evidence that negative mood states bias attention and sensory
processes toward negative information.

7

1.3.3 Cognitive Bias in Depression
Mood congruent cognitive bias is a common finding in currently depressed individuals
(Gaddy and Ingram, 2014). A recent meta-analysis of eye tracking in attention tasks found that
individuals with current MDD show blunted orienting responses and reduced maintenance of
attention to pleasant stimuli but maintain attention for negatively valenced stimuli (Armstrong
and Olatunji, 2013). Negative cognitive bias not only affects processing of emotional
information but appears to be related to emotional responding to psychosocial stress. Individuals
with current MDD fixate longer and more frequently on sad faces than healthy controls, and also
take longer to recover from to negative mood following a laboratory stressor (Sanchez et al.,
2013). Negative cognitive bias in current MDD may result from mood-congruent cognitive
processing during depressive episodes; negative information is processed more readily because it
accords with internal emotional processes during depressive episodes. However, according to
Beck’s cognitive model of depression (Beck and Haigh, 2014; Beck, 2005), cognitive bias for
negative information remains during remission and presents a trait vulnerability for depression
rather than a consequence of negative mood. A causative link between cognitive bias and mood
is also suggested by the finding that experimental methods that modulate attention bias also
affect anxiety and depression symptoms. Cognitive bias modification (CBM) is an experimental
technique in which attention is trained away from or towards negative stimuli and has been
found to be effective in modulating depressive symptoms as well as attentional performance
(Hallion and Ruscio, 2011). The mood effects of CBM training demonstrate that cognitive bias
may be a causative factor in mood disruption rather than a consequence (Hallion and Ruscio,
2011).
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Cognitive models of MDD accord with neural system dysregulation models in that
cognitive bias is associated with altered activity in dorsal and ventral systems (Raedt and Koster,
2010). Greater activity in ventral system structures and less activity in dorsal structures to
negative stimuli is a consistent finding in MDD (Drevets et al., 2008; Savitz and Drevets, 2009).
Enhanced amygdala activity in currently depressed and at risk individuals (Arnone et al., 2012;
Zhong et al., 2012) may indicate greater signal driven automatic evaluation or reduced regulation
by dorsal system structures resulting in biased processing of negative information (Sears et al.,
2011). Neuroimaging studies show that in MDD additional regions of the prefrontal cortex are
recruited during automatic control of emotional responses, suggesting that compensatory activity
in dorsal regions may be activated to control enhanced bottom-up activity, driven by amygdala
hyperactivity in MDD (Drevets, 2003; Drevets et al., 2002; Zhong et al., 2012).
Individuals with MDD appear to have diminished dorsal system capacity to regulate
ventral-driven sensory and emotional processing of negatively valenced information.
Establishing dorsal system regulation of emotional processing may be an important component
of successful MDD remission (Erk et al., 2010; Gotlib and Joormann, 2010). However, even
during remission, automatic ventral system processes may be prioritized when cognitive
resources need to be allocated efficiently (such as during stress) resulting in negative mood and
reinforcing negative cognitive bias. Cognitive bias in remitted MDD may reflect continued
dysregulation in emotional processes and a neurobiological basis for vulnerability to MDD
recurrence, especially following stress.

9

1.4 Stress and Major Depression
1.4.1 The Stress Response System
Stressors are perceived or actual threats to homeostasis that may be physical or
psychosocial and the healthy stress response is a coordinated neuroendocrine reaction that
maintains or restores homeostasis (Gold, 2015). The system that is involved in the response to
stress includes the autonomic nervous system, the hypothalamic pituitary adrenal (HPA) axis,
and the brain regions that orchestrate the autonomic, hormonal, and emotional response to stress
(Chrousos and Gold, 1992; Johnson et al., 1992; Sternberg et al., 1992). This system normally
serves to coordinate optimal neuroendocrine, immune, and autonomic responses to stress (for
review see Stokes, 1995). During stress, the peptides cortisol releasing factor and arginine
vasopressin are secreted from the hypothalamus and induce the release of adrenocorticotropic
hormone from the anterior pituitary. In response to adrenocorticotropic hormone, glucocorticoids
are released from the cortex of the adrenal glands. In humans the primary glucocorticoid is
cortisol. Cortisol acts throughout the body to increase the energy available to manage the
demands of the stressor and maintain homeostasis. The endocrine response to stress is regulated
through negative feedback mechanisms of glucocorticoids at the pituitary, hypothalamus,
hippocampus, and limbic regions (Gillies and McArthur, 2010) (Figure 2).

10

Figure 2: Hypothalamic-pituitary-adrenal axis

The optimal HPA axis response to stress is dynamic, both quickly releasing cortisol and
quickly stopping the action of cortisol. An efficient HPA response prevents peripheral and
central nervous system damage due to prolonged cortisol exposure (Lupien et al., 2005).
Inefficient regulation of the HPA axis and chronic high cortisol exposure is associated with
increased blood pressure, increased risk for diabetes, hypertension, arterial diseases, impaired
growth and tissue repair, and suppressed immune function (Derijk and Sternberg, 1994; Lupien
et al., 2009; Moulton et al., 2015; Munck and Guyre, 1991). Thus, HPA dysregulation is a
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common factor in co-morbid diseases such as depression and cardiovascular disease(Carney and
Freedland, 2003; Chen et al., 2007; Jiang et al., 2002; Joynt et al., 2003; Miller et al., 2002;
Nikkheslat et al., 2015). Chronic cortisol dysregulation may negatively impact a variety of body
systems and may present a general vulnerability factor that contributes to the risk for a number of
diseases including MDD.

1.4.2 Ventral and Dorsal Systems in the Stress Response
The hypothesis that stress system dysfunction is integral to the etiology of MDD is
consistent with neuroanatomical models of MDD that posit mood dysregulation as a result of an
imbalance in functional activity in the ventral and dorsal systems, which are sensitive to cortisol
and show reciprocal activity changes during stress responding (Drevets et al., 2008; Mayberg,
1997; Phillips et al., 2008).
During the healthy stress response activity in the brain shifts from dorsal system mood
regulation to ventral system threat evaluation and management as cognitive resources are
preferentially allocated to automatic processes for responding to threat (Arnsten, 2009).
Enhanced ventral activity results in acute dysphoria which is a normal and necessary component
of the stress response as negative mood motivates managing stressors (Gold, 2015). There are
two regulatory components of the dorsal system; hippocampal activity is automatically enhanced
in response to amygdala activity while frontal activity is recruited through later stage or
voluntary processes (Phillips et al., 2008). In the unstressed state the subgenual PFC inhibits
amygdala activity and consequently attenuates amygdala-driven attention (Gold, 2015). During
stress dorsal system function is down-regulated in favor of automatic, rapid emotional responses
12

in the ventral system. Once dorsal activity is decreased through automatic or voluntary
processes, the amygdala is released from inhibition (Drevets et al., 1997; Simpson et al., 2001).
The amygdala has a central role in both the mood and cognitive response to stress,
through reciprocal projections with dorsal system structures, and in orchestrating endocrine and
autonomic responses through projections to the hypothalamus and central autonomic centers
(Gold, 2015). The release of amygdala inhibition promotes negative mood and cognitive
response to stress and both directly and indirectly (through down-regulation of dorsal region
activity) drives HPA axis and autonomic responses. In a recent expert review Gold posits that an
unregulated feed-forward system decreased dorsal system activity and increased amygdala
activation causes a prolonged dysphoric state and biases cognitive processes towards negative
emotionally valenced information (Gold, 2015).

1.4.3 Stress and Cognition
The changes in ventral and dorsal activity that occur during that normal stress response
result in altered cognitive processing of emotional information including memory (McGaugh,
2004) and attention bias for threatening or negatively valenced stimuli (Arnsten, 2009).
Normally short-term cognitive bias towards negative information serves to efficiently process
and manage stressors, however in a dysregulated stress system persistent cognitive bias may
become established and contribute to cognitive vulnerability for depression.
The organization of the stress system in the brain allows for cognitive alterations in
response to acute cortisol changes. There are two types of receptors for glucocorticoids,
mineralocorticoid receptors (MRs) and glucocorticoid receptors (GRs) (Reul and de Kloet,
13

1985). MRs are expressed exclusively in limbic regions and have much higher affinity for
glucocorticoids (6-10 times) than GRs which are expressed throughout the brain with high
density in frontal regions (Fuxe et al., 1985; Patel et al., 2000; Reul and de Kloet, 1985). Because
of the difference in affinity, MRs are occupied at low glucocorticoid levels while GRs only
become significantly occupied at high glucocorticoid levels. This dynamic ratio of activation
between receptors allows for the effects of acute stress to be mediated mainly through GRs
(Lupien et al., 2005). Basal and acutely elevated glucocorticoid levels have different effects on
brain function via action at MRs or GRs respectively.
In human and rodent studies acute glucocorticoids appear to have a biphasic effect on
cognition with both significantly decreased and increased glucocorticoids impairing memory.
Low to moderate GR activity may benefit memory and cognitive performance while high GR
activity under acute stress has detrimental effects on those domains (Lupien et al., 2002;
Newcomer et al., 1994, 1998, 1999; de Quervain et al., 2000). In both young and older adults
hippocampal function is impaired under high endogenous cortisol paralleling reduced long term
potentiation related to high GR occupation in animal models (Lupien et al., 2005, 2009). These
findings in healthy adults, as well as memory impairment, and hippocampal volume loss in
patients with Cushing’s disease or on cortisol treatments support the “Glucocorticoid cascade
hypothesis” which posits a direct effect of chronic high cortisol on hippocampal integrity
(impaired function and decreased volume) (Sapolsky et al., 1986).
The hippocampus is an important negative feedback site for cortisol and regulator of
HPA axis activity (Herman and Cullinan, 1997; Jankord and Herman, 2008). Glucocorticoid
receptors occupation results in increased hippocampal activity and inhibits HPA axis function;
however this regulatory loop is suppressed during acute stress to maintain the endocrine response
14

(Feldman and Weidenfeld, 1999). Mild acute stress promotes neurogenesis in the dentate gyrus
of the hippocampus and appears to support adaptive responding to stress and the efficient return
to basal HPA axis activity and cortisol levels (Duman and Li, 2012; Ming and Song, 2011).
Blocking hippocampal neurogenesis during acute stress in mice produces depression-like
behavior (Snyder et al., 2011), suggesting that hippocampal adaptation may be an integral
component of the healthy stress response that prevents depressive responding. Additionally,
animal studies suggest a beneficial effect of acute glucocorticoids on hippocampal function,
removing corticosterone impairs hippocampally-mediated memory, and replacing corticosterone
rescues performance (Lupien et al., 2005). However, under chronic stress in rodent models
hippocampal volume and plasticity is reduced (Magariños and McEwen, 1995; Watanabe et al.,
1992), suggesting that chronically elevated glucocorticoids negatively impact the hippocampus.
These alterations in hippocampal structure and function may result in stress system dysregulation
as hippocampal regulation of the HPA axis is reduced. Reduced ability of the hippocampus to
regulate stress responding and modify its activity in response to acute stress may result in stress
system dysregulation.
Prolonged HPA dysregulation may alter the dynamics of MR/ GR activity and modify
the cognitive effects of acute stress. Chronic high cortisol is reduces MR expression in animal
studies and thus results in high GR activation (Herman et al., 1995; Kitraki et al., 1999; Sapolsky
et al., 1986). Lupien’s longitudinal studies in older adults provide evidence that chronically high
cortisol similarly alters the cognitive effects of stress in humans. Older adults with normal,
moderate basal cortisol show a beneficial effect of acute cortisol increase on memory, however
in older adults with high basal cortisol, acutely increased cortisol impairs memory performance,
suggesting that chronic high cortisol reduces the effect of acute cortisol changes in humans
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(Lupien et al., 2005). As MR expression decreases under prolonged HPA dysregulation and GRs
become occupied at lower cortisol levels the cognitive impact of acute stress and chronic high
cortisol may become more pronounced (Lupien et al., 2005).
The acute stress response in the brain is characterized by a shift towards ventral system
activity and away from dorsal system activity. This shift results in dysphoric mood which
motivates behavioral responses to stress and cognitive bias in attention and memory that focus
cognitive resources on managing the stressor. In healthy systems these responses only last as
long as necessary to cope with the stressor. However, dysregulation of the stress response may
result in prolonged dysphoric state and a cognitive bias for negative information followed by
depression. Cognitive and stress-exposure models of MDD are complimentary as altered
cognitive processing of negative emotional information may result from and be maintained by
stress system dysregulation.

1.4.4 Stress Dysregulation in MDD
Altered HPA axis function is common in MDD (Burke et al., 2005; Lupien et al., 2009)
and the onset of depressive episodes is often attributed to stressful life events (Frank et al., 1994;
Kendler et al., 2000, 1999). The association of stress with MDD supports a stress-exposure
model of MDD in which depressive episodes are triggered by stressful events and maladaptive
responding (Hankin et al., 2007; Liu and Alloy, 2010). Individuals with MDD show chronically
elevated cortisol, however, cortisol feedback at the pituitary appears to be intact indicating that
HPA axis dysregulation originates from blunted feedback at the hypothalamus or in higher level
brain systems that regulate HPA axis activity (Holsboer et al., 1984). Evidence that frontal dorsal
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system regions may be less sensitive to HPA axis negative feedback in depression is provided by
reduced cortisol releasing hormone receptor densities in frontal regions in post mortem studies
following suicide (Nemeroff et al., 1988) indicating that. Cortisol releasing hormone levels are
elevated in depressed patients and decrease with successful treatment (Nemeroff et al., 1985;
Widerlöv et al., 1988) again suggesting that MDD is characterized by HPA axis dysregulation
and remission is associated with restored regulation. Chronically altered sensitivity for cortisol
releasing hormone and cortisol may have long-term effects on brain regions that respond to these
hormones.
The alterations in brain structure and function that are found under chronic stress
parallel changes in MDD; patients with MDD show structural changes in brain regions that are
integral to stress responding including decreased subgenual PFC and hippocampal volume and
increased amygdala volume (McKinnon et al., 2009). Dorsal system volume reductions are likely
due to the loss of neuronal and glial cells and diminished dendritic arborization (Drevets et al.,
1997, 2008; Jaako-Movits et al., 2006), while in the amygdala dendritic arborization and spine
density are increased (Drevets, 2003; Price and Drevets, 2012). These changes suggest that
plasticity is reduced in dorsal regions and increased in amygdala which accords with disrupted
dorsal system-amygdala interactions as a mechanism in MDD etiology (Gold, 2015).
Cognitive alterations in MDD also parallel shifts in cognitive resource allocation during
stress responding (Gotlib et al., 2004; Isaac et al., 2014; Suslow et al., 2001), indicating that
dysregulated stress system function may contribute to behavioral changes in MDD. In addition to
the effects of amygdala hyperactivity, altered HPA axis function and reduced negative feedback
by glucocorticoids may contribute to hippocampal atrophy seen in MDD. MDD is associated
with bilateral hippocampal atrophy (8-19%) that appears to have functional significance, as
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individuals with past MDD (currently in remission) continue to show deficits in hippocampallymediated tasks (declarative and verbal memory) (Sheline, 2000). The origin of HPA axis
dysregulation in MDD remains unknown; however the organization of peripheral and brain stress
systems make these systems vulnerable to dysregulation (Gold, 2015). MDD may result from an
initial alteration in stress system function (perhaps through genetic traits or environmental
factors) that is maintained and amplified through the numerous feedback loops and reciprocal
interactions that constitute the stress system.
In a recent expert review, Gold defines MDD as a disease that contributes to “multiple
system pathologies” (Gold, 2015). The organization of the stress system with multiple feed
forward loops to assure successful management of stressors and the mood and cognitive effects
of even acute, well-managed, stress create a system that is vulnerable to dysregulation when
confronted with genetic vulnerability or extreme life stressors. The symptoms that characterize
MDD resemble prolonged unregulated stress responses; once the stress system becomes
dysregulated, feed-forward mechanisms sustain hypercortisolism and enhanced amygdala
function, reinforcing the mood and cognitive consequences of stress system activity (Gold,
2015). Successful MDD treatment likely requires approaches that target multiple mechanisms
that are impacted by stress system activity including promoting neuroplasticity and cognitive
strategies to support adaptive cognitive processes.
Altered HPA function may be especially important in the etiology of MDD in women.
Although there is no difference in the number of stressful life events (Young and Korszun,
2010), or the perception of these events (Burt et al., 1988) between men and women, the cortisol
response to stress does show sex differences, and decreases during high estrogen phases of the
menstrual cycle (Kirschbaum et al., 1992, 1999) and during pregnancy (Altemus, 2006). Also,
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women appear to remain more sensitive than men to lower levels of cortisol following repeated
stressors (Vamvakopoulos, 1995; Wang et al., 2007). These findings provide evidence that
ovarian hormone levels may modulate stress system functioning in women. Estrogen may
support efficient and dynamic stress responding and prevent disrupted ventral-dorsal system
interactions through supporting neuroplasticity in prefrontal areas and hippocampus. Maintaining
function in dorsal system structures preserves regulatory control over ventral activity
(particularly the amygdala) and allows for the efficient return to a non-stressed state. Loss of
dorsal system function may predispose the brain to rely on ventral system processes which bias
attention and memory towards negative information and prolongs emotional, endocrine, and
autonomic stress responding aberrantly. Periods of increased stress sensitivity, due to ovarian
hormone changes, may present windows of vulnerability to mood dysregulation in women who
are at risk for MDD.

1.5 Hypothalamic-Pituitary-Gonadal Axis
Depressive symptoms and depressive episodes in women appear to be linked to ovarian
hormone changes. Women with a history of depression are more likely to experience increased
depressive symptoms during periods of ovarian hormone fluctuation than at other times (Young
and Korszun, 2002). Also a history of MDD increases a woman’s risk for mood disorders that
are directly associated with ovarian hormone changes including premenstrual mood disorder
(Halbreich et al., 1986, 1984), postpartum (Reich and Winokur, 1970) and perimenopausal
depression (Freeman et al., 2014). Even in healthy women, low estrogen phases of the menstrual
cycle are associated with increased symptoms of negative mood (Gonda et al., 2008). Women
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with MDD and reproductive phase-related mood disorders generally have normal ovarian
hormone levels (O’Toole and Rubin, 1995; Schmidt and Rubinow, 2010; Schmidt et al., 1998),
indicating that these disorders aren’t directly contributable to abnormally low estrogen (Young et
al., 2000). While most women do not develop mood disorders as a result of ovarian hormone
changes, the increased risk for first onset depression as estrogen declines during the late
perimenopause (Bromberger et al., 2010; Harsh et al., 2009; Schmidt and Rubinow, 2010), and
the relation of premenstrual dysphoric disorder to the low estrogen phase of the menstrual cycle
(Steiner et al., 2003), suggests that some women are susceptible to mood dysregulation as a
result of normally low estrogen levels. It may be that the role of estrogen in MDD is
characterized by altered brain response to circulating levels rather than differences in estrogen
levels.
The hypothalamic-pituitary-gonadal axis is a multilevel hormonal system that regulates
the secretion of ovarian hormones in females (estrogen and progesterone) through multiple
feedback mechanisms at the ovary, pituitary, and brain (for review see Vadakkadath Meethal and
Atwood, 2005). Gonadotropin releasing hormone (GnRH) from the hypothalamus induces the
release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the anterior
pituitary. LH and FSH modulate the ovarian cycle, with FSH stimulating follicle maturation and
the release of estrogen during the follicular phase and LH triggering ovulation as well as
progesterone release from the corpus luteum (ruptured follicle) during the luteal phase. Estrogen
feedback to the pituitary and hypothalamus controls the release of GnRH, FSH, and LH and this
system of feed forward and feedback mechanisms orchestrates activity within the HPG system
that establishes the menstrual cycle (Figure 3).
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Figure 2: Ovarian Hormones
(A) Hypothalamic-pituitary-gonadal axis in women. (B) The menstrual cycle
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Women experience dramatic changes in cyclic ovarian hormones across the lifespan.
During reproductive life estrogen and progesterone levels fluctuate across the monthly menstrual
cycle. During the early follicular phase and menstruation both estradiol (the main circulating
estrogen in non-pregnant reproductive aged women) and progesterone levels are low. Estradiol
increases in the mid to late follicular phase prior to ovulation. Estradiol levels decrease
immediately following ovulation, and both estradiol and progesterone levels increase during the
luteal phase until menstruation. Outside of the periovulatory phase, progesterone fluctuations
parallel those of estradiol, thus it is difficult to ascertain that separate effects of progesterone in
studies of endogenous ovarian hormones. Progesterone generally appears to antagonize that
effect of estradiol on mood and cognition (Greendale et al., 1998; Resnick et al., 1998; Toren et
al., 1996), however progesterone effect have been much less studied.
The reproductive life phase is both preceded and followed by hypogonadal states prior
to puberty and during menopause. The menopause transition is characterized by irregular ovarian
hormone fluctuations; both estradiol and progesterone levels can vary dramatically during the
early transition period (which may last years), and generally settles into a stable low estradiol
state proximal (within 6 months) to the final menstrual period. This variability in ovarian
hormones during the reproductive years and menopausal transition creates a dynamic
environment for the functioning of mood regulatory and cognitive systems that are influenced by
these hormones.
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1.6 Estrogen in the Brain
Estrogen has a variety of effects at the cellular level including genomic actions,
interaction with second messenger and G-protein systems, effects on calcium signaling, and
neuroprotection (McEwen et al., 2012). Classical nuclear receptors (ERα and ERβ) are liganddependent transcription factors that interact at estrogen response elements on DNA and result in
cascades of intra-cellular reactions which alter protein synthesis (Greene et al., 1986; Kuiper et
al., 1996). These actions are relatively slow, but result in long-lasting changes at the synapse or
in neural function (Luine, 2014). Recently, membrane-bound estrogen receptors have been
discovered that may activate signaling pathways and have rapid effects on the order of seconds
and minutes (Kelly and Levin, 2001; Kelly et al., 2003). These membrane-bound receptors are
found in the prefrontal cortex and hippocampus, and may be responsible the acute effects of
estrogen on cognition (Luine, 2014).
Estrogen modulation of overlapping and interacting systems for stress responding and
emotional and cognitive processing of information provides a number of pathways through
which estrogen fluctuations may contribute to MDD risk. In women with MDD vulnerability,
estrogen may support healthy function of these systems, while having little or opposite effects
for women in whom these systems are already functioning optimally. Periods of low estrogen
may represent windows of risk to depressive episodes in women with a previous history of MDD
because of differential effects of estrogen on mood regulation, stress, and cognitive systems
(Newhouse and Albert, 2015). Understanding the interactions of vulnerability to MDD, stress,
and estrogen will be important for developing more effective prevention and treatments for
women with MDD.
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1.6.1 Estrogen and Emotion Processing
Sex differences in evaluating and responding to emotional information provides a basis
for understanding the effects of ovarian hormones on emotional processing in women. It is
important to note that androgens are aromatized to estrogen in the brain so that men generally
experience constant high estrogen activity in the brain, while women experience fluctuations in
estrogen including periods of low estrogen (Fink et al., 1998). Thus, emotional processing in
men may represent the effects of high estrogen (although interactions with organizational sex
differences must be considered). Accordingly, sex differences in emotional processing are most
apparent when men are compared to women during low estrogen. Neuroimaging studies of
emotion detection or recognition show sex differences in brain regions used during these tasks,
with women showing greater limbic, inferior frontal, and temporal activity and men showing
greater prefrontal and parietal activity (Whittle et al., 2011). It has been suggested that this
difference in activation patterns during emotion recognition may indicate that men and women
perceive emotion at different levels of visual processing (Hall et al., 2004). Greater limbic
activity in women suggests that emotion perception occurs at a primary level, while emotion
perception in men occurs at a secondary level involving the prefrontal areas. This sex difference
in emotion perception may contribute to the speed and accuracy advantage in women (especially
for identifying negative emotions such as fear and anger) (Hampson et al., 2006; Merten, 2005;
Montagne et al., 2005; Thompson and Voyer, 2014), as emotion recognition occurs early in
visual processing, while in men emotion detection requires additional information about the
learned significance of emotional facial expressions (Whittle et al., 2011).
Earlier recognition of negative emotional information in women may influence women’s
ability to regulate emotional responses to such stimuli. Enhanced emotional detection at lower
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levels of processing may represent greater signal driven automatic activity in the ventral system
in women that requires greater top-down modulation to maintain adaptive mood responses.
Earlier detection of emotional information and greater amygdala activity to negative information
in women suggest that emotional evaluative processes in women are predominated by ventral
system activity. Regulation of ventral system activity in women may be particularly important
for healthy mood and supported by estrogen’s action in the dorsal system, while loss of estrogen
may predispose emotional responding through the ventral system.
Generally studies of passive viewing of emotional images or words have found that
women are more reactive to emotional stimuli whether measured through self-report, behavioral
response, physiological response, or neuroimaging (Kret and De Gelder, 2012; Whittle et al.,
2011). The sex difference appears to be specific for negative emotional information, with
consistent findings of greater amygdala activity during negative images or words in women
(regardless of valence or arousal ratings) (Whittle et al., 2011). Sex differences in activation
patterns during encoding and recalling emotional information indicate greater overlap in activity
in brain areas that are involved in processing current emotional experiences and encoding
emotional information into memory in women including limbic, insular and prefrontal regions
(Damasio et al., 2000; George et al., 1996; Piefke et al., 2005). In women this overlap in activity
correlates with subsequent successful memory recall (Canli et al., 2002), suggesting that
differences in memory encoding for emotional information may contribute to better memory for
emotional experiences in women than men. More integrated brain circuits for emotional and
cognitive processes may enhance attention and memory for emotional information and contribute
to a cognitive vulnerability for depression in women.
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Sex differences in emotion processing and responding are modulated by ovarian
hormone fluctuations, indicating that these processes and vulnerability to mood dysregulation
may be influenced by circulating ovarian hormones. Sex differences in emotion recognition
(Hampson et al., 2006) are reduced during high estrogen in women (Derntl et al., 2008),
suggesting that estrogen enhances emotional processing through higher-level association
pathways and may support healthy mood responding to emotional information. High estrogen
levels reduce ventral activity (Derntl et al., 2008; Goldstein et al., 2005; Pearson and Lewis,
2005) Fluctuating ovarian hormones in women alter the perception of emotionally valenced
information and the mood and cognitive responses to such information. In healthy women these
changes may be experienced as the “normal” mood changes that accompany periods of low
estrogen, however in a subset of vulnerable women they may contribute to increased depression
risk. Although studies demonstrate that estrogen attenuates emotional processing and supports
mood regulation in healthy women, the effects of estrogen in women with current or remitted
MDD, in whom ventral-dorsal interactions are likely altered, remain unclear.
1.6.2 Estrogen and Cognition
In addition to the putative indirect effects through emotional processing, estrogen may
directly modulate cognitive processes that are altered in MDD (Halbreich et al., 1995). Cognitive
declines in a number of cognitive domains including attention an processing speed following
menopause are greater than would be expected from the effects of age alone (Halbreich et al.,
1995 b), indicating that estrogen has positive effects on cognition that diminish as estradiol
declines in menopause. Consistent findings of cognitive decline and increased risk for dementia
in women who undergo early menopause, and thus experience a greater period of life with low
ovarian hormone levels, further supports a negative impact of estrogen loss beyond the effects of
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age in older women (Farrag et al., 2002; Nappi et al., 1999; Rocca et al., 2008). In meta-analyses
estrogen replacement generally benefits cognition in young postmenopausal women (Hogervorst
and Bandelow, 2010; Maki, 2005) and following oophorectomy (Bove et al., 2014; Phillips and
Sherwin, 1992; Rocca et al., 2008; Sherwin, 1988; Sherwin and Gelfand, 1985), while combined
estrogen and progestin treatments have little or negative effect Hogervorst and Bandelow, 2010)
indicating that estrogen withdraw at menopause is a significant factor in cognitive decline with
age in women (for review see: Maki and Dumas, 2009; Newhouse and Dumas, 2015; Sherwin
and Henry, 2008).
Studies examining the effects of estrogen fluctuation across the menstrual cycle indicate
that performance on tasks that rely on the hippocampus and prefrontal cortex are enhanced
during high estradiol phases of the menstrual cycle (Sundström, Poromaa, and Gingnell, 2014)
including cognitive control, response inhibition (Colzato et al., 2010, 2012), and verbal
(Rosenberg and Park, 2002) and spatial memory (Hampson and Morley, 2013). Suppression of
estradiol in young women causes reductions in blood flow and metabolism to frontal regions
which are restored with estradiol administration (Berman et al., 1997), demonstrating that even
acute and short-term changes in estrogen may impact dorsal region function (Craig and Murphy,
2007).
Estrogen’s effects at the amygdala and hippocampus may alter processing and
subsequent memory for emotionally valenced information. Memory for emotional information is
enhanced during menstrual phases when estradiol is low and progesterone is high (Ertman et al.,
2012). Of note is that memory is not only enhanced for the emotional content, but also for
peripheral information (Nielsen et al., 2013), indicating that low estradiol may enhance
attentional vigilance for emotional information and more strongly associate previously neutral
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information with emotional information. This linking of neutral and emotional information in
memory may underlie spontaneous intrusive recollections in PTSD or rumination in depression.
Intrusive recollections are more common for traumatic events that occur during low estradiol/
high progesterone phases of the menstrual cycle (Bryant et al., 2011; Ferree and Cahill, 2009;
Ferree et al., 2011), suggesting that ovarian hormone effects on memory may contribute to
maladaptive cognitive processes following psychosocial stress. Further evidence that estradiol
levels and menstrual phase impact memory processes for emotional information is provided by a
series of studies by Milad and colleagues which demonstrated that extinction of fear conditioning
is greater during high estradiol phases of the menstrual cycle and even after acute exogenous
estradiol administration (Milad et al., 2006, 2010; Zeidan et al., 2011). Whereas low estrogen or
high progesterone appear to enhance emotional processing and memory for negative information,
high estradiol supports top-down modulation of cognitive processes and may restrain ventral
participation in attention and memory.

1.7 Potential Mechanisms of Estrogen’s Role in MDD
Acting at nuclear and membrane-associated receptors allows estrogen to have both rapid
and long-term effects on neuronal function, as well as varied modes of action in brain regions
that are important for emotional and cognitive processes. There are a number of mechanisms
through which ovarian hormones may affect brain function; including modulating
neurotransmitter system functions and neurotrophic effects that promote neuronal plasticity
(Rubinow and Schmidt, 1995, 2006; Schmidt and Rubinow, 2010). Estrogen interactions with
and modulation of serotoninergic and cholinergic neurotransmitter systems have particular
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relevance as putative mechanisms that intersect with estrogen’s support of dorsal regulatory
system function.

1.7.1 Neurotransmitter Systems
Commonly used antidepressant medications alter synaptic levels of the monoamines
serotonin and norepinephrine or alter receptors for these neurotransmitters (Stahl, 1998). The
effectiveness of these treatments accord with the monoamine hypothesis of MDD that altered
levels of serotonin or norepinephrine underlay the etiology of depression (Schildkraut, 1973;
Schildkraut et al., 1969). Norepinephrine from the locus ceruleus has projections to frontal and
limbic regions (Moore and Bloom, 1979) and appears to participate in a number of stress system
feedback loops with effect on arousal and sympathetic activity (Gold, 2015). There is some
evidence that estrogen increases central norepinephrine levels (Etgen and Karkanias, 1994) and
that the reduction of hot flashes following hormone replacement in menopausal women may be
due to estrogen’s effect on norepinephrine (Archer et al., 2011). However, estrogennorepinephrine interactions and the role of these effects in depression has been little studied
(Borrow and Cameron, 2014; Genazzani et al., 2005). The effects of estrogen on the serotonergic
system has been more studied and is one of the strongest candidate mechanisms by which
estrogen influences depression (Borrow and Cameron, 2014)
Studies using tryptophan depletion (which decreases central serotonin) demonstrate that
lower serotonin levels are more likely to precipitate depressive symptoms in women than in men
(Booij et al., 2002; Ellenbogen et al., 1996; Moreno et al., 2006), however this sex difference
was not seen following norepinephrine depletion (Moreno et al., 2006), suggesting that serotonin
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dysfunction may be of particular importance to MDD in women. The antidepressant and SSRI
augmentative effects of estrogen in women also suggest that estrogen may have beneficial mood
effects through action on the serotonergic system (Halbreich et al., 1995a). In animal models,
ovariectomy reduces and estrogen add-back increases serotonin receptors in the dorsal raphe
nucleus (Sumner and Fink, 1993), anterior frontal, and cingulate regions (Sumner and Fink,
1995). This experimental finding is paralleled by an increased density of serotonin receptors in
the forebrains of female rats during natural pro-estrus when endogenous estrogen levels are high
(Sumner and Fink, 1997). Further evidence that the presence of estrogen alters serotonin function
in the brain arises from studies of androgens in male animals. Testosterone, but not nonaromatizable androgens, in male animals increase serotonin receptor density (Sumner and Fink,
1998) suggesting that the effects of testosterone on serotonin function are mediated through
aromatization of testosterone to estrogen.
In women, serotonin responsivity is reduced after menopause and restored following
estrogen treatment (Halbreich et al., 1995b). While studies of estrogen alone as an antidepressant
agent in peri and postmenopausal depression have had inconsistent findings (Cohen et al., 2003;
Morrison et al., 2004; Rasgon et al., 2001; Schmidt et al., 2000; Soares et al., 2001; Stahl, 2001),
estrogen-serotonin interactions may impact depressive symptoms or vulnerability to MDD
through the cognitive and mood regulatory functions of the serotonergic system. Tryptophan
depletion impairs the consolidation of episodic memory (Mendelsohn et al., 2009), reduces
activity in brain areas important to the encoding of memory (hippocampus) (van der Veen et al.,
2006), and induces negative memory and attentional bias (Delgado et al., 1989; Roiser et al.,
2008) and difficulty with autobiographical memory (Haddad et al., 2009; Hayward et al., 2005)
in remitted depressed individuals. These cognitive changes under reduced serotonin support the
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hypothesis that diminished serotonin function may contribute to cognitive mechanisms of
depression, such as preferential processing of and memory for negative information. Epperson
and colleagues have shown that estrogen treatment reduces the effects on tryptophan depletion
on brain activity during both verbal working memory and emotion recognition tasks, suggesting
that estrogen supports serotonergic cognitive function (Epperson et al., 2012).
Tryptophan depletion generally has little mood effect in healthy individuals (Young,
2013) however, mood effects are common in individuals with remitted MDD or family histories
of MDD (Booij et al., 2003; Ruhé et al., 2007; Young and Leyton, 2002). Increased risk for
mood dysregulation during periods of low estrogen may be due to the loss of estrogen support of
the serotonergic system (Halbreich et al., 1995b) or indirect effects on shared pathways (Schmidt
and Rubinow, 2010).
Estrogen’s pro-cognitive effects may be mediated though interactions with the
cholinergic system which is critical for global cognitive function, including primary processes
such as attention and memory which underlie higher order cognition. Loss of cholinergic
function appears to be one of the primary mechanisms of cognitive change in pathological aging,
particularly the memory detriments seen in Alzheimer’s disease (AD) (Grothe et al., 2015;
Iraizoz et al., 1999; Schliebs and Arendt, 2006; Whitehouse et al., 1982). Cholinergic function
modulates both bottom-up and top-down attentional processes, and is thus involved in cognitive
processes that require the differentiation of relevant and irrelevant information and the efficient
allocation of attentional resources (Gibbs, 2010; Sarter and Bruno, 1997; Sarter et al., 2003).
In animal models ovariectomy produces poor performance on learning and memory
tasks paralleled by a decline in cholinergic activity and choline acetyltransferase levels in several
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brain regions including basal forebrain neurons projecting to the hippocampus (Gibbs, 2010;
Luine and Rodriguez, 1994; O’Malley et al., 1987) and treatment with estrogen replacement
restores these markers (Gibbs, 2000; Luine, 1985). Estrogen replacement in ovariectomized
animals counteracts the negative effects of cholinergic antagonists on spatial learning and
memory (Gibbs, 2000a; Luine, 1985). Studies in postmenopausal women similarly demonstrate
that estrogen replacement protects against impaired verbal working memory, episodic memory,
learning, and attention following cholinergic antagonism (Dumas et al., 2006, 2008, 2012).
However the beneficial effect of estrogen is only seen in animals with relatively intact
cholinergic systems (Gibbs, 2002, 2007), suggesting that estrogen modulates cholinergic
function rather than acting through a separate parallel mechanism. Estrogen’s support of
cholinergic function may essentially increase cognitive resources and maintain dorsal regulation
of emotional cognition.

1.7.2 Estrogen Effects in the Dorsal Regulatory System
The amygdala has reciprocal interactions with the prefrontal cortex and hippocampus,
such that amygdala activity suppresses activity in dorsal regions. During the healthy stress
response these reciprocal interactions allow for quick evaluation and response to stressors,
however these feed-forward systems may become dysregulated; reduced dorsal activity releases
amygdala inhibition and may have long-term negative effects on dorsal region structure and
function (Gold, 2015). Loss of estrogen support for dorsal system functioning may contribute to
this dysregulation and thus increase depression risk in vulnerable women.
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The hippocampus is uniquely situated at the intersection of cognitive, emotional, and
endocrine circuits and thus may have a particularly central role in vulnerability to MDD.
Hippocampal structure appears to be sensitive to depression history; a meta-analysis of imaging
studies in depression found that reduced hippocampal volume is a consistent finding in
individuals with MDD (Videbech and Ravnkilde, 2004). Furthermore, hippocampal volume
reduction is associated with depression recurrence with smaller volume in individuals with more
past episodes (Sheline et al., 1996) and longer illness duration (Colla et al., 2007). Whether
smaller hippocampal volume is the result of depression or rather a marker of vulnerability due to
developmental differences (Lupien et al., 2007) remains unclear, however the association
between depression history and hippocampal structure accords with the hippocampus as a central
component of overlapping networks for endocrine regulation, emotion, and cognitive processes
that are integral to MDD etiology.
Estrogen may support adaptive mood regulation through effects on hippocampal
functioning and neuronal plasticity. Estrogen has been shown to increase the density of dendritic
spines on CA1 pyramidal neurons (especially following neuronal damage or estrogen loss
(McEwen et al., 1995; Woolley, 1999; Woolley and McEwen, 1992) ), and estrogen receptor
antagonists block this effect (McEwen et al., 1999). Estrogen receptor localization to the plasma
membrane in dendritic shafts and spines (McEwen et al., 1995; Woolley and McEwen, 1992)
suggest that estrogen may have local effects on plasticity in the hippocampus. The presence of
estrogen appears to prime the neuron for new synapse creation through an increase in dendritic
spines, however these new spines are only maintained following synapse activation (Woolley,
1998, 2000; Woolley and McEwen, 1992; Woolley et al., 1997) ; estrogen does not globally
increase hippocampus synapses, but supports the production and maintenance of synapses that
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are used. Additionally, estrogen treatment protects hippocampal synapses from the detrimental
effects of acute cortisol increases (Ooishi et al., 2012). Paralleling to these structural changes,
estrogen replacement in animal models improves performance on cognitive tasks that are
hippocampally mediated (Gibbs, 2000b; Inagaki et al., 2010; Luine and Rodriguez, 1994).
Similarly, cognitive performances changes across the menstrual cycle and with estrogen
replacement in postmenopausal women suggest that ovarian hormones have specific effects on
cognitive tasks that rely on hippocampal function.
Estrogen receptor density in the hippocampus responds dynamically to ovarian
hormone changes; increasing in dendritic spines during low estrogen phases of the estrous cycle
and decreasing during high estrogen phases (McEwen et al., 2012). These changes in ER density
may be part of a coping mechanism that maintains stable hippocampal function across estrogen
fluctuations. A deficit in this dynamic response to estrogen changes may be associated with
increased vulnerability to mood and anxiety disorders in some women.
Estrogen has similar effects on cholinergic and serotonergic functioning that may
converge in the dorsal system that are supported by these neurotransmitter systems. In
postmenopausal women, estradiol treatment prevents anticholinergic impairment in memory and
attention tasks (Dumas et al., 2006, 2008, 2012), indicating that estrogen’s support of cholinergic
function benefits prefrontal and hippocampal function. Similarly, estrogen replacement in
postmenopausal women increases serotonin tone in the hippocampus (Compton et al., 2008),
prefrontal cortex, and anterior cingulate, paralleled by improvements in tasks of executive
function and verbal memory (Kugaya et al., 2003). Estrogen’s effects in the prefrontal cortex
may modulate executive function thus having global implications for cognition and emotional
response regulation. Neuroimaging studies examining the effects of estrogen replacement in
34

postmenopausal women show that estrogen replacement enhances hippocampal and prefrontal
activity during tasks in which estrogen treatment improves performance (episodic memory and
working memory encoding) (Joffe et al., 2006; Maki and Resnick, 2000; Resnick et al., 1998;
Shaywitz et al., 1999). Additionally, ovarian hormone suppression in young women impairs
executive function and cognitive flexibility and decreases metabolism in prefrontal, temporal,
and parietal regions (Berman et al., 1997). Enhanced function in these dorsal system regions may
support higher order cognitive resources and decrease automatic emotional processing or provide
better top-down regulation of emotional responses.

1.8 Introduction to Current work
Although the sex difference in MDD and concurrence of ovarian hormone fluctuation
with increased risk for mood disorders in women suggest that estrogen may have a significant
role in MDD, how estrogen influences depression vulnerability is not clear. Perhaps estrogen’s
role in MDD can be best understood through examining estrogen’s role in emotional and
cognitive processes that are integral to healthy mood. MDD is characterized by dysfunction in
mood regulation and endocrine responses to stress and negative emotional information. These
core symptoms are indicative of altered function in proposed systems for emotional evaluation
and response (ventral system) and regulation of emotional and cognitive processes (dorsal
system).
The ventral and dorsal systems are interconnected and work to manage acute responses
to environmental stimuli and coordinate long-term cognitive consequences through attention and
memory. As detailed in Gold’s model, dysphoric mood is a natural and healthy response to
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stress, however the ability to efficiently return to normal ventral-dorsal system dynamics and
euthymic mood confers resilience (Gold, 2015). Healthy stress responses acutely bias stimuli
processing towards automatic ventral evaluation and response pathways. Consistent findings of
endocrine dysregulation in the HPA axis and the relation of stressful life event to depressive
episodes indicate that in MDD stress system function is dysregulated with possible consequences
for cognitive processing of emotional information. When information must be evaluated quickly,
such as during stress, altered brain networks in MDD may be prone to ventral activity, resulting
in enhanced attention and cognitive processing of negative information along with dysphoric
mood. According to cognitive models of MDD, these alterations remain during remission and
contribute to continued recurrence risk, especially following psychosocial stress.
Evidence of estrogen’s positive effects on both cognitive and emotional processes in
dorsal system structures indicates that estrogen supports healthy functioning in dorsal regions
(particularly hippocampus and prefrontal cortex). Estrogen’s effect of enhancing dorsal system
function may attenuate ventral system activity or allow dorsal system regions to regain
regulatory function more efficiently. Conversely, low estradiol reproductive phases in women
and loss of estrogen support of dorsal systems may predispose brain activity to ventral system
automatic processing. Sex differences in emotion recognition suggest that women recognize and
respond to emotional information at earlier stages in visual processing, before modulation by
dorsal system and integration with associative information. Loss of estrogen support for dorsal
systems may bias emotional processing to these lower-level automatic systems predominated by
amygdala activity and enhance the salience of negative emotional information, thus increasing
depression risk in vulnerable women.
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The general aim of this dissertation was to investigate the role of estrogen in the
cognitive and emotional processes that are associated with depression to better understand the
greater prevalence of MDD in women. Previous studies indicate that in healthy young women
endocrine response to physical and psychosocial stress is altered across that menstrual cycle and
by hormonal contraception. However, the neural processes that are associated with psychosocial
stress responding and the effects of estrogen on brain systems that are involved in emotional and
cognitive responses to psychosocial stress in women have not been examined. Additionally,
whether estrogen’s effects on endocrine response to stress are related to mood response to stress
has not been investigated. In Chapter 2 of this dissertation, the effect of menstrual phase and
estradiol level on the neural and mood response to psychosocial stress in young, normally
cycling women was investigated. We hypothesized that high estradiol around ovulation reduces
negative mood response and dorsal system deactivation during psychosocial stress compared to
low estradiol during the early follicular phase around menstruation.
Cognitive models of MDD posit that altered cognitive processing of emotional
information maintains negative mood in depressive episodes and confers recurrence risk during
remission. Attention and memory bias for negative information is a consistent finding in studies
of currently depressed individuals. Attention bias and the postulated relation to enhanced
amygdala activity that remains in remitted MDD has been less studied. In Chapter 3 the effect of
MDD history on neural response and attention to emotionally valenced images was investigated.
We hypothesized that women with a history of MDD would show enhanced amygdala activity
and attentional bias for negative image compared to women with no history of MDD.
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1.9 Magnetic Resonance Imaging Methodology
Magnetic resonance imaging (MRI) produces images of biologic tissue through the use
of strong magnetic fields (for review see Huettel, et al. 2009). Because the body has a high water
content (50-60% by weight), MRI is commonly implemented to detect and measure signals
based on the properties of hydrogen nuclei (protons) in magnetic fields. Hydrogen protons have a
positive electric charge that creates a small magnetic field as they spin. These magnetic fields are
normally randomly directed and thus the net magnetization is nearly zero. In MRI a strong
magnetic field tuned to the frequency of hydrogen protons induces alignment of the magnetic
spins and increases the net magnetization of hydrogen protons in the body. Once the magnetic
spins of the hydrogen protons are aligned, energy can be applied to the system and the release of
that energy as the system returns to a lower energy state can be measured to provide information
about biologic tissues.
For both structural and function MRI, radio frequency pulses are applied to the target
tissue (for the purposes of the following studies that target will be the brain). Radio frequency
applied to the brain perturbs the equilibrium state created by the static field and the energy from
these pulses are absorbed by hydrogen protons. Hydrogen protons release the radio frequency
energy and realign with the static magnetic field; the release of this energy can be detected and
defines the raw MRI signal.
The time that it takes for proton spins to realign with the static magnetic field is unique
to each tissue type because of local magnetic field inhomogeneities. The difference in energy
released over time between tissues allows for the detection of tissue types in structural MRI.
Local magnetic properties are also disturbed by difference in blood oxygenation in and near
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tissue. These local disruptions in magnetic field affect the time to return to alignment with the
static field and are the basis for blood oxygen level-dependent (BOLD) imaging used in function
MRI (fMRI). In areas of increased neural activity blood flow increases to supply oxygen for
aerobic metabolism. Blood flow to active areas is increased beyond the need for oxygen so that
areas of increased activity have higher levels of oxygenated blood relative to less active areas.
Deoxygenated hemoglobin has unbound electrons in the iron within the heme group and is thus
diagmagnetic. Because of the diamagnetic properties of deoxygenated hemoglobin, realignment
of hydrogen protons with the static field occurs faster in less active than more active areas.
Measuring radio frequency energy released at a time lag after realignment by less active areas
but before realignment by more active areas allows for the identification of areas of increased
neural activity.
These imaging techniques are combined with carefully designed tasks for task-related
fMRI which identifies areas of the brain that are presumed to be active during particular brain
functions or cognitive processes. Resting fMRI is used to identify functional connectivity
between brain regions and networks. During resting fMRI BOLD imaging is implemented
without the participant explicitly performing a task. Spontaneous activity is measured and the
activity in different brain regions is analyzed for correlated time courses which are interpreted as
integrated function between regions.

39

References for Comprehensive Literature Review
Adli, M., Bauer, M., and Rush, A.J. (2006). Algorithms and collaborative-care systems for
depression: are they effective and why? A systematic review. Biological Psychiatry 59,
1029–1038.
Altemus, M. (2006). Sex differences in depression and anxiety disorders: potential biological
determinants. Hormones and Behavior 50, 534–538.
American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders
(5th ed.) (Washington, DC: American Psychiatric Association).
Archer, D.F., Sturdee, D.W., Baber, R., de Villiers, T.J., Pines, A., Freedman, R.R., Gompel,
A., Hickey, M., Hunter, M.S., Lobo, R.A., et al. (2011). Menopausal hot flushes and
night sweats: where are we now? Climacteric 14, 515–528.
Armstrong, T., and Olatunji, B.O. (2013). Eye tracking of attention in the affective disorders: a
meta-analytic review and synthesis. Clinical Psychology Review 32, 704–723.
Arnone, D., McKie, S., Elliott, R., Thomas, E.J., Downey, D., Juhasz, G., Williams, S.R.,
Deakin, J.F., and Anderson, I.M. (2012). Increased amygdala responses to sad but not
fearful faces in major depression: relation to mood state and pharmacological treatment.
The American Journal of Psychiatry 169, 841–850.
Arnsten, A.F. (2009). Stress signalling pathways that impair prefrontal cortex structure and
function. Nature Reviews Neuroscience 10, 410–422.
Beck, A.T., and Haigh, E.A. (2014). Advances in cognitive theory and therapy: the generic
cognitive model. Clincal Psychology 10, 1–24.
40

Berman, K.F., Schmidt, P.J., Rubinow, D.R., Danaceau, M.A., Van Horn, J.D., Esposito, G.,
Ostrem, J.L., and Weinberger, D.R. (1997). Modulation of cognition-specific cortical
activity by gonadal steroids: a positron-emission tomography study in women.
Proceedings of the National Academy of Sciences 94, 8836–8841.
Bishop, S.J., Duncan, J., and Lawrence, A.D. (2004). State anxiety modulation of the amygdala
response to unattended threat-related stimuli. The Journal of Neuroscience 24, 10364–
10368.
Booij, L., Van der Does, W., Benkelfat, C., Bremner, J.D., Cowen, P.J., Fava, M., Gillin, C.,
Leyton, M., Moore, P., Smith, K.A., et al. (2002). Predictors of mood response to acute
tryptophan depletion. A reanalysis. Neuropsychopharmacology 27, 852–861.
Booij, L., Van der Does, A.J., and Riedel, W.J. (2003). Monoamine depletion in psychiatric and
healthy populations: review. Molecular Psychiatry 8, 951–973.
Borrow, A.P., and Cameron, N.M. (2014). Estrogenic mediation of serotonergic and
neurotrophic systems: implications for female mood disorders. Progress in NeuroPsychopharmacology & Biological Psychiatry 54, 13–25.
Bove, R, Secor, E, Chibnik, L.B., and Barnes, L.L. (2014). Age at surgical menopause
influences cognitive decline and Alzheimer pathology in older women. Neurology 82,
222–229.
Bromberger, J.T., Schott, L.L., Kravitz, H.M., Sowers, M., Avis, N.E., Gold, E.B., Randolph,
J.F., and Matthews, K.A. (2010). Longitudinal change in reproductive hormones and
depressive symptoms across the menopausal transition: results from the Study of

41

Women’s Health Across the Nation (SWAN). Archives of General Psychiatry 67, 598–
607.
Brundtland, G.H. (2001). From the World Health Organization. Mental health: new
understanding, new hope. JAMA 286, 2391.
Bryant, R.A., Felmingham, K.L., Silove, D., Creamer, M., O’Donnell, M., and McFarlane, A.C.
(2011). The association between menstrual cycle and traumatic memories. Journal of
Affective Disorders 131, 398–401.
Burt, C.E., Cohen, L.H., and Bjorck, J.P. (1988). Perceived family environment as a moderator
of young adolescents’ life stress adjustment. American Journal of Community
Psychology 16, 101–122.
Canli, T., Desmond, J.E., Zhao, Z., and Gabrieli, J.D. (2002). Sex differences in the neural basis
of emotional memories. Proceedings of the National Academy of Sciences 99, 10789–
10794.
Carney, R.M., and Freedland, K.E. (2003). Depression, mortality, and medical morbidity in
patients with coronary heart disease. Biological Psychiatry 54, 241–247.
Chen, P., Kales, H.C., Weintraub, D., Blow, F.C., Jiang, L., and Mellow, A.M. (2007).
Antidepressant treatment of veterans with Parkinson’s disease and depression: analysis of
a national sample. Journal of Geriatric Psychiatry and Neurology 20, 161–165.
Chrousos, G.P., and Gold, P.W. (1992). The concepts of stress and stress system disorders.
Overview of physical and behavioral homeostasis. JAMA 267, 1244–1252.

42

Chun, M.M., and Turk-Browne, N.B. (2007). Interactions between attention and memory.
Current Opinion in Neurobiology 17, 177–184.
Cohen, L.S., Soares, C.N., Poitras, J.R., Prouty, J., Alexander, A.B., and Shifren, J.L. (2003).
Short-term use of estradiol for depression in perimenopausal and postmenopausal
women: a preliminary report. The American Journal of Psychiatry 160, 1519–1522.
Colla, M., Kronenberg, G., Deuschle, M., Meichel, K., Hagen, T., Bohrer, M., and Heuser, I.
(2007). Hippocampal volume reduction and HPA-system activity in major depression.
Journal of Psychiatric Research 41, 553–560.
Colzato, L.S., Hertsig, G., van den Wildenberg, W.P., and Hommel, B. (2010). Estrogen
modulates inhibitory control in healthy human females: evidence from the stop-signal
paradigm. Neuroscience 167, 709–715.
Colzato, L.S., Pratt, J., and Hommel, B. (2012). Estrogen modulates inhibition of return in
healthy human females. Neuropsychologia 50, 98–103.
Compton, J., Travis, M.J., Norbury, R., Erlandsson, K., van Amelsvoort, T., Daly, E.,
Waddington, W., Matthiasson, P., Eersels, J.L., Whitehead, M., et al. (2008). Long-term
estrogen therapy and 5-HT (2A) receptor binding in postmenopausal women; a single
photon emission tomography (SPET) study. Hormones and Behavior 53, 61–68.
Cornwell, B.R., Alvarez, R.P., Lissek, S., Kaplan, R., Ernst, M., and Grillon, C. (2011). Anxiety
overrides the blocking effects of high perceptual load on amygdala reactivity to threatrelated distractors. Neuropsychologia 49, 1363–1368.

43

Craig, M.C., and Murphy, D.G. (2007). Estrogen: effects on normal brain function and
neuropsychiatric disorders. Climacteric 10, 97–104.
Damasio, AR, Grabowski, TJ, and Bechara, A. (2000). Subcortical and cortical brain activity
during the feeling of self-generated emotions. Nature 10, 1049-56.
Delgado, P.L., Charney, D.S., Price, L.H., Landis, H., and Heninger, G.R. (1989).
Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy
subjects. Life Sciences 45, 2323–2332.
Dent, J., and Teasdale, J.D. (1988). Negative cognition and the persistence of depression.
Journal of Abnormal Psychology 97, 29–34.
Derijk, R., and Sternberg, E.M. (1994). Corticosteroid Action and Neuroendocrine‐Immune
Interactions. Annals of the New York Academy of Science 746, 33–41.
Derntl, B, Windischberger, C, and Robinson, S (2008). Facial emotion recognition and
amygdala activation are associated with menstrual cycle phase.
Psychoneuroendocrinology 32, 704–723.
Disner, S.G., Beevers, C.G., Haigh, E.A., and Beck, A.T. (2011). Neural mechanisms of the
cognitive model of depression. Nature Reviews Neuroscience 12, 467–477.
Drevets, W.C. (2003). Neuroimaging abnormalities in the amygdala in mood disorders. Annals
of the New York Academy of Sciences 985, 420–444.
Drevets, W.C., Price, J.L., Simpson, J.R., Todd, R.D., Reich, T., Vannier, M., and Raichle,
M.E. (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386,
824–827.
44

Drevets, W.C., Price, J.L., Bardgett, M.E., Reich, T., Todd, R.D., and Raichle, M.E. (2002).
Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype
and plasma cortisol levels. Pharmacology, Biochemistry, and Behavior 71, 431–447.
Drevets, W.C., Price, J.L., and Furey, M.L. (2008). Brain structural and functional
abnormalities in mood disorders: implications for neurocircuitry models of depression.
Brain Structure and Function 213, 93–118.
Duman, R.S., and Li, N. (2012). A neurotrophic hypothesis of depression: role of
synaptogenesis in the actions of NMDA receptor antagonists. Philosophical Transactions
of the Royal Society of London. Series B, Biological Sciences 367, 2475–2484.
Dumas, J., Hancur-Bucci, C., Naylor, M., Sites, C., and Newhouse, P. (2006). Estrogen
treatment effects on anticholinergic-induced cognitive dysfunction in normal
postmenopausal women. Neuropsychopharmacology 31, 2065–2078.
Dumas, J., Hancur-Bucci, C., Naylor, M., Sites, C., and Newhouse, P. (2008). Estradiol
interacts with the cholinergic system to affect verbal memory in postmenopausal women:
evidence for the critical period hypothesis. Hormones and Behavior 53, 159–169.
Dumas, J., Kutz, A.M., Naylor, M.R., Johnson, J.V., and Newhouse, P.A. (2012). Estradiol
treatment altered anticholinergic-related brain activation during working memory in
postmenopausal women. Neuroimage 60, 1394–1403.
Egeth, H.E., and Yantis, S. (1997). Visual attention: control, representation, and time course.
Annual Review of Psychology 48, 269–297.

45

Ellenbogen, M.A., Young, S.N., Dean, P., Palmour, R.M., and Benkelfat, C. (1996). Mood
response to acute tryptophan depletion in healthy volunteers: sex differences and
temporal stability. Neuropsychopharmacology 15, 465–474.
Epperson, C.N., Amin, Z., Ruparel, K., Gur, R., and Loughead, J. (2012). Interactive effects of
estrogen and serotonin on brain activation during working memory and affective
processing in menopausal women. Psychoneuroendocrinology 37, 372–382.
Erk, S., Mikschl, A., Stier, S., Ciaramidaro, A., Gapp, V., Weber, B., and Walter, H. (2010).
Acute and Sustained Effects of Cognitive Emotion Regulation in Major Depression. The
Journal of Neuroscience 30, 15726–15734.
Ertman, N., Andreano, J.M., and Cahill, L. (2012). Progesterone at encoding predicts
subsequent emotional memory. Learning & Memory 18, 759–763.
Etgen, A.M., and Karkanias, G.B. (1994). Estrogen regulation of noradrenergic signaling in the
hypothalamus. Psychoneuroendocrinology 19, 603–610.
Fader, A.J., Hendricson, A.W., and Dohanich, G.P. (1998). Estrogen improves performance of
reinforced T-maze alternation and prevents the amnestic effects of scopolamine
administered systemically or intrahippocampally. Neurobiology of Learning and Memory
69, 225–240.
Fader, A.J., Johnson, P.E., and Dohanich, G.P. (1999). Estrogen improves working but not
reference memory and prevents amnestic effects of scopolamine of a radial-arm maze.
Pharmacology, Biochemistry, and Behavior 62, 711–717.

46

Farrag, A.F., Khedr, E.M., Abdel-Aleem, H., and Rageh, T.A. (2002). Effect of surgical
menopause on cognitive functions. Dementia and Geriatric Cognitive Disorders 13, 193–
198.
Feldman, S., and Weidenfeld, J. (1999). Glucocorticoid receptor antagonists in the hippocampus
modify the negative feedback following neural stimuli. Brain Research 821, 33–37.
Ferree, and Cahill (2009). Post-event spontaneous intrusive recollections and strength of
memory for emotional events in men and women. Consciousness and Cognition 18,12634.
Ferree, Kamat, and Cahill (2011). Influences of menstrual cycle position and sex hormone
levels on spontaneous intrusive recollections following emotional stimuli. Consciousness
and Cognition 20:4, 1154–1162.
Fink, G., Sumner, B., Rosie, R., Grace, O., and Quinn, J. (1995). Estrogen control of central
neurotransmission: Effect on mood, mental state, and memory. Cellular and Molecular
Neurobiology 16, 325–344.
Fink, G., Sumner, B.E., McQueen, J.K., Wilson, H., and Rosie, R. (1998). Sex steroid control of
mood, mental state and memory. Clinical and Experimental Pharmacology & Physiology
25, 764–775.
Freeman, E.W., Sammel, M.D., Boorman, D.W., and Zhang, R. (2014). Longitudinal pattern of
depressive symptoms around natural menopause. JAMA Psychiatry 71, 36–43.
Fuxe, K., Härfstrand, A., Agnati, L.F., Yu, Z.Y., Cintra, A., Wikström, A.C., Okret, S., Cantoni,
E., and Gustafsson, J.A. (1985). Immunocytochemical studies on the localization of
47

glucocorticoid receptor immunoreactive nerve cells in the lower brain stem and spinal
cord of the male rat using a monoclonal antibody against rat liver glucocorticoid receptor.
Neuroscience Letters 60, 1–6.
Gaddy, M., and Ingram, R. (2014). A meta-analytic review of mood-congruent implicit memory
in depressed mood. Clinical Psychology Review 34, 402416.
Genazzani, A.R., Bernardi, F., Pluchino, N., Begliuomini, S., Lenzi, E., Casarosa, E., and Luisi,
M. (2005). Endocrinology of menopausal transition and its brain implications. CNS
Spectrums 10, 449–457.
George, MS, Ketter, TA, Parekh, PI, and Herscovitch, P (1996). Gender differences in regional
cerebral blood flow during transient self-induced sadness or happiness. Biological
Psychiatry 1, 859-71.
Gibbs, R.B. (2000a). Effects of gonadal hormone replacement on measures of basal forebrain
cholinergic function. Neuroscience 101, 931–938.
Gibbs, R.B. (2000b). Estrogen replacement enhances acquisition of a spatial memory task and
reduces deficits associated with hippocampal muscarinic receptor inhibition. Hormones
and Behavior 36, 222–233.
Gibbs, R.B. (2002). Basal forebrain cholinergic neurons are necessary for estrogen to enhance
acquisition of a delayed matching-to-position T-maze task. Hormones and Behavior 42,
245–257.

48

Gibbs, R.B. (2007). Estradiol enhances DMP acquisition via a mechanism not mediated by
turning strategy but which requires intact basal forebrain cholinergic projections.
Hormones and Behavior 52, 352–359.
Gibbs, R.B. (2010). Estrogen therapy and cognition: a review of the cholinergic hypothesis.
Endocrine Reviews 31, 224–253.
Gillies, G., and McArthur, S. (2010). Estrogen Actions in the Brain and the Basis for
Differential Action in Men and Women: A Case for Sex-Specific Medicines.
Pharmacological Reviews 62, 155-98.
Glue, P., Donovan, M., Kolluri, S., and Emir, B. (2010). Meta-analysis of relapse prevention
antidepressant trials in depressive disorders. Australian and New Zealand Journal of
Psychiatry 44, 697–705.
Gold, P.W. (2015). The organization of the stress system and its dysregulation in depressive
illness. Molecular Psychiatry 20, 32–47.
Goldstein, J.M., Jerram, M., Poldrack, R., Ahern, T., Kennedy, D.N., Seidman, L.J., and
Makris, N. (2005). Hormonal cycle modulates arousal circuitry in women using
functional magnetic resonance imaging. The Journal of Neuroscience 25, 9309–9316.
Gonda, X., Telek, T., Juhász, G., Lazary, J., Vargha, A., and Bagdy, G. (2008). Patterns of
mood changes throughout the reproductive cycle in healthy women without premenstrual
dysphoric disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry 32,
1782–1788.

49

Gotlib, I., and Joormann, J. (2010). Cognition and Depression: Current Status and Future
Directions. Clinical Psychology 6, 285–312.
Gotlib, I.H., Krasnoperova, E., Yue, D.N., and Joormann, J. (2004). Attentional biases for
negative interpersonal stimuli in clinical depression. Journal of Abnormal Psychology
113, 121–135.
Greendale, G.A., Reboussin, B.A., Hogan, P., Barnabei, V.M., Shumaker, S., Johnson, S., and
Barrett-Connor, E. (1998). Symptom relief and side effects of postmenopausal hormones:
results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstetrics and
Gynecology 92, 982–988.
Greene, G.L., Gilna, P., Waterfield, M., Baker, A., Hort, Y., and Shine, J. (1986). Sequence and
expression of human estrogen receptor complementary DNA. Science 231, 1150–1154.
Grothe, M.J., Heinsen, H., Amaro, E., Grinberg, L.T., and Teipel, S.J. (2015). Cognitive
Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild
Cognitive Impairment. Cerebral Cortex 48, 413-421.
Haddad, A., Williams, M., McTavish, S., and Harmer, C. (2009). Low-dose tryptophan
depletion in recovered depressed women induces impairments in autobiographical
memory specificity. Psychopharmacology 207, 499-508.
Halbreich, U., Lumley, L.A., Palter, S., Manning, C., Gengo, F., and Joe, S.H. (1995a). Possible
acceleration of age effects on cognition following menopause. Journal of Psychiatric
Research 29, 153–163.

50

Halbreich, U., Rojansky, N., Palter, S., Tworek, H., Hissin, P., and Wang, K. (1995b). Estrogen
augments serotonergic activity in postmenopausal women. Biological Psychiatry 37,
434–441.
Hall, G., Witelson, SF, Szechtman, H, and Nahmias, C (2004). Sex differences in functional
activation patterns revealed by increased emotion processing demands. Neuroreport 9,
219-23.
Hallion, L., and Ruscio, A. (2011). A meta-analysis of the effect of cognitive bias modification
on anxiety and depression. Psychological Bulletin 137, 940–958.
Hammen, C. (1991). Generation of stress in the course of unipolar depression. Journal of
Abnormal Psychology 100, 555–561.
Hampson, E., and Morley, E.E. (2013). Estradiol concentrations and working memory
performance in women of reproductive age. Psychoneuroendocrinology 38.
Hampson, E., Anders, S., and Mullin, L. (2006). A female advantage in the recognition of
emotional facial expressions: Test of an evolutionary hypothesis. Evolution and Human
Behavior 27, 401–416.
Hankin, B.L., Mermelstein, R., and Roesch, L. (2007). Sex differences in adolescent depression:
stress exposure and reactivity models. Child Development 78, 279–295.
Hardeveld, F., Spijker, J., and Graaf, D.R. (2010). Prevalence and predictors of recurrence of
major depressive disorder in the adult population. Acta Psychiatrica Scandinavica 122,
184–191.

51

Harsh, V., Meltzer-Brody, S., Rubinow, D.R., and Schmidt, P.J. (2009). Reproductive aging,
sex steroids, and mood disorders. Harvard Review of Psychiatry 17, 87–102.
Hayward, G., Goodwin, G.M., Cowen, P.J., and Harmer, C.J. (2005). Low-dose tryptophan
depletion in recovered depressed patients induces changes in cognitive processing
without depressive symptoms. Biological Psychiatry 57, 517–524.
Herman, J.P., and Cullinan, W.E. (1997). Neurocircuitry of stress: central control of the
hypothalamo-pituitary-adrenocortical axis. Trends in Neurosciences 20, 78–84.
Herman, J.P., Adams, D., and Prewitt, C. (1995). Regulatory changes in neuroendocrine stressintegrative circuitry produced by a variable stress paradigm. Neuroendocrinology 61,
180–190.
Hogervorst, E., and Bandelow, S. (2010). Sex steroids to maintain cognitive function in women
after the menopause: a meta-analyses of treatment trials. Maturitas 66, 56–71.
Holsboer, F., Von Bardeleben, U., Gerken, A., Stalla, G.K., and Müller, O.A. (1984). Blunted
corticotropin and normal cortisol response to human corticotropin-releasing factor in
depression. The New England Journal of Medicine 311, 1127.
Holtmann, J., Herbort, M.C., and Wüstenberg, T. (2013). Trait anxiety modulates fronto-limbic
processing of emotional interference in borderline personality disorder. Frontiers in
Human Neuroscience 7.
Huettel, S. A., Song, A. W., and McCarthy, G. (2009). Functional magnetic resonance imaging.
Sunderland, Mass: Sinauer Associates

52

Inagaki, T., Gautreaux, C., and Luine, V. (2010). Acute estrogen treatment facilitates
recognition memory consolidation and alters monoamine levels in memory-related brain
areas. Hormones and Behavior 58, 415–426.
Iraizoz, I., Guijarro, J.L., Gonzalo, L.M., and de Lacalle, S. (1999). Neuropathological changes
in the nucleus basalis correlate with clinical measures of dementia. Acta
Neuropathologica 98, 186–196.
Isaac, L., Vrijsen, J.N., Rinck, M., Speckens, A., and Becker, E.S. (2014). Shorter gaze duration
for happy faces in current but not remitted depression: evidence from eye movements.
Psychiatry Research 218, 79–86.
Jaako-Movits, K., Zharkovsky, T., Pedersen, M., and Zharkovsky, A. (2006). Decreased
hippocampal neurogenesis following olfactory bulbectomy is reversed by repeated
citalopram administration. Cellular and Molecular Neurobiology 26, 1559–1570.
Jankord, R., and Herman, J.P. (2008). Limbic regulation of hypothalamo-pituitaryadrenocortical function during acute and chronic stress. Annals of the New York
Academy of Sciences 1148, 64–73.
Jiang, W., Krishnan, R.R., and O’Connor, C.M. (2002). Depression and heart disease: evidence
of a link, and its therapeutic implications. CNS Drugs 16, 111–127.
Joffe, H., Hall, J.E., Gruber, S., Sarmiento, I.A., Cohen, L.S., Yurgelun-Todd, D., and Martin,
K.A. (2006). Estrogen therapy selectively enhances prefrontal cognitive processes: a
randomized, double-blind, placebo-controlled study with functional magnetic resonance

53

imaging in perimenopausal and recently postmenopausal women. Menopause 13, 411–
422.
Johnson, E.O., Kamilaris, T.C., Chrousos, G.P., and Gold, P.W. (1992). Mechanisms of stress: a
dynamic overview of hormonal and behavioral homeostasis. Neuroscience and
Biobehavioral Reviews 16, 115–130.
Joynt, K.E., Whellan, D.J., and O’Connor, C.M. (2003). Depression and cardiovascular disease:
mechanisms of interaction. Biological Psychiatry 54, 248–261.
Kelly, M.J., and Levin, E.R. (2001). Rapid actions of plasma membrane estrogen receptors.
Trends in Endocrinology and Metabolism 12, 152–156.
Kelly, M.J., Qiu, J., and Rønnekleiv, O.K. (2003). Estrogen modulation of G-protein-coupled
receptor activation of potassium channels in the central nervous system. Annals of the
New York Academy of Sciences 1007, 6–16.
Kessler, R., McGonagle, K., Nelson, C., Hughes, M., Swartz, M., and Blazer, D. (1994). Sex
and depression in the National Comorbidity Survey. II: Cohort effects. Journal of
Affective Disorders 30, 15–26.
Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., Rush, J.A.,
Walters, E.E., and Wang, P.S. (2003). The Epidemiology of Major Depressive Disorder:
Results From the National Comorbidity Survey Replication (NCS-R). JAMA 289, 3095–
3105.

54

Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R., and Walters, E.E. (2005a).
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National
Comorbidity Survey Replication. Archives of General Psychiatry 62, 593–602.
Kessler, R.C., Chiu, W.T., Demler, O., Merikangas, K.R., and Walters, E.E. (2005b).
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National
Comorbidity Survey Replication. Archives of General Psychiatry 62, 617–627.
Kirschbaum, C., Wüst, S., and Hellhammer, D. (1992). Consistent sex differences in cortisol
responses to psychological stress. Psychosomatic Medicine 54, 648–657.
Kirschbaum, C., Kudielka, B.M., Gaab, J., Schommer, N.C., and Hellhammer, D.H. (1999).
Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the
hypothalamus-pituitary-adrenal axis. Psychosomatic Medicine 61, 154–162.
Kitraki, E., Karandrea, D., and Kittas, C. (1999). Long-lasting effects of stress on glucocorticoid
receptor gene expression in the rat brain. Neuroendocrinology 69, 331–338.
Kret, M., and De Gelder, B. (2012). A review on sex differences in processing emotional
signals. Neuropsychologia 50, 1211–1221.
Kugaya, A., Epperson, C.N., Zoghbi, S., van Dyck, C.H., Hou, Y., Fujita, M., Staley, J.K.,
Garg, P.K., Seibyl, J.P., and Innis, R.B. (2003). Increase in prefrontal cortex serotonin 2A
receptors following estrogen treatment in postmenopausal women. The American Journal
of Psychiatry 160, 1522–1524.

55

Kuiper, G.G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J.A. (1996). Cloning
of a novel receptor expressed in rat prostate and ovary. Proceedings of the National
Academy of Sciences 93, 5925–5930.
Lee, R.S., Hermens, D.F., Porter, M.A., and Redoblado-Hodge, M.A. (2012). A meta-analysis
of cognitive deficits in first-episode Major Depressive Disorder. Journal of Affective
Disorders 140, 113–124.
Liu, R.T., and Alloy, L.B. (2010). Stress generation in depression: A systematic review of the
empirical literature and recommendations for future study. Clinical Psychology Review
30, 582–593.
Luine, V.N. (1985). Estradiol increases choline acetyltransferase activity in specific basal
forebrain nuclei and projection areas of female rats. Experimental Neurology 89, 484–
490.
Luine, V.N. (2014). Estradiol and cognitive function: Past, present and future. Hormones and
Behavior 66, 602-618.
Luine, V., and Rodriguez, M. (1994). Effects of estradiol on radial arm maze performance of
young and aged rats. Behavioral and Neural Biology 62, 230–236.
Lupien, S.J., Wilkinson, C.W., Brière, S., Ng Ying Kin, N.M., Meaney, M.J., and Nair, N.P.
(2002). Acute modulation of aged human memory by pharmacological manipulation of
glucocorticoids. The Journal of Clinical Endocrinology and Metabolism 87, 3798–3807.

56

Lupien, S.J., Fiocco, A., Wan, N., Maheu, F., Lord, C., Schramek, T., and Tu, M.T. (2005).
Stress hormones and human memory function across the lifespan.
Psychoneuroendocrinology 30, 225–242.
Lupien, S.J., Evans, A., Lord, C., Miles, J., Pruessner, M., Pike, B., and Pruessner, J.C. (2007).
Hippocampal volume is as variable in young as in older adults: implications for the
notion of hippocampal atrophy in humans. NeuroImage 34, 479–485.
Lupien, S.J., McEwen, B.S., Gunnar, M.R., and Heim, C. (2009). Effects of stress throughout
the lifespan on the brain, behaviour and cognition. Nature Reviews Neuroscience 10,
434–445.
Magariños, A.M., and McEwen, B.S. (1995). Stress-induced atrophy of apical dendrites of
hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory
amino acid receptors. Neuroscience 69, 89–98.
Maki, P.M. (2005). A systematic review of clinical trials of hormone therapy on cognitive
function: effects of age at initiation and progestin use. Annals of the New York Academy
of Sciences 1052, 182–197.
Maki, P.M., and Dumas, J. (2009). Mechanisms of action of estrogen in the brain: insights from
human neuroimaging and psychopharmacologic studies. Seminars in Reproductive
Medicine 27, 250–259.
Maki, P.M., and Resnick, S.M. (2000). Longitudinal effects of estrogen replacement therapy on
PET cerebral blood flow and cognition. Neurobiology of Aging 21, 373–383.

57

Van Marle, H.J., Hermans, E.J., Qin, S., and Fernández, G. (2009). From specificity to
sensitivity: how acute stress affects amygdala processing of biologically salient stimuli.
Biological Psychiatry 66, 649–655.
Mayberg, H.S. (1997). Limbic-cortical dysregulation: a proposed model of depression. The
Journal of Neuropsychiatry and Clinical Neurosciences 9, 471–481.
McEwen, B.S., Gould, E., Orchinik, M., Weiland, N.G., and Woolley, C.S. (1995). Oestrogens
and the structural and functional plasticity of neurons: implications for memory, ageing
and neurodegenerative processes. Ciba Foundation Symposium 191 - Non-Reproductive
Actions of Sex Steroids 191, 52–66; discussion 66–73.
McEwen, B.S., Tanapat, P., and Weiland, N.G. (1999). Inhibition of dendritic spine induction
on hippocampal CA1 pyramidal neurons by a nonsteroidal estrogen antagonist in female
rats. Endocrinology 140, 1044–1047.
McEwen, B.S., Akama, K.T., and Spencer-Segal, J.L. (2012). Estrogen effects on the brain:
actions beyond the hypothalamus via novel mechanisms. Behavioral Neuroscience 126,
4–16.
McGaugh, J.L. (2004). The amygdala modulates the consolidation of memories of emotionally
arousing experiences. Annual Review of Neuroscience 27, 1–28.
McHugo, M., Olatunji, B.O., and Zald, D.H. (2013). The emotional attentional blink: what we
know so far. Frontiers in Human Neuroscience 7.

58

McKinnon, M.C., Yucel, K., Nazarov, A., and MacQueen, G.M. (2009). A meta-analysis
examining clinical predictors of hippocampal volume in patients with major depressive
disorder. Journal of Psychiatry & Neuroscience 34, 41–54.
Mendelsohn, D., Riedel, W.J., and Sambeth, A. (2009). Effects of acute tryptophan depletion on
memory, attention and executive functions: a systematic review. Neuroscience and
Biobehavioral Reviews 33, 926–952.
Merten, J. (2005). Culture, gender and the recognition of the basic emotions. Psychologia 48,
306–316.
Milad, Goldstein, Orr, and Wedig (2006). Fear conditioning and extinction: influence of sex and
menstrual cycle in healthy humans. Behavioral Neuroscience 120, 1196-203.
Milad, M.R., Zeidan, M.A., Contero, A., Pitman, R.K., Klibanski, A., Rauch, S.L., and
Goldstein, J.M. (2010). The influence of gonadal hormones on conditioned fear
extinction in healthy humans. Neuroscience 168, 652–658.
Miller, G.E., Stetler, C.A., Carney, R.M., Freedland, K.E., and Banks, W.A. (2002). Clinical
depression and inflammatory risk markers for coronary heart disease. The American
Journal of Cardiology 90, 1279–1283.
Ming, G.L., and Song, H. (2011). Adult neurogenesis in the mammalian brain: significant
answers and significant questions. Neuron 70, 687–702.
Mohanty, A., and Sussman, T.J. (2013). Top-down modulation of attention by emotion.
Frontiers in Human Neuroscience 7, 102.

59

Monroe, S.M., and Harkness, K.L. (2005). Life stress, the “kindling” hypothesis, and the
recurrence of depression: considerations from a life stress perspective. Psychological
Review 112, 417–445.
Montagne, B., Kessels, R.P., Frigerio, E., de Haan, E.H., and Perrett, D.I. (2005). Sex
differences in the perception of affective facial expressions: do men really lack emotional
sensitivity? Cognitive Processing 6, 136–141.
Moore, R.Y., and Bloom, F.E. (1979). Central catecholamine neuron systems: anatomy and
physiology of the norepinephrine and epinephrine systems. Annual Review of
Neuroscience 2, 113–168.
Moreno, F.A., McGahuey, C.A., Freeman, M.P., and Delgado, P.L. (2006). Sex differences in
depressive response during monoamine depletions in remitted depressive subjects. The
Journal of Clinical Psychiatry 67, 1618–1623.
Morrison, M.F., Kallan, M.J., Ten Have, T., Katz, I., Tweedy, K., and Battistini, M. (2004).
Lack of efficacy of estradiol for depression in postmenopausal women: a randomized,
controlled trial. Biological Psychiatry 55, 406–412.
Moulton, C.D., Pickup, J.C., and Ismail, K. (2015). The link between depression and diabetes:
the search for shared mechanisms. The Lancet. Diabetes & Endocrinology 3, 461–471.
Munck, A., and Guyre, P.M. (1991). Glucocorticoids and immune function.
Psychoneuroimmunology 2, 447–474.

60

Murray, C., Atkinson, C., Bhalla, K., Birbeck, G., Burstein, R., Chou, D., Dellavalle, R.,
Danaei, G., Ezzati, M., Fahimi, A., et al. (2013). The State of US Health, 1990-2010:
Burden of Diseases, Injuries, and Risk Factors. JAMA 310, 591–606.
Nappi, RE, Sinforiani, E, Mauri, M, and Bono, G (1999). Memory functioning at menopause:
impact of age in ovariectomized women. Gynecologic and Obstetric Investigation 47, 2936.
Nemeroff, C.B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C.D.,
Loosen, P.T., and Vale, W. (1985). Elevated concentrations of CSF corticotropinreleasing factor-like immunoreactivity in depressed patients. Science 226, 1342–1344.
Nemeroff, C.B., Owens, M.J., Bissette, G., Andorn, A.C., and Stanley, M. (1988). Reduced
corticotropin releasing factor binding sites in the frontal cortex of suicide victims.
Archives of General Psychiatry 45, 577–579.
Newcomer, J.W., Craft, S., Hershey, T., Askins, K., and Bardgett, M.E. (1994). Glucocorticoidinduced impairment in declarative memory performance in adult humans. The Journal of
Neuroscience 14, 2047–2053.
Newcomer, J.W., Craft, S., Askins, K., Hershey, T., Bardgett, M.E., Csernansky, J.G.,
Gagliardi, A.E., and Vogler, G. (1998). Glucocorticoid interactions with memory
function in schizophrenia. Psychoneuroendocrinology 23, 65–72.
Newcomer, J.W., Selke, G., Melson, A.K., Hershey, T., Craft, S., Richards, K., and Alderson,
A.L. (1999). Decreased memory performance in healthy humans induced by stress-level
cortisol treatment. Archives of General Psychiatry 56, 527–533.

61

Newhouse, P., and Albert, K. (2015). Estrogen, Stress, and Depression: A Neurocognitive
Model. JAMA Psychiatry 72, 727–729.
Newhouse, P., and Dumas, J. (2015). Estrogen-cholinergic interactions: Implications for
cognitive aging. Hormones and Behavior. Advance online publication. doi:
10.1016/j.yhbeh.2015.06.022.
Nielsen, S.E., Ahmed, I., and Cahill, L. (2013). Sex and menstrual cycle phase at encoding
influence emotional memory for gist and detail. Neurobiology of Learning and Memory
106, 56–65.
Nikkheslat, N., Zunszain, P.A., Horowitz, M.A., Barbosa, I.G., Parker, J.A., Myint, A.M.,
Schwarz, M.J., Tylee, A.T., Carvalho, L.A., and Pariante, C.M. (2015). Insufficient
glucocorticoid signaling and elevated inflammation in coronary heart disease patients
with comorbid depression. Brain, Behavior, and Immunity 48, 8–18.
Oestergaard, S., and Møldrup, C. (2011). Improving outcomes for patients with depression by
enhancing antidepressant therapy with non-pharmacological interventions: a systematic
review of reviews. Public Health 125, 357–367.
Ooishi, Y., Mukai, H., Hojo, Y., Murakami, G., Hasegawa, Y., Shindo, T., Morrison, J.H.,
Kimoto, T., and Kawato, S. (2012). Estradiol rapidly rescues synaptic transmission from
corticosterone-induced suppression via synaptic/extranuclear steroid receptors in the
hippocampus. Cerebral Cortex 22, 926–936.

62

O’Malley, C.A., Hautamaki, R.D., Kelley, M., and Meyer, E.M. (1987). Effects of ovariectomy
and estradiol benzoate on high affinity choline uptake, ACh synthesis, and release from
rat cerebral cortical synaptosomes. Brain Research 403, 389–392.
O’Toole, S.M., and Rubin, R.T. (1995). Neuroendocrine aspects of primary endogenous
depression--XIV. Gonadotropin secretion in female patients and their matched controls.
Psychoneuroendocrinology 20, 603–612.
Patel, P.D., Lopez, J.F., Lyons, D.M., Burke, S., Wallace, M., and Schatzberg, A.F. (2000).
Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey
brain. Journal of Psychiatric Research 34, 383–392.
Pearson, R., and Lewis, M.B. (2005). Fear recognition across the menstrual cycle. Hormones
and Behavior 47, 267–271.
Peers, P.V., Simons, J.S., and Lawrence, A.D. (2013). Prefrontal control of attention to threat.
Frontiers in Human Neuroscience 7, 24.
Phillips, S.M., and Sherwin, B.B. (1992). Effects of estrogen on memory function in surgically
menopausal women. Psychoneuroendocrinology 17, 485–495.
Phillips, M.L., Drevets, W.C., Rauch, S.L., and Lane, R. (2003). Neurobiology of emotion
perception II: Implications for major psychiatric disorders. Biological Psychiatry 54,
515–528.
Phillips, M.L., Ladouceur, C.D., and Drevets, W.C. (2008). A neural model of voluntary and
automatic emotion regulation: implications for understanding the pathophysiology and
neurodevelopment of bipolar disorder. Molecular Psychiatry 13, 829, 833–857.
63

Piefke, M, Weiss, PH, and Markowitsch, HJ (2005). Gender differences in the functional
neuroanatomy of emotional episodic autobiographical memory. Human Brain 4, 313-24.
Pourtois, G., Schettino, A., and Vuilleumier, P. (2013). Brain mechanisms for emotional
influences on perception and attention: what is magic and what is not. Biological
Psychology 92, 492–512.
Price, J.L., and Drevets, W.C. (2012). Neural circuits underlying the pathophysiology of mood
disorders. Trends in Cognitive Sciences 16, 61–71.
De Quervain, D.J., Roozendaal, B., Nitsch, R.M., McGaugh, J.L., and Hock, C. (2000). Acute
cortisone administration impairs retrieval of long-term declarative memory in humans.
Nature Neuroscience 3, 313–314.
Raedt, R., and Koster, E. (2010). Understanding vulnerability for depression from a cognitive
neuroscience perspective: A reappraisal of attentional factors and a new conceptual
framework. Cognitive, Affective, & Behavioral Neuroscience 10, 50–70.
Rasgon, N.L., Altshuler, L.L., and Fairbanks, L. (2001). Estrogen-replacement therapy for
depression. The American Journal of Psychiatry 158, 1738.
Reich, T., and Winokur, G. (1970). Postpartum psychoses in patients with manic depressive
disease. The Journal of Nervous and Mental Disease 151, 60–68.
Resnick, S.M., Maki, P.M., Golski, S., Kraut, M.A., and Zonderman, A.B. (1998). Effects of
estrogen replacement therapy on PET cerebral blood flow and neuropsychological
performance. Hormones and Behavior 34, 171–182.

64

Reul, J.M., and de Kloet, E.R. (1985). Two receptor systems for corticosterone in rat brain:
microdistribution and differential occupation. Endocrinology 117, 2505–2511.
Rocca, WA, Bower, JH, and Maraganore, DM (2008). Increased risk of cognitive impairment or
dementia in women who underwent oophorectomy before menopause. Neurology 69,
1074-83.
Roiser, J.P., Levy, J., Fromm, S.J., Wang, H., Hasler, G., Sahakian, B.J., and Drevets, W.C.
(2008). The effect of acute tryptophan depletion on the neural correlates of emotional
processing in healthy volunteers. Neuropsychopharmacology 33, 1992–2006.
Rosenberg, L., and Park, S. (2002). Verbal and spatial functions across the menstrual cycle in
healthy young women. Psychoneuroendocrinology 27, 835–841.
Rubinow, D.R., and Schmidt, P.J. (1995). The neuroendocrinology of menstrual cycle mood
disorders. Annals of the New York Academy of Sciences 771, 648–659.
Rubinow, D.R., and Schmidt, P.J. (2006). Gonadal steroid regulation of mood: the lessons of
premenstrual syndrome. Frontiers in Neuroendocrinology 27, 210–216.
Ruhé, H.G., Mason, N.S., and Schene, A.H. (2007). Mood is indirectly related to serotonin,
norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion
studies. Molecular Psychiatry 12, 331–359.
Sanchez, A., Vazquez, C., Marker, C., LeMoult, J., and Joormann, J. (2013). Attentional
disengagement predicts stress recovery in depression: an eye-tracking study. Journal of
Abnormal Psychology 122, 303–313.

65

Sapolsky, Krey, and McEwen (1986). The Neuroendocrinology of Stress and Aging: The
Glucocorticoid Cascade Hypothesis. Endocrine Reviews 7, 284301.
Sarter, M, and Bruno, JP (1997). Cognitive functions of cortical acetylcholine: toward a
unifying hypothesis. Brain Research Reviews 23, 28-46.
Sarter, M, Bruno, J.P., and Givens, B (2003). Attentional functions of cortical cholinergic
inputs: what does it mean for learning and memory? Neurobiology of Learning and
Memory 8, 245–256.
Savitz, J.B., and Drevets, W.C. (2009). Imaging phenotypes of major depressive disorder:
genetic correlates. Neuroscience 164, 300–330.
Schildkraut, J.J. (1973). Neuropharmacology of the affective disorders. Annual Review of
Pharmacology 13, 427–454.
Schildkraut, J.J., Schanberg, S.M., Kopin, I.J., and Durell, J. (1969). Affective disorders and
norepinephrine pharmacology. International Psychiatry Clinics 6, 83–141.
Schiller, C.E., Meltzer-Brody, S., and Rubinow, D.R. (2015). The role of reproductive
hormones in postpartum depression. CNS Spectrums 20, 48–59.
Schliebs, R., and Arendt, T. (2006). The significance of the cholinergic system in the brain
during aging and in Alzheimer’s disease. Journal of Neural Transmission 113, 1625–
1644.
Schmidt, P.J., and Rubinow, D.R. (2010). Sex hormones and mood in the perimenopause.
Annals of the New York Academy of Sciences 1179, 70–85.

66

Schmidt, P.J., Nieman, L.K., Danaceau, M.A., Adams, L.F., and Rubinow, D.R. (1998).
Differential behavioral effects of gonadal steroids in women with and in those without
premenstrual syndrome. The New England Journal of Medicine 338, 209–216.
Schmidt, P.J., Nieman, L., Danaceau, M.A., Tobin, M.B., Roca, C.A., Murphy, J.H., and
Rubinow, D.R. (2000). Estrogen replacement in perimenopause-related depression: a
preliminary report. American Journal of Obstetrics and Gynecology 183, 414–420.
Sears, C., Newman, K., Ference, J., and Thomas, C. (2011). Attention to Emotional Images in
Previously Depressed Individuals: An Eye-Tracking Study. Cognitive Therapy and
Research 35, 517–528.
Shackman, A.J., Maxwell, J.S., McMenamin, B.W., Greischar, L.L., and Davidson, R.J. (2011).
Stress potentiates early and attenuates late stages of visual processing. The Journal of
Neuroscience 31, 1156–1161.
Shaywitz, S.E., Shaywitz, B.A., Pugh, K.R., Fulbright, R.K., Skudlarski, P., Mencl, W.E.,
Constable, R.T., Naftolin, F., Palter, S.F., Marchione, K.E., et al. (1999). Effect of
estrogen on brain activation patterns in postmenopausal women during working memory
tasks. JAMA 281, 1197–1202.
Sheline, Y. (2000). 3D MRI studies of neuroanatomic changes in unipolar major depression: the
role of stress and medical comorbidity. Biological Psychiatry 15, 791–8000.
Sheline, Wang, Gado, Csernansky, and Vannier (1996). Hippocampal atrophy in recurrent
major depression. Proceedings of the National Academy of Sciences 93, 3908-3913.

67

Sherwin, B.B. (1988). Affective changes with estrogen and androgen replacement therapy in
surgically menopausal women. Journal of Affective Disorders 14, 177–187.
Sherwin, B.B., and Gelfand, M.M. (1985). Sex steroids and affect in the surgical menopause: a
double-blind, cross-over study. Psychoneuroendocrinology 10, 325–335.
Sherwin, B.B., and Henry, J.F. (2008). Brain aging modulates the neuroprotective effects of
estrogen on selective aspects of cognition in women: a critical review. Frontiers in
Neuroendocrinology 29, 88–113.
Snyder, j S., Soumier, A., Brewer, M., Pickel, J., and Cameron, H.A. (2011). Adult
hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 476,
458–461.
Soares, C.N., Almeida, O.P., Joffe, H., and Cohen, L.S. (2001). Efficacy of estradiol for the
treatment of depressive disorders in perimenopausal women: a double-blind, randomized,
placebo-controlled trial. Archives of General Psychiatry 58, 529–534.
Stahl, S.M. (1998). Basic psychopharmacology of antidepressants, part 2: Estrogen as an
adjunct to antidepressant treatment. The Journal of Clinical Psychiatry 59, 15–24.
Stahl, S.M. (2001). Effects of estrogen on the central nervous system. The Journal of Clinical
Psychiatry 62, 317–318.
Steiner, M., Dunn, E., and Born, L. (2003). Hormones and mood: from menarche to menopause
and beyond. Journal of Affective Disorders 74, 67–83.
Sternberg, E.M., Chrousos, G.P., Wilder, R.L., and Gold, P.W. (1992). The stress response and
the regulation of inflammatory disease. Annals of Internal Medicine 117, 854–866.
68

Stokes, P.E. (1995). The potential role of excessive cortisol induced by HPA hyperfunction in
the pathogenesis of depression. European Neuropsychopharmacology 5 Suppl, 77–82.
Stollstorff, M., Munakata, Y., Jensen, A.P., Guild, R.M., Smolker, H.R., Devaney, J.M., and
Banich, M.T. (2013). Individual differences in emotion-cognition interactions: emotional
valence interacts with serotonin transporter genotype to influence brain systems involved
in emotional reactivity and cognitive control. Frontiers in Human Neuroscience 7.
Substance Abuse and Mental Health Services Administration, (2013). Results from the 2012
National Survey on Drug Use and Health: Summary of National Findings, NSDUH
Series H-48, HHS Publication No. (SMA) 14-4863.
Sumner, B.E., and Fink, G. (1993). Effects of acute estradiol on 5-hydroxytryptamine and
dopamine receptor subtype mRNA expression in female rat brain. Molecular and Cellular
Neurosciences 4, 83–92.
Sumner, B.E., and Fink, G. (1995). Estrogen increases the density of 5-hydroxytryptamine (2A)
receptors in cerebral cortex and nucleus accumbens in the female rat. The Journal of
Steroid Biochemistry and Molecular Biology 54, 15–20.
Sumner, B.E., and Fink, G. (1997). The density of 5-hydoxytryptamine2A receptors in forebrain
is increased at pro-oestrus in intact female rats. Neuroscience Letters 234, 7–10.
Sumner, B.E., and Fink, G. (1998). Testosterone as well as estrogen increases serotonin2A
receptor mRNA and binding site densities in the male rat brain. Brain Research.
Molecular Brain Research 59, 205–214.

69

Sundström Poromaa, I., and Gingnell, M. (2014). Menstrual cycle influence on cognitive
function and emotion processing-from a reproductive perspective. Frontiers in
Neuroscience 8, 380.
Suslow, T., Junghanns, K., and Arolt, V. (2001). Detection of facial expressions of emotions in
depression. Perceptual and Motor Skills 92, 857–868.
Thompson, A.E., and Voyer, D. (2014). Sex differences in the ability to recognise non-verbal
displays of emotion: a meta-analysis. Cognition & Emotion 28, 1164–1195.
Toren, P., Dor, J., Rehavi, M., and Weizman, A. (1996). Hypothalamic-pituitary-ovarian axis
and mood. Biological Psychiatry 40, 1051–1055.
Trivedi, M.H., Rush, J.A., Wisniewski, S.R., Nierenberg, A.A., Warden, D., Ritz, L., Norquist,
G., Howland, R.H., Lebowitz, B., and McGrath, P.J. (2006). Evaluation of outcomes with
citalopram for depression using measurement-based care in STAR* D: implications for
clinical practice. American Journal of Psychiatry 163, 28–40.
Vadakkadath Meethal, S., and Atwood, C.S. (2005). The role of hypothalamic-pituitary-gonadal
hormones in the normal structure and functioning of the brain. Cellular and Molecular
Life Sciences 62, 257–270.
Vamvakopoulos, N.V. (1995). Sexual dimorphism of stress response and immune/
inflammatory reaction: the corticotropin releasing hormone perspective. Mediators of
Inflammation 4, 163–174.

70

Van der Veen, F.M., Evers, E.A., van Deursen, J.A., Deutz, N.E., Backes, W.H., and Schmitt,
J.A. (2006). Acute tryptophan depletion reduces activation in the right hippocampus
during encoding in an episodic memory task. Neuroimage 31, 1188–1196.
Videbech, P., and Ravnkilde, B. (2004). Hippocampal volume and depression: a meta-analysis
of MRI studies. The American Journal of Psychiatry 161, 1957–1966.
Vogel, E.K., and Luck, S.J. (2000). The visual N1 component as an index of a discrimination
process. Psychophysiology 37, 190–203.
Wang, J., Korczykowski, M., Rao, H., Fan, Y., Pluta, J., Gur, R.C., McEwen, B.S., and Detre,
J.A. (2007). Gender difference in neural response to psychological stress. Social
Cognitive and Affective Neuroscience 2, 227–239.
Watanabe, Y., Gould, E., and McEwen, B.S. (1992). Stress induces atrophy of apical dendrites
of hippocampal CA3 pyramidal neurons. Brain Research 588, 341–345.
Whitehouse, P.J., Price, D.L., Struble, R.G., and Clark, A.W. (1982). Alzheimer’s disease and
senile dementia: loss of neurons in the basal forebrain. Science 215, 1237–1239.
Whittle, S., Yücel, M., Yap, M.B., and Allen, N.B. (2011). Sex differences in the neural
correlates of emotion: evidence from neuroimaging. Biological Psychology 87, 319–333.
Widerlöv, E., Bissette, G., and Nemeroff, C.B. (1988). Monoamine metabolites, corticotropin
releasing factor and somatostatin as CSF markers in depressed patients. Journal of
Affective Disorders 14, 99–107.
Woolley, C.S. (1998). Estrogen-mediated structural and functional synaptic plasticity in the
female rat hippocampus. Hormones and Behavior 34, 140–148.
71

Woolley, C.S. (1999). Effects of estrogen in the CNS. Current Opinion in Neurobiology 9, 349–
354.
Woolley, C.S. (2000). Effects of oestradiol on hippocampal circuitry. Novartis Foundation
Symposium 230, 173–180.
Woolley, C.S., and McEwen, B.S. (1992). Estradiol mediates fluctuation in hippocampal
synapse density during the estrous cycle in the adult rat. The Journal of Neuroscience 12,
2549–2554.
Woolley, C.S., Weiland, N.G., McEwen, B.S., and Schwartzkroin, P.A. (1997). Estradiol
increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptormediated synaptic input: correlation with dendritic spine density. The Journal of
Neuroscience 17, 1848–1859.
Young, S.N. (2013). The effect of raising and lowering tryptophan levels on human mood and
social behaviour. Philosophical Transactions of the Royal Society of London. Series B,
Biological Sciences 368.
Young, E., and Korszun, A. (2002). The hypothalamic–pituitary–gonadal axis in mood
disorders. Endocrinology and Metabolism Clinics of North America 31, 6378.
Young, E., and Korszun, A. (2010). Sex, trauma, stress hormones and depression. Molecular
Psychiatry 15, 23–28.
Young, S.N., and Leyton, M. (2002). The role of serotonin in human mood and social
interaction. Insight from altered tryptophan levels. Pharmacology, Biochemistry, and
Behavior 71, 857–865.
72

Young, E.A., Midgley, A.R., Carlson, N.E., and Brown, M.B. (2000). Alteration in the
hypothalamic-pituitary-ovarian axis in depressed women. Archives of General Psychiatry
57, 1157–1162.
Zeidan, M., Igoe, S., Linnman, C., Vitalo, A., Levine, J., Klibanski, A., Goldstein, J., and
Milad, M. (2011). Estradiol modulates medial prefrontal cortex and amygdala activity
during fear extinction in women and female rats. Biological Psychiatry 70, 920–927.
Zhong, M., Wang, X., Xiao, J., Yi, J., Zhu, X., Liao, J., Wang, W., and Yao, S. (2012).
Amygdala hyperactivation and prefrontal hypoactivation in subjects with cognitive
vulnerability to depression. Biological Psychiatry 88, 233–242.

73

CHAPTER 2: ESTRADIOL LEVELS MODULATE BRAIN ACTIVITY AND
NEGATIVE RESPONSES TO PSYCHOSOCIAL STRESS ACROSS THE MENSTRUAL
CYCLE
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Abstract:
Although ovarian hormones are thought to have a potential role in the well-known sex
difference in mood and anxiety disorders, the mechanisms through which ovarian hormone
changes contribute to stress regulation are not well understood. One mechanism by which
ovarian hormones might impact mood regulation is by mediating the effect of psychosocial
stress, which often precedes depressive episodes and may have mood consequences that are
particularly relevant in women. In the current study, brain activity and mood response to
psychosocial stress was examined in healthy, normally cycling women at either the high or low
estradiol phase of the menstrual cycle. Twenty eight women were exposed to the Montreal
Imaging Stress Task (MIST), with brain activity determined through functional magnetic
resonance imaging, and behavioral response assessed with subjective mood and stress measures.
Brain activity responses to psychosocial stress differed between women in the low versus high
estrogen phase of the menstrual cycle: women with high estradiol levels showed significantly
less deactivation in limbic regions during psychosocial stress compared to women with low
estradiol levels. Additionally, women with higher estradiol levels also had less subjective distress
in response to the MIST than women with lower estradiol levels. The results of this study
suggest that, in normally cycling premenopausal women, high estradiol levels attenuate the brain
activation changes and negative mood response to psychosocial stress. Normal ovarian hormone
fluctuations may alter the impact of psychosocially stressful events by presenting periods of
increased vulnerability to psychosocial stress during low estradiol phases of the menstrual cycle.
This menstrual cycle – related fluctuation in stress vulnerability may be relevant to the greater
risk for affective disorder or post-traumatic stress disorder in women.
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Introduction
The sex difference in affective and stress-related disease rates (2 to 3 times greater
incidence and prevalence of major depression in women compared to men (Bromet et al., 2011;
Kessler et al., 2005)) emerges at puberty and remains until menopause (Kessler et al., 1994). The
stress exposure model of depression suggests that MDD is the result of a vulnerability to
depression, combined with the trigger of stressful life events (Hankin et al., 2007; Liu and Alloy,
2010). Accordingly, psychosocial stressors are among the top reported antecedents to depression
episodes (Frank et al., 1994; Kendler et al., 1999, 2000), and dysregulation of the hypothalamicpituitary-adrenal (HPA) axis response is a consistent finding in major depression (Burke et al.,
2005; Lupien et al., 2005). Psychosocial stress may be especially important in the etiology of
mood disorders in women as the depressogenic effects of life stressors are reportedly greater in
women than men (Mezulis et al., 2010), even when there is no difference in the number of
stressful life events or in the subjective perception of these events (Young and Korszun, 2010).
Although this finding is consistent and has been replicated by studies across the globe (Bromet et
al., 2011), the reasons for the sex difference in incidence and prevalence of mood and anxiety
disorders are not well understood.
The cortisol response to stress shows consistent sex differences (Vamvakopoulos, 1995),
and changes across the menstrual cycle, decreasing during the late follicular phase when
circulating estrogen is high (Kirschbaum et al., 1992, 1999). Women are more likely than men to
show variations in HPA function in response to stressors (Weiss et al., 1999) and during
depressive episodes (Young and Korszun, 2010). These differences in stress system response
likely contribute to mood disorder risk in women (Weiss et al., 1999), and may be modulated by
ovarian hormone fluctuations across the menstrual cycle (Kajantie and Phillips, 2006; Roca et
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al., 2005). The role of corticosteroids in stress response and regulation is well known, however
the effects of gonadal steroids (e.g. estradiol) –which may be specifically important in womenare less well characterized. .
The concurrence of increased major depressive disorder (MDD) and post-traumatic stress
disorder (PTSD) risk in women during the reproductive period of life suggests that the cyclic
fluctuation of ovarian hormones during this period may contribute to the risk for
psychopathology. Understanding the role of ovarian hormones in emotional processing and
mood regulation in women may provide important insight into the mechanisms underlying the
stress response and potentially the increased incidence of MDD and PTSD in women.
Ovarian hormones may modulate the effects of stress on mood. Brain areas that are
central to mood regulation (including the amygdala and hippocampus) show some of the largest
densities of estrogen receptors in the human brain (Merchenthaler et al., 2004; Ostlund et al.,
2003); interestingly, those areas are also very rich in cortisol receptors. Estrogen may modulate
the activity of these areas; large community and clinic based studies indicate that negative mood
complaints (Davydov et al., 2005; Gonda et al., 2008) (even in healthy women) and suicidal
behavior (Baca-Garcia et al., 2004; Saunders and Hawton, 2006) increase in women during low
estrogen phases of the menstrual cycle. Brain activity related to processing negative emotional
information is also modulated by changing estradiol levels across the menstrual cycle (Goldstein
et al., 2005; Merz et al., 2012), suggesting that estrogen may alter the mood response to negative
information, making this information more or less salient to cognitive processes and
subsequently mood states.
Although there is strong evidence that estrogen modulates the response to negatively
valenced stimuli, such as negative images (Andreano and Cahill, 2010; Goldstein et al., 2005),
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the effect of estrogen on the response to psychosocial stress is less well understood. Psychosocial
stress differs from processing emotional information in a number of ways - stress includes
elements of self-esteem, uncontrollability, and personal threat. Further, studies using
performance–based stressors provide evidence that there is a sex difference in the endocrine
(cortisol) response to this type of stress, and that cycling ovarian hormones may modulate this
response in women (Kirschbaum et al., 1992, 1999). Social-evaluative threat is one element of
psychosocial stress that may be especially salient for women, and has face validity for the real
life stressors women experience and that contribute to mood disorder risk (Kendler et al., 1999,
2000; Stroud et al., 2002). Understanding the effect of ovarian hormones on the response to these
types of stressors is thus important in understanding the role of ovarian hormones in the brain
mechanisms of emotional processing and mood in women. Investigating the stress response,
under controlled laboratory conditions, provides an opportunity to examine the effects of ovarian
hormones on emotional processing, stress response, and subsequent mood.
In this study, we examined the effect of estradiol levels across the menstrual cycle on
both the brain activity and behavioral response to a laboratory-based model of psychosocial
stress. We hypothesized that high circulating estrogen would reduce the effect of acute stress on
brain activity and be associated with less subjective distress following the stress-inducing task.
Methods
Overview:
This cross sectional study included 28 normally cycling women (ages18-45) who were
examined during early follicular phase (day 1-2 of menstrual cycle), or at ovulation (day 12-14),
and who participated in a psychological stress fMRI task. Due to the psychosocial stress task
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used in this study, and the requirement to debrief participants about the focus of the study once
the stress task was completed, we were unable to repeat the stress task for a within subjects
comparison, and were limited to between subjects/ group comparisons. Approximately half of
the participants were studied at the University of Vermont and half were completed at Vanderbilt
University. The study coordinator was the same throughout the study and the MRI scanners were
the identical make and model, with the same software version in operation at the time of the
study. The study procedures were identical at both Universities, and imaging and behavior data
were analyzed for study location effects. The study was reviewed and approved by both the
University of Vermont and Vanderbilt University Institutional Review Boards, and all
participants provided written informed consent.
Participants:
Participants were recruited and told that they would be participating in a study to examine
the effects of menstrual cycle hormone changes on mathematical ability in women. All
participants were healthy, with regular menstrual cycles (21-35 days), no hormonal contraceptive
or centrally active medication use, and no history of severe pain or mood changes related to their
menstrual cycles. We excluded participants with current or past Axis I psychiatric disorders
using the Structured Clinical Interview for DSM Disorders (Spitzer et al., 1992). Beck
Depression Index score was required to be less than 7, and Beck Anxiety Index score less than
15 (Beck et al., 1961). Current illicit drug use and pregnancy were exclusions.
Screening and Characterization:
To assure all participants were of at least average intelligence, we administered the
Wechsler Abbreviated Scale of Intelligence (Wechsler, 1999). The Composite International
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Diagnostic Interview for premenstrual dysphoric disorder (Kessler and Ustun, 2004) was used to
collect menstrual cycle history and to rule out premenstrual dysphoric disorder, and physical and
psychological symptoms associated with the menstrual cycle were assessed using the Moos
Menstrual Distress Questionnaire (Moos, 1968). Personality factors were assessed at screening
using the NEO Five Factor Inventory (Costa and McCrae, 2000). Following screening,
participants tracked their menstrual cycles for three months to determine an average cycle length
and to calculate the study day date. At the University of Vermont, participants tracked using a
paper calendar; at Vanderbilt University, women filled in daily surveys using the on-line
REDCap system.
Women were randomly assigned to return for the study day during the early follicular
phase (days 1-2 of the menstrual cycle) or at ovulation (day 12-14); before the study began,
participant research ID numbers were assigned a randomly generated number, ranked according
to this random number and then alternatingly assigned to the two groups . The study day took
approximately 3 hours to complete. Upon arrival at the Clinical Research Center, participants
completed the State and Trait Anxiety Inventories (Spielberger, 2010) and the Beck Depression
and Anxiety Inventories (Beck et al., 1961).
Stress Task:
We employed the Montreal Imaging Stress Task (MIST) for psychosocial stress
induction (Pruessner et al., 2008). The MIST produces moderate psychosocial stress through a
combination of motivated performance and social-evaluative threat. We presented the MIST as
an arithmetic task in the MRI scanner, and instructed participants that they should achieve an 8090% correct performance for their data to be usable in the context of this experiment.
Unbeknownst to the subjects, the MIST contains an algorithm producing script that
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automatically adjusts the difficulty of the math tasks to the aptitude of the participant, this way
maintaining a low performance rate (between 40-50%) by changing either the problem difficulty
or the allotted time. A “control” condition, in which the participants solve arithmetic problems
with no time limit and no performance limit, serves as a contrast to control for brain activity
changes induced by arithmetic task demands (visual stimuli, motor response, and mental
arithmetic). Social evaluative threat comes from scripted experimenter interaction; the
experimenters enter the MRI room between runs and inform the participants that they are not
doing well enough and that they need to improve their performance for the experiment to be
successful.
In this study, participants completed three runs of the MIST; the MRI sessions were
scheduled during the afternoon when baseline cortisol levels are low. After the first run,
experimenter 1 entered the scanner room and provided the scripted feedback and asked the
participant to complete a second run of the task. After the second run the experimenter 1 entered
the scanner room and told the participant that the experimenter 2 (“doctor”) would like to speak
with them about their performance, at which point the experimenter 2 entered the scanner room
and provided the scripted feedback and asked the participant to complete a third run of the task.
This protocol was designed to maintain both performance and social evaluative threat throughout
the MIST and to prevent participants from habituating to the performance challenge or giving up
on completing the task. Specifically the interaction of the participants and the experimenters was
structured to generate psychosocial stress. To habituate the participants to the scanning
environment and decrease scanner-related stress at the study day, participants entered an MRI
simulator during the screening visit; in the MRI simulator, participants watched a nature video
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while being exposed to the MRI environment (simulated MRI sounds, head coil, and being
placed in the MRI bore) and the stimulus presentation system.
The MIST was presented in a block design; each condition was presented twice per 3
runs (“stress”: 100 seconds, “control”: 50 seconds, ‘rest”: 30 seconds). Participants practiced the
MIST task (control trials only) in the MRI simulator, before the MRI session.
Subjective Measures
Participants completed subjective measures: the Stress and Arousal Checklist (King et al.,
1983) (before and after the MIST), the Profile of Mood States (McNair et al., 1989), and a Visual
Analogue Scale for mood and task experience (both after the MIST).
Endocrine Measurements:
Saliva samples were collected, using Salimetrics salivettes placed under the tongue, at
seven times during the study day to assess the cortisol response to the stress task (Fig.1).
Salivettes remained under the tongue for two minutes, and then were stored at -80°C freezer until
analysis. Cortisol levels were assessed using the Salimetrics High Sensitivity Salivary Cortisol
Enzyme Immunoassay Kit for quantitative determination of salivary cortisol with a sensitivity of
0.007 ug/dL for 25µl sample volume (Salimetrics LLC, Philadelphia, PA). All cortisol
measurements were assayed in duplicate, with mean intra-assay coefficient of variation of 7.5%
and inter-assay coefficient of variation of 14.3%. Cortisol area under the curve measurements for
each participant (over the study day) were calculated using Graphpad Prism.
Blood samples were collected from each participant at the end of the study day to
determine the estradiol level and to verify menstrual phase. Estradiol was assessed from sera
using the Immulite 1000 endocrine panel immunoassay system with mean intra-assay coefficient
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of variation of 5.9%. For analyses by menstrual phase, we required that both the participant’s
menstrual cycle tracking and estradiol level indicated that they were in the assigned menstrual
phase. Participants’ whose estradiol levels did not concord with their randomly assigned
menstrual phase at the study day; women whose estradiol levels were higher or lower than the
reference values for their assigned phase, were not included in the low or high estradiol groups,
as they could not be accurately assigned to either group. These data were included in all other
analyses.
Progesterone levels were assessed using the Salimetrics Salivary Progesterone (P4)
Enzyme Immunoassay Kit with a sensitivity of 5pg/mL for 25µl sample volume (Salimetrics
LLC, Philadelphia, PA). The first saliva sample of the day was used for progesterone
measurements. All progesterone measurements were assayed in duplicate, with mean intra-assay
coefficient of variation of < 1%.
MRI Scan parameters:
Participants were scanned on a Philips 3.0 Tesla Achieva scanner, with an 8 channel head
coil. All participants received the following MR sequences: 1) A sagittal T1-weighted 3D Turbo
Field Echo Sensitivity Encoding (TFE SENSE) sequence perpendicular to the anterior
commissure (AC) -posterior commissure (PC) line, repetition time (TR) of 9.9 ms, echo time
(TE) of 4.6 ms, a flip angle of 8°, number signal averages (NSA) 1.0, a field of view (FOV) of
256 mm, a 256 × 256 matrix, and 1.0 mm slice thickness with no gap for 140 contiguous slices.
2) A T2- weighted Gradient and Spin Echo (GRASE) sequence was run parallel to the AC-PC
line, TR 2470 ms, TE 80 ms, NSA 3.0, FOV of 230 mm, 0.7 mm slice thickness with 5.0 mm
gap for 28 slices. 3) Three Echoplanar Blood Oxygenation Level Dependent (EpiBOLD)
functional sequences, transverse orientation, TR 2500 ms, TE 35 ms, flip angle 90°, 1 NSA for
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FOV 240, 240X128 matrix, and 4.0 mm slice thickness with no gap, with ascending interleaved
acquisition, for 35 contiguous slices.
fMRI Analysis:
fMRI data was processed using Statistical Parametric Mapping (SPM8) (Wellcome
Department of Cognitive Neurology, 2008). Preprocessing included: realignment of the three
functional runs and correction for bulk-head motion, coregistration of functional and anatomical
images for each participant, segmentation of the anatomical image, and normalization of the
anatomical and functional images to the standard MNI template, and spatial smoothing with a
Gaussian filter (8 mm at full width, half maximum).
Artifact detection was performed on functional images using the ART toolbox in SPM,
and outliers for signal intensity (z>3) and motion (movement >3 mm in either translation or
rotation) were entered as nuisance regressors at the first level, single-participant analysis. At first
level analysis, T-maps were created from linear contrasts for task conditions and between
condition comparisons; these T-maps were used in the second level whole-brain random effects
analysis of participant group effects with two-sample t-tests. The preprocessed functional images
had a voxel size of 2X2X2 mm and cluster threshold correction was used to control for multiple
comparisons (from voxel wise p = 0.005) to corrected p < 0.001 with k = 58 (corrected voxelwise p = 0.000001) (from alpha simulation in REST(Song et al., 2011) toolbox for SPM, using
whole brain mask).
Two sets of second level analyses were conducted, one analysis with groups defined by
menstrual phase and estradiol level at the study day, and a second analysis with groups defined
by subjective distress to the MIST (change in Stress Arousal Checklist score). Separate
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regression analyses were run for estradiol level and subjective distress by hippocampal activity
(using a bilateral hippocampus region of interest mask created from the Automated Anatomical
Labeling (AAL) in WFU Pickatlas (Maldjian et al., 2003). Percent signal change in right and left
hippocampus was calculated with the REX toolbox for SPM; using masks created from the
average peak cluster in the hippocampus ROI (using the contrast “control” condition > “stress”
condition in the full subject set) with cluster threshold correction (from voxel wise p = 0.05) to
corrected p < 0.001 with k = 101 (corrected voxel-wise p = 0.0001).
Results
Participants:
Average participant age was 30.4 years (SD = 8.2 years). There was no difference in age
between subject groups either by estradiol level (t (8) = -1.01, p = 0.33), or distress (t (26) = 0.83, p = 0.41). No participants had Menstrual Distress Questionnaire scores that indicated
severe premenstrual somatic or affective changes. There were no differences between any of the
participant groups at screening, including Beck Depression Inventory scores, Beck Anxiety
Inventory scores, NEO Five Factor Inventory personality measures, or any of the Menstrual
Distress Questionnaire measures, and none of the participants had elevated scores on these scales
(Table 1). For the analysis of the effect of menstrual phase on stress related brain activity, we
included only participants whose estradiol level at the study day confirmed their assigned
menstrual phase. The reference value for median early follicular phase estradiol levels using the
Immulite 1000 endocrine panel immunoassay system is 31 pg/mL. Women were included in the
low estradiol phase group if they were assigned to the early follicular group and had an estradiol
level on the study day less than 40 pg/mL (M = 24.91 pg/mL). Women were included in the high
estradiol phase group if they were assigned to the ovulatory group and had an estradiol level on
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the study day greater than 50 pg/mL (M = 103.52pg/mL). This resulted in 8 participants (4 from
the low estradiol, and 4 from the high estradiol group) not being included in stress-brain imaging
analyses for low vs. high estradiol phase groups; these participants’ data were included in all
other analyses
Brain Activity - Psychosocial Stress Response
Second level comparison using a one sample t–test of average images of all subjects (n =
28) (using the 1st level contrast of control condition > stress condition) revealed significantly
(uncorr p = 0.005, cluster size = 58, corr p < 0.0001) greater activation in cingulate, temporal
(including hippocampus), and frontal regions and activation in parietal and precentral gyrus
regions during the control condition compared to the stress condition (Fig.2 and Table 2). This
activity pattern is consistent with the activity pattern previously shown by studies using the
MIST (Pruessner et al., 2008); reduced activation of hippocampus and para-limbic regions
during the stress condition. These results confirm that the overall brain activity response to
psychosocial stress in a sample including only women is similar to the brain activity seen in
studies that include both men and women.
Menstrual Cycle Phase/ Estradiol Effects
Estradiol level was significantly higher in the high estradiol phase group (M = 103.52
pg/mL, SD = 34.09) than the low estradiol phase group (M = 24.91 pg/ mL, SD = 9.17) (t (18) =
7.04, p < 0.001). All women had salivary progesterone levels under 105 pg/mL (M = 49.72
pg/mL, SD = 35.54), consistent with the follicular phase (Chatterton et al., 2005). Progesterone
levels did not differ between the low estradiol phase group (M = 48.90 pg/mL, SD = 36.10) and
high estradiol phase group (M = 50.54 pg/mL, SD = 36.91) (t (18) = 0.099, p = 0.92) (Fig.3).
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The fMRI estradiol phase group analysis for the effect of psychosocial stress, including
participants who showed concordance of assigned menstrual phase and estradiol level, (high
estradiol n = 10, low estradiol n = 10), showed a significant (uncorr p = 0.05, cluster size = 529,
corr p < 0.005) effect of estradiol level on brain activity during psychosocial stress and perceived
distress following the MIST, however these findings did not survive more conservative
correction for multiple comparisons . Women with low estradiol levels had significantly less
activity in the left hippocampus than women with high estradiol levels during the stress condition
(Fig.4 and Table 3). This finding indicates that women in the high estradiol phase of the
menstrual cycle have a greater left hippocampal activity during psychosocial stress than women
in the low estradiol phase.
Bilateral hippocampal activity during psychosocial stress was directly associated with
estradiol levels in an analysis of the 20 participants included in the estradiol phase group analysis
(uncorr p = 0.005, cluster size = 58, corr p < 0 .0001) with greater activity in the bilateral
hippocampal ROI being associated with higher estradiol levels. Examining the individual right or
left hippocampal ROIs showed that the correlation between estradiol level and percent signal
change in either right or left hippocampus did not meet statistical significance (right
hippocampus: r = - 0.14, n = 28, p = 0.45; left hippocampus: r = - 0.21, n = 28, p = 0.37),
indicating that the effect of estradiol was not lateralized.
In an analysis that included all participants grouped according to their assigned menstrual
phase (without confirmation by estradiol level), there were no brain areas that showed greater
activity in the periovulatory group compared to the early follicular phase group at either
corrected p < 0.01 or corrected p < 0.05.
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Brain Activity - Subjective Distress Effects
To compute a group contrast for the effects of subjective distress on brain activation
changes, we performed a median split of subjective distress scores; difference in pre vs. post
MIST stress score on the Stress and Arousal Checklist (high distress n = 14, low distress n = 14).
The subsequent fMRI analysis with the high and low distress groups showed an associated of
distress and brain activity during the psychosocial stress task. Women with lower distress scores
showed significantly more activity in bilateral hippocampus (Fig5), midbrain, left parietal, and
left frontal regions than women with higher distress scores and (Table 4). By contrast, greater
subgenual cingulate activity was seen in women with higher distress scores compared to women
with lower distress scores (Table 4). These differences indicate that women who respond to the
MIST with high subjective distress have a greater change in brain activity during psychosocial
stress than women with low subjective distress following the MIST.
Bilateral hippocampal activity during psychosocial stress was inversely associated with
distress scores in an analysis of all participants (p < 0.001) with lower activity in the
hippocampal ROI being associated with greater distress. These correlations were statistically
significant bilaterally (left hippocampus r = 0.51, n = 28, p = 0.006, right hippocampus r = 0.49,
n = 28, p = 0.008). We re-analyzed the correlation after step-wise removal of percent signal
change extreme values and association between left hippocampal percent signal change and
distress remained significant (r = 0.39, n = 28, p = 0.04) but the right hippocampus did not( r =
0.31, n = 28, p = 0.10).
There was no significant difference in brain activity between participants run at the two
study locations in any of the contrasts of interest at any level of significance including
uncorrected p < 0.05.
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Behavioral and Mood Measures - Estradiol Effects
There was no effect of estradiol phase group or distress group on pre-MIST Stress and
Arousal Checklist scores, Trait Anxiety Inventory scores, or State Anxiety scores (Table 5), and
no effect on any of the Profile of Mood scores, Arousal scores, or any of the scales of the Stress
Task Visual Analogue Scale following the MIST (Table 6). Distress scores (difference in SACL
Stress score before and after the MIST) were lower in women with high estradiol than in women
with low estradiol levels (Table 6). A multiple regression was run to predict stress change from
estradiol level, progesterone level, and age, F (3, 24) = 4.2, p < 0.05, R2 = .344. Only estradiol
added statistically significantly to the prediction, p < 0.05.
Behavioral and Mood Measures - Distress Effects
There was no significant difference between groups on Stress and Arousal Checklist
scores, Trait Anxiety Inventory scores, or State Anxiety scores before completing the MIST
(Table 5). Women with higher distress scores had higher scores (worse mood) on all negative
scales of the post-task Profile of Mood States (including tension, depression, anger, fatigue,
confusion, and total mood disturbance) compared to women with lower distress scores,
indicating worse mood following the MIST (Table 6). Additionally, women with higher distress
scores had significantly lower estradiol levels (M = 43.47 pg/mL, SD = 35.26) than women with
lower distress scores (M = 74.49 pg/mL, SD = 40.93) (t (26) = 2.15, p < 0.05), and there was an
inverse correlation between estradiol and distress with lower estradiol levels associated with
greater distress (r = -0.50, n = 29, p = < 0.01). There was no difference in progesterone levels
between distress groups - low distress progesterone (M = 41.04 pg/mL, SD = 35.49), high
distress progesterone (M = 58.96 pg/mL, SD = 36.84), (t (26) = - 1.31, p = 0.20) (Fig 4).
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There was no significant difference in any of the screening or study day subjective or
behavioral measures between participants run at the two study locations at p < 0.05.
Cortisol
All subjects showed an increase in cortisol related to the MIST and cortisol AUC was
associated with decreased medial prefrontal activity during psychosocial stress (Fig.6); however
there was no significant correlation between estradiol level or distress score group with cortisol
response to the MIST. Cortisol AUC showed substantial inter-subject variability with an average
AUC for the entire sample of 0.8 and a standard deviation of 2.8.
Discussion
Overall, women showed brain activity patterns during psychosocial stress that were
similar to the patterns previously seen in studies that included both men and women; deactivation
of limbic regions (Pruessner et al., 2008). However, this study showed that higher estradiol levels
at periovulation were associated with greater hippocampal activity during psychosocial stress in
normally cycling premenopausal women. Menstrual cycle phase and corresponding estradiol
levels were directly correlated with hippocampal activity during the stress condition of the
MIST; activity in the hippocampus during stress was significantly lower in women in the low
estradiol levels compared to women with higher estradiol levels. These results suggest that low
estradiol levels during the early follicular phase of the menstrual cycle exaggerate the effect of
psychosocial stress on brain activity. Women with higher periovulatory estradiol levels also had
lower distress scores following the psychosocial stress task. Group analysis based on distress
following the MIST confirmed the relationship between estradiol and both brain and mood
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response to stress: women with higher distress had lower left hippocampal activity during the
MIST, more negative mood following the MIST, and lower estradiol levels.
Previous work using the MIST has revealed deactivations during the stress condition of
the task, in brain areas that are part of the limbic circuit (including hippocampus, hypothalamus,
medio-orbitofrontal cortex and anterior cingulate cortex) (Pruessner et al., 2008). These studies
have proposed that reduced limbic circuit function is associated, perhaps causally, with the stress
response. Additionally, hippocampal deactivation during the stress condition of the MIST has
been directly related to cortisol release and inversely correlated with measures of self-esteem,
indicating that hippocampal activity is a marker of both the peripheral endocrine response to
stress and related to psychological vulnerability to psychosocial stress (Pruessner et al., 2008).
These findings are consistent with previous studies showing that the hippocampus is an
important inhibitor of the HPA system (Jacobson and Sapolsky, 1991). Hippocampal function is
also important in processing emotionally valenced information (Canli et al., 2002), especially in
women, and in evaluating the context of social interactions (Berthoz et al., 2002). Our findings
suggest that higher circulating estradiol may support continued hippocampal activity during
psychosocial stress.
The brain regions that are commonly indicated in studies of major depression and in
recent neuroimaging studies of psychosocial stress are important targets for investigating
vulnerability to mood disorder and the interaction with stressful life events. That these same
regions are responsive to estradiol manipulation (Andreano and Cahill, 2010; Goldstein et al.,
2005) is interesting in light of the mood effects of estradiol in both healthy women (Gonda et al.,
2008) and mood disorders related to ovarian hormone fluctuations . Estradiol has been shown to
modulate activity on brain circuits important for emotional processing; estradiol level changes
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across the menstrual cycle are associated with changes in brain activity related to arousal for
negative valenced images (Goldstein et al., 2005), and in fear conditioning (Zeidan et al., 2011).
These findings provide evidence that estradiol may affect emotional responding through
increased top-down modulation of emotional circuitry, including brain areas involved in the
stress response, and may be protective against fear and anxiety. Our findings suggest that greater
estradiol levels during the periovulatory phase of the menstrual cycle decrease the brain activity
change in response to psychosocial stress, and reduce the acute behavioral and mood
consequences of the stress experience. This interpretation is further supported by the location of
estradiol receptors in the central nervous system; the hippocampus is rich in both estradiol and
glucocorticoid receptors, making it an important area of interaction between these hormones.
Estradiol receptors are located in a number of brain areas, including regions important
for the autonomic, hormonal, and cognitive-emotional response to psychosocial stress (Love et
al., 2010). The relation of stress to depression onset (Frank et al., 1994; Kendler et al., 1999,
2000) and the altered function of the stress system in major depression (Burke et al., 2005;
Lupien et al., 2005) suggest that modulation of the psychosocial stress response may be a
mechanism through which estradiol fluctuation may contribute to MDD and PTSD risk. The
results of this study suggest that estradiol levels may modulate activity in brain areas important
for processing emotional information during psychosocial stress. Increased emotional processing
and physiological response to psychosocial stress, during low estrogen menstrual phases, may
contribute to depressed mood in women with vulnerability to MDD. Indeed, women with MDD
have greater HPA axis dysregulation than men with MDD (Young and Ribeiro, 2006; Young et
al., 1994), suggesting that the stress system may be particularly important to depression in
women. Estradiol may attenuate sympathetic and HPA axis activity to stress (Kajantie and
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Phillips, 2006; Roca et al., 2005). Although our study did not include women with mood
disorders, the effect of estradiol on brain activity and mood response to psychosocial stress
suggest that periods of low estradiol are associated with heightened negative emotional
responding. These phases may thus present windows of increased vulnerability to the
depressogenic effects of psychosocial stress in women. Further work is needed to determine
whether the effects of estradiol on stress responding differ in women with vulnerability to mood
and anxiety disorders, and if there is a relation between the occurrence of stressful events during
different phases of the menstrual cycle and subsequent MDD or PTSD onset in vulnerable
women.
We recognize that menstrual cycle effects are likely not the only, or even the main,
determinant of psychosocial stress responding in women; future studies are needed to examine
the effects of personality factors, and lifetime trauma or chronic stress. Limitations also include
that the separate roles and mechanisms of estradiol and progesterone in emotional processing and
response remain to be delineated. Although we did not directly investigate the effect of differing
progesterone levels on stress responding, we attempted to isolate the effects of estradiol by
having women experience the psychosocial stress task during the early follicular phase or the
periovulatory phases when progesterone levels are low. We excluded women whose estradiol
levels were not in concordance with their assigned menstrual phase from our menstrual cycle
phase/ estradiol fMRI analysis, as these women were likely in the mid luteal phase, when both
estradiol and progesterone levels are increasing. The periovulatory phase is a very short duration
of time (2-4 days) and it is possible that some women in our study were studied after ovulation.
Indeed, brain activity during the psychosocial stress task did not show a difference between
groups based only on assigned menstrual phase, suggesting that the women who were omitted
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from the estradiol level-based analysis may not have been in the correct phase or that estradiol
level rather than phase has a stronger effect on neural activity in response to psychosocial stress.
Although we believe this approach was appropriate to investigate the effects of estradiol level, it
resulted in a reduced sample size for the menstrual cycle phase/ estradiol level analysis. As
progesterone levels did not appear to have an effect on distress in this study, we included all
participants in the analyses by subjective distress. This study was not designed to investigate the
separate effects of estradiol and progesterone by menstrual phase, however it did reveal a linear
inverse relationship between estradiol levels and subjective distress that did not exist for
progesterone.
Additionally, this study did not include women who experience mood disruption directly
related to menstrual phase or ovarian hormones (such as Premenstrual Dysphoric Disorder or
Polycystic Ovarian Syndrome), nor did this study model these disorders. The effect of ovarian
hormone level/menstrual phase on brain activity during emotional processes in women with
these disorders likely differs from healthy women, and the effects on stress responding in these
populations should be examined separately. Another potential limitation of this study is the
difference in block length between stress and control conditions of the MIST. The stress
conditions of the task needed to be of sufficient length to allow the stress response to develop,
however the limitations in task time (and efficient block length) did not allow for the control
conditions to be of similar length. We believe the control condition was of sufficient length and
had enough repetitions to use as a comparison to isolate brain activity related to the stress
response.
This study is unique in that that we used a moderate psychosocial stressor in the MRI
environment at different menstrual phases, which allowed us to examine both the subjective
94

mood response and brain activity response to the stress task. Also our stress task included social
evaluative threat- a type of stress that may be particularly relevant for mood in women (Kendler
et al., 2001). Our data suggest that estradiol buffers the brain activity changes and negative mood
response to psychosocial stress in normally cycling women. This work has important implication
for an understanding of the relationship between estradiol levels and the response to stressful life
events. Whether this has implications for the development of psychopathology remains to be
studied. Future work should extend the investigation of ovarian hormone effects on psychosocial
stress responding to women with vulnerability mood or anxiety disorders and further examine
the relation of these effects to known risk factors for mood disorders.
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Table 1: Participant Behavioral Measures at Screening

8.15

High
E2
(n=10)
Mean
28.30

SD

E2
Groups
p

9.07

Low
E2
(n=10)
Mean
32.10

0.33

High
Distress
(n=14)
Mean
31.71

SD

Distress
Groups
p

7.69

Low
Distress
(n=14)
Mean
28.69

7.78

8.86

0.35

4.02

3.06

4.32

3.85

4.64

2.59

0.74

4.18

2.39

4.14

3.74

0.97

4.50

3.02

4.73

3.87

4.59

2.70

0.89

4.18

2.55

5.04

3.49

0.30

0.27

0.71

0.50

0.67

0.45

0.80

0.83

0.14

0.59

0.43

0.84

0.15

5.12

5.11

6.32

6.18

4.64

4.87

0.30

4.11

3.60

6.25

6.40

0.13

1.48

2.05

2.23

3.08

1.50

1.23

0.29

1.43

1.53

1.54

2.62

0.85

1.63

1.98

1.86

2.16

2.45

2.19

0.35

1.93

2.04

1.43

2.04

0.36

0.15

0.40

0.32

0.49

0.27

0.31

0.70

0.12

0.33

0.11

0.42

0.73

Neuroticism

16.34

7.44

18.30

9.80

16.44

4.03

0.60

14.29

5.01

18.38

9.58

0.17

Extraversion

29.72

6.30

28.30

6.27

30.56

3.81

0.36

31.57

4.18

27.62

7.73

0.11

Openness

31.76

5.79

31.40

4.50

30.44

8.05

0.75

31.43

6.17

31.54

5.83

0.96

Agreeableness

36.03

5.71

34.90

4.25

36.44

6.41

0.54

35.79

5.12

35.54

6.46

0.91

Conscientiousness

35.03

6.78

33.00

7.77

34.00

5.96

0.76

36.79

6.24

33.62

7.32

0.24

BDI Total

2.07

2.80

2.30

3.23

2.70

3.47

0.79

1.93

3.15

2.14

2.74

0.85

BAI Total

3.20

3.75

3.80

5.55

2.90

2.69

0.65

1.93

2.46

4.50

4.67

0.08

IQ Score

118.43

11.25

120.60

12.69

111.90

9.69

0.10

116.71

9.85

119.93

12.93

0.47

Overall
(n=28)
Mean

SD

30.43

Pain (max 24)
Water Retention (max
16)
Autonomic Reactions
(max 16)
Negative Affect (max
36)
Impair Concentration
(max 36)
Behavior Change (max
20)
Control (max 24)

Age

SD

SD

MDQ

FFI

E2 = Estradiol
MDQ = Menstrual Distress Questionnaire (mean of most recent period and four days before)
FFI = NEO Five Factory Personality Inventory
BDI = Beck Depression Inventory
BAI = Beck Anxiety Inventory
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Table 2: Brain Activity during Psychosocial Stress
Stress condition - control condition: All subjects (pooled across menstrual cycle, n = 28),
cluster corrected uncorr p = 0.005, k =58 for p < 0.0001
Peak MNI coordinates
x

y

z

Peak Description

-36

-4

Right Middle Temporal Gyrus

-2

64

4

-26

-30

0

Deactivation 58

Activation

Cluster extent(k)

Peak t peak p(uncor)

19813 5.78

1.91E-06

Superior Medial Frontal

4.95

1.75E-05

-22

Left Hippocampus/ Parahippocampus

4.94

1.79E-05

-18

34

Left Cingulate Gyrus

3923 5.65

2.66E-06

0

-48

26

Left Posterior Cingulate Gyrus

5.25

7.78E-06

0

-46

34

Left Middle Cingulate Gyrus

4.78

2.73E-05

-52

-60

26

Left Angular Gyrus

769 5.14

1.05E-05

-58

-56

32

Left Supramarginal Gyrus

5.05

1.34E-05

-42

-60

24

Left Middle Temporal Gyrus

4.09

1.76E-04

-28

-46

36

Left Parietal

2525 5.45

4.51E-06

-28

-48

44

Left Parietal

5.03

1.41E-05

-26

-54

50

Left Parietal

4.68

3.60E-05

16

-70

54

Right Parietal

929 4.08

1.79E-04

28

-64

42

Right Parietal

3.78

3.97E-04

30

-54

54

Right Inferior Parietal

3.70

4.91E-04

-28

-4

60

Left Precentral Gyrus

556 4.07

1.84E-04

-36

-4

48

Left Precentral Gyrus

3.28

1.43E-03

-42

-2

58

Left Precentral Gyrus

3.17

1.86E-03
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Table 3: Menstrual Cycle/Estradiol Effect on Brain Activity during Psychosocial Stress
Stress condition - control condition: Low estradiol (n =10) – High estradiol (n =10), cluster corrected
uncorr p = 0.05, k = 529 for p < 0.005.

Peak MNI coordinates
x

y

z

Peak Description

-60

28

Precuneus

1183 3.00

3.83E-03

-12

-64

18

Precuneus

2.87

5.03E-03

10

-74

38

Precuneus

2.83

5.55E-03

-22

-24

-24

Left Hippocampus/ Parahippocampus

586 2.88

5.02E-03

-18

-34

-4

Left Hippocampus/ Parahippocampus

2.74

6.71E-03

-30

-26

-14

Left Hippocampus

2.60

9.01E-03

18

32

-6

Right Frontal Lobe

821 2.78

6.14E-03

26

32

4

Right Frontal Lobe

2.75

6.62E-03

26

34

12

Right Frontal Lobe

2.70

7.35E-03

Deactivation 14

Activation
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Cluster extent(k)

Peak t

peak p (uncor)

Table 4: Distress Effect on Brain Activity during Psychosocial Stress.
Stress condition - Control condition: Low distress (n = 14) – High distress (n = 14),
cluster corrected uncorr p = 0.005 k = 58 for p < 0.001

Distress = Post SACL Stress – Pre SACL Stress
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Table 5: Behavioral Measures at Study Day – Pre MIST
High E2
(n=10)
Mean

SD

Low E2
(n=10)
Mean

SD

High
E2
Groups Distress
(n=14)
p
Mean

SD

Low
Distress
(n=14)
Mean

Distress
Groups
SD

p

STAI State
Anxiety 29.3

7.54

29.80

7.13

0.88

29.07

6.40

28.64

7.60

0.87

STAI Trait
Anxiety 34.6

10.55

33.10

7.40

0.71

33.64

10.10

30.43

6.27

0.32

SACL Stress

1.90

2.88

2.20

4.32

0.86

2.57

4.13

0.64

1.08

0.10

SACL Arousal 9.00

3.71

8.10

3.31

0.57

8.00

3.68

7.93

3.24

0.96

E2 =Estradiol
STAI = State and Trait Anxiety Inventory
SACL = Stress and Arousal Checklist
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Table 6: Behavioral Measures at Study Day – Post MIST

E2 =Estradiol
STAI = State and Trait Anxiety Inventory
SACL = Stress and Arousal Checklist
POMS = Profile of Mood States
STVAS = Stress Task Visual Analogue Scale
Distress = Post SACL Stress – Pre SACL Stress
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Figure 1: Overview of study day procedures and timing
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Figure 2: Psychosocial Stress Effect fMRI Stress Condition – Control Condition. All participants (n =
28). Greater deactivation in limbic regions during the stress condition compared to the control condition
(corrected to p < 0.0001).
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Figure 3: Estradiol and Progesterone Levels for all Participants (n = 28)
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Figure 4: Estradiol Effects fMRI.
Stress Condition – Control Condition: High estradiol (n = 10) – Low estradiol (n = 10). Greater
activity in left hippocampus during the stress condition in the High estradiol group than the Low
estradiol group (cluster-level corrected to p < 0.005).
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Figure 5: Subjective Distress Effects fMRI.
Stress Condition – Control Condition: Low Distress (n = 14) – High Distress (n = 14). Greater activity in
bilateral hippocampus during the stress condition in the Low Distress group than the High Distress group
(cluster-level corrected to p < 0.0001).
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Figure 6: Cortisol fMRI.
Stress Condition – Control Condition: All (pooled across menstrual phase, n = 28). Greater deactivation
in medial prefrontal regions during the stress condition related to salivary cortisol AUC (corrected to p <
0.0001).
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CHAPTER 3: ATTENTION BIAS IN REMITTED DEPRESSION IS ASSOCIATED
WITH ENHANCED AMYGDALA ACTIVITY AND FUNCTIONAL CONNECTIVITY
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Abstract
Cognitive bias is a common characteristic of major depression and is posited to remain
during remission and contribute to recurrence risk. Attention bias may be related to enhanced
amygdala activity or altered functional connectivity to amygdala and within attention networks
in depression. The current study examined attention bias, brain activity for emotional images and
functional connectivity in participants with and without a history of major depression. Attention
bias for negative, positive, and neutral images in an emotion dot probe task during fMRI was
examined in 33 postmenopausal women with (n = 12) and without (n = 21) a history of major
depression. Additionally, group differences in functional connectivity to amygdala was assessed
using a resting state MRI scan. There was a significant group difference for attention facilitation
(t (31) = 2.83, p < 0.01) and amygdala activity (corr p < 0.001) during the emotion dot probe
task. There were significant group differences in functional connectivity between the amygdala
and hippocampal complex (corr p < 0.001). In all participants amygdala activity for negative
images was positively correlated with attention facilitation for negative and positive trials.
Additionally, amygdala activity and amygdala –hippocampal connectivity were positively
correlated with attention facilitation for negative images. These findings provide evidence that
differences in activity and functional connectivity in limbic and attentional networks may
provide a neurobiological basis for continued cognitive bias in remitted depressed individuals.
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Introduction
Cognitive bias for negative emotional information is a common characteristic of mood
and anxiety disorders; depressed and dysthymic individuals show enhanced memory and
attention (Sears et al., 2011; Wiens and Syrjänen, 2013; Isaac et al., 2014; Duque and Vázquez,
2015) for negative information consistent with cognitive models of depression. Beck’s model
(Beck, 2005; Beck and Haigh, 2014) posits that greater attention or memory for negative events
contributes to the development, maintenance, and recurrence of depression by influencing
schemas about the self and the world. A causative link between cognitive bias and mood is
suggested by the finding that methods that modulate attention bias also affect anxiety and
depressive symptoms (Hallion and Ruscio, 2011). Experimentally, cognitive bias modification
has been shown to be able to both decrease depressive symptoms (by reducing negative bias) and
increase depressive symptoms (by increasing negative bias), indicating that bias in attention may
contribute directly to depressive symptoms rather than being a consequence of depressed mood.
An important component of the cognitive model of depression is that cognitive bias is a
trait marker of depression vulnerability and should remain in euthymic individuals with remitted
depression (Sears et al., 2011). Mood congruent cognitive biases have been reliably found in
currently depressed individuals and are associated with the severity of depressive symptoms and
specific for depression-related information (Gaddy and Ingram, 2014). Cognitive biases in
euthymic, remitted depressed individuals may indicate a trait cognitive vulnerability for
depression (Joormann and Gotlib, 2007; Sears et al., 2011) that contributes to a high risk of
recurrence (Kessler et al., 2003,Solomon et al., 1997; Keller and Berndt, 2002).
Altered activity in fronto-limbic circuits has been associated with cognitive bias, negative
mood, and rumination in currently depressed individuals. De Raedt and Koster (2010) posit a
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model of depression vulnerability in which decreased dorsal prefrontal activity and increased
stress-related amygdala activity contributes to negative mood and risk for future depressive
episodes (Raedt and Koster, 2010). This model is supported by studies demonstrating that both
currently depressed (Arnone et al., 2012), and at risk populations (Zhong et al., 2011) show
greater amygdala activity to negative emotional stimuli than never depressed healthy controls.
Attentional bias for negative information in remitted depressed individuals may be related to
greater amygdala responses and enhanced attention to negative stimuli (Sears et al., 2011).
Whether attentional bias in individuals with remitted depression is associated with parallel
alterations in neural activity to emotional stimuli has not been previously examined. Brain
activity or functional connectivity differences that remain in remission may represent a
neurobiological basis for continued cognitive biases and vulnerability to depression.
To assess attentional bias in euthymic individuals with remitted depression we examined
performance and functional brain activity in participants with and without a history of depression
during an emotion dot probe (EDP) task. We used fMRI during the EDP task and a resting scan
before the task to examine task-related brain activity and functional connectivity differences
between participants with and without a history of MDD. We hypothesized that participants with
a history of MDD would show attentional bias for negative images that would not be seen in
participants without a history of MDD, and that attentional bias would be associated with greater
amygdala activity for negative images and altered amygdala functional connectivity.
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Methods
Participants
Thirty three right handed postmenopausal (Past MDD: n =12; No MDD: n = 21) women
between the ages of 45-75 were included in this study. None of the participants were taking
ovarian hormones and were at least one year without such treatment. Participants were recruited
for a larger study examining the effects of estradiol replacement on stress responding in
postmenopausal women with and without a history of depression, thus all participants in this
study were postmenopausal women. No participants received estradiol treatment prior to or
during participation in this study. This study was approved by the Vanderbilt University
Institutional Review Board and informed consent was obtained from all participants.
Cognitive Screening:
All participants were cognitively assessed using: the Wechsler Abbreviated Scale of
Intelligence (WASI) (Wechsler, 1996), the Mini Mental State Exam (MMSE) (Folstein et al.,
1975), Brief Cognitive Rating Scale (Reisberg and Ferris, 1988), and the Mattis Dementia Rating
Scale (Schmidt et al., 2005) to establish a Global Deterioration Scale score (GDS) (Reisberg et
al., 1988). Participants were required to have a GDS score of 1-2 and a MMSE score of greater
than 26. No participant scored below 123 on the Mattis scale or below 90 on the WASI;
participants were of average or above intelligence with no evidence of dementia or mild
cognitive impairment.
MDD History Screening
Participants were screened for current and past depression, mania and dysthymia using
the partial Structured Clinical Interview for DSM-IV-TR (SCID) (Spitzer et al., 1992). No
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participants met criteria for a history of premenstrual dysphoric disorder on the Composite
International Diagnostic Interview for premenstrual dysphoric disorder (CICI-PMDD).
Criteria for never depressed participants were: no current or past episodes that met SCID
criteria for MDD, dysthymia, or mania, a current score less than 7 on the Beck Depression
Inventory (BDI), and less than 15 on Beck Anxiety Inventory (BAI) (Beck et al., 1961).
Criteria for prior history of MDD were: at least one episode, in the last ten years that met criteria
for MDD on the SCID, no MDD episodes in the last year, current BDI score less than 7, and
current BAI less than .
Emotion Dot Probe (EDP) Task
The EDP task is a spatial attention task that measures attention facilitation (Kimonis et
al., 2006). The EDP task used in this study was a picture variant using images from the
International Affective Pictures System (Lang et al., 1999) and included neutral, positive, and
negative images. Trials of the EDP consisted of a fixation cross presented in the middle of the
screen, followed by a brief presentation (500 ms) of a picture pair with one image each on the
right and left of the screen. After the picture presentation, a target (asterisk) appeared either on
the right or left of the screen (replacing one of the images) and the participant was instructed to
indicate by finger button press the side of the screen on which the target appeared as quickly as
possible (available response duration was 1750ms). The time between the target’s appearance
and the subject’s response was used for the calculations of reaction time; with incorrect trials
excluded.
The EDP was adapted for MRI and run as an event related design with three trial types
relevant to the presented data: “Neutral” trials: neutral-neutral pair; “Negative” trials: neutral120

negative pair; and “Positive” trials: neutral-positive image. There were no trials in which
negative and positive images were presented together and the presentation order of trial types
was randomized. In 2/3 of “Negative” or “Positive” trials the target replaced the emotionally
valenced image. These trials were used for the measurement of attention facilitation. Attention
facilitation for each emotional trial type was defined as the difference in reaction time between
“Negative” or “Positive” trials and “Neutral” trials. A shorter reaction time for “Negative” or
“Positive” trials indicated attention facilitation for negative or positive images. In 1/3 of
“Negative” and “Positive” trials the target replaced the neutral image. These trials were used for
the measurement of attentional preference (in other literature referred to as attentional bias).
Attentional preferences was measured as the difference in reaction time for trials in which the
target replaced the neutral image and trials in which the target replaced the emotionally valenced
image. Only correct trials were included in performance measure calculations. ANOVAs were
run for group differences in attention facilitation and preference for “Negative” and “Positive”
trials. Independent t-tests were run for group differences in attention facilitation for “Negative”
and “Positive” trials.
Self-rated Measures
Before the EDP, participants completed self-rated measures including: the State – Trait
Anxiety Inventory (STAI) (Spielberger, 2010), the Stress Arousal Checklist (SACL) (King et al.,
1983), and the Profile of Mood States (POMS) (McNair et al., 1989). Following the EDP,
participants completed a second SACL and POMS, and a visual analogue scale (VAS) for task
perception including: the extent of their personal involvement, how stressful, new,
uncontrollable, and unpredictable the task was, and whether they anticipated negative
consequences. These measures have been previously used to assess the stressfulness of
121

laboratory tasks and procedures (Kirschbaum et al., 1999; Kudielka et al., 2004). Independent ttests were run for group differences in STAI, VAS, and for difference score on the SACL and
POMS (pre to post EDP).
Imaging Parameters
Participants were scanned on a Philips 3.0 Tesla Achieva scanner, with an 8 channel head
coil. All participants received the following MR sequences:
1) Sagittal T1-weighted 3D Turbo Field Echo Sensitivity Encoding (TFE SENSE) sequence
perpendicular to the anterior commissure (AC) -posterior commissure (PC) line, repetition time
(TR) of 9.9 ms, echo time (TE) of 4.6 ms, a flip angle of 8°, number signal averages (NSA) 1.0,
a field of view (FOV) of 256 mm, a 256 × 256 matrix, and 1.0 mm slice thickness with no gap
for 140 contiguous slices.
2) T2- weighted Gradient and Spin Echo (GRASE) sequence parallel to the AC-PC line, TR
2470 ms, TE 80 ms, NSA 3.0, FOV of 230 mm, 0.7 mm slice thickness with 5.0 mm gap for 28
slices
3) Echoplanar Blood Oxygenation Level Dependent (EpiBOLD) functional resting-state scan
with transverse orientation, TR 1500 ms, TE 35 ms, flip angle 90°, 1 NSA for FOV 240 mm,
80X80 matrix, and 5.0 mm slice thickness with no gap, for 24 slices.
4) EpiBOLD functional sequence during the EDP with transverse orientation, TR 2500 ms, TE
35 ms, flip angle 90°, 1 NSA for, FOV 240, 240X128 matrix, and 4.0 mm slice thickness with no
gap, with ascending interleaved acquisition, for 35 contiguous slices.
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Imaging Analysis
fMRI data was processed using Statistical Parametric Mapping (SPM8) (Wellcome
Department of Cognitive Neurology, 2008). Preprocessing included: realignment of the
functional runs and correction for bulk-head motion, coregistration of functional and anatomical
images for each participant, segmentation of the anatomical image, normalization of the
anatomical and functional images to the standard MNI template, and spatial smoothing with a
Gaussian filter (8 mm at full width, half maximum).
At first level analysis, T-maps were created from linear contrasts for the task conditions
“Negative – Neutral” and “Positive – Neutral”; these T-maps were used in the whole-brain
(masked for gray matter) second level random effects analysis of participant group effects with
two-sample t-tests. The preprocessed functional images had a voxel size of 2X2X2 mm and
cluster threshold correction was used to control for multiple comparisons (from voxel wise p =
0.005) to corrected p < 0.001 with k = 58 (corrected voxel-wise p = 0.000001)from alpha
simulation in REST (Song et al., 2011) toolbox for SPM. Average percent signal change (task
condition – fixation time between trials) was calculated for each significant cluster from the
second level group comparison using MARSBAR (Brett et al., 2002).
Functional Connectivity Analysis
Each participant completed a resting scan (eyes open with fixation cross) before the EDP
task scan. Images from the resting scan were preprocessed in SPM8 including: realignment of
the functional runs and correction for bulk-head motion, coregistration of functional and
anatomical images for each participant, segmentation of the anatomical image, and normalization
of the anatomical and functional images to the standard MNI template. To evaluate resting state
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functional connectivity to amygdala, we entered right and left amygdala (anatomical ROI from
the human AAL atlas defined in WFU PickAtlas) as seeds in a resting state functional
connectivity analysis performed using the MATLAB-based functional connectivity toolbox
CONN (Whitfield-Gabrieli and Nieto-Castanon, 2011). Each subject’s normalized structural and
functional images and T1W tissue maps were used as input into CONN. The resulting BOLD
time series were band-pass filtered (0.01-0.1Hz) to further reduce noise and increase sensitivity.
The output matrices of SPM movement were entered into Conn as first-level covariates; the
mean BOLD time series from each seed was entered as a predictor in a multiple regression
general linear model at each voxel.
Individual subject functional connectivity maps (in beta-weight units) were entered into a
whole-brain (masked for gray matter) second level random effects analysis of participant group
effects with two-sample t-tests. Cluster threshold correction was used to control for multiple
comparisons (from voxel wise p = 0.005) to corrected p < 0.001 with k = 58 (corrected voxelwise p = 0.000001) (from alpha simulation in REST (Song et al., 2011) toolbox for SPM).
Results
Participants
Participants in this study were 33 postmenopausal women. Twenty one women had no
history of depression (MDD Hx-), and 12 had a past history of depression (MDD Hx+).
Depression history was assessed using the SCID: time since first episode (M = 17.81 years, SD =
10.85), number of episodes (M = 2.1, SD = 0.95), time since last episode (M = 4.1 years, SD =
2.38). There was no significant difference in age between the participant groups (Table 1). All
participants scored within the normal range for age on the DRS, WASI IQ, and MMSE, and no
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participants endorsed significant impairments on the BCRS or GDS. There were no significant
difference between groups on these measures nor on the NEO, BDI, or BAI (Table 1),
additionally all participants scored within the non-clinical range on these measures consistent
with a euthymic state. Two of the participants in the MDD HX+ group (and no participants in the
MDD Hx-) were currently taking antidepressants during study participation. Participants taking
antidepressant medication were required to have been on the same medication and dosage for at
least 3 months. The effect of removing the 2 participants taking antidepressant medication from
analysis was examined; all results remained significant and the direction of effects was not
changed.
Self-rated Measures
There were no differences between participant groups on any of the subjective measures
(Table 2). In an analysis including all participants, SACL arousal significantly decreased after
the EDP compared to before the EDP (t (35) = 4.65, p < 0.001); there was no significant change
in SACL stress (t (35) = -0.88, p = 0.38) or POMS total mood disturbance (p = 0.13). There was
no significant difference between groups in the change in SACL arousal (t (34) = 0.52, p = 0.61),
SACL stress (t (34) = 0.38, p = 0.71), or POMS total mood disturbance (t (34) = 0.80, p = 0.43)
pre and post EDP. The EDP did not increase subjective stress or negative mood, and there was
no difference between the MDD Hx+ and MDD Hx- groups in these self-rated measures.
Emotion Dot Probe Performance
There was a difference between groups in attention facilitation for negative images
(reaction time “Neutral” trial – reaction time “Negative” trials) (F(1) = 5.40, p = 0.03); the MDD
Hx+ group had similar reaction times for “Negative” trials compared to “Neutral” trials (M = -
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.30 ms, SD = 16.08), while the MDD Hx- group had faster reaction times during “Neutral” trials
compared to “Negative” trials (M = 18.71 ms, SD = 13.65) (Figure 1).Thus the MDD Hx- group
showed attention facilitation for neutral images, while the MDD Hx+ group did not.
There was no difference in attention facilitation for positive images compared to neutral
images between the groups (F (1) = 0.58, p = 0.45). Both groups had faster reaction times for
“Neutral” trials compared to “Positive” trials: MDD Hx- (M = 18.70 ms, SD = 15.82) MDD Hx+
(M = 12.90, SD = 17.43).
There was no difference between groups for attention preference for negative (F (1) =
0.18, p = 0.68) or positive (F (1) = 0.00, p = 0.97). Further analysis and discussion will address
attention facilitation only. In an analysis of reaction time for each trial type, the MDD HX+
group was slower for all trial types, however there was no significant differences in reaction time
between groups for any trial types (negative trials: t(32) = -0.52, p = 0.61; positive trials; t(32) =
-0.99, p = 0.33; neutral trials; t(32) = -0.99, p = 0.31).
Task fMRI
There was a difference between groups in brain activity during task trials which
contained either negative or positive images (corrected p < 0.001) (Figure 1). The MDD Hx+
group had significantly greater activity in the left amygdala, right parahippocampal gyrus, and
bilateral precuneus during negative image trials (“Negative”- “Neutral”) than the MDD HXgroup (Figure 2). During positive image trials (“Positive”- “Neutral”), the MDD Hx+ group had
greater activity in the left amygdala and bilateral precentral gyrus than the MDD Hx- group.
There was no difference in activity during trials that contained only neutral images.
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Left amygdala activity for negative images was positively correlated with attention
facilitation for both negative and positive images in an analysis of all participants, with the
correlation stronger for negative facilitation (negative facilitation: r = 0.44, p < 0.01, positive
facilitation: r = 0.34, p < 0.05). However, there was no association between amygdala activity
for positive images and attention facilitation for either negative or positive images. Activity in
the right parahippocampus and bilateral precuneus was not significantly correlated with negative
or positive facilitation.
Functional Connectivity
Seeding right or left amygdala in a single t-test for all participants resulted in positive
connectivity maps that include bilateral limbic regions (amygdala and hippocampus), temporal
pole, inferior and superior temporal regions, basal ganglia, middle cingulum, insula, and inferior
frontal regions. A second level independent t-test comparison of participants groups showed
greater connectivity in the MDD Hx+ group between left amygdala and right
parahippocampus/hippocampus and bilateral precuneus (corrected p < 0.001) (Figure 3). In an
analysis of all participants, left amygdala resting connectivity to the right
parahippocampus/hippocampus was correlated with negative facilitation (r = 0.36, p < 0.05) and
amygdala activity during the EDP task (negative images: r = 0.47, p < 0.01; positive images; r =
0.38, p < 0.05; neutral images: r = 0.47, p < 0.01). Left amygdala connectivity to precuneus did
not significantly correlate with amygdala activity or performance during the EDP task. There
were no significant differences between groups for right amygdala connectivity.
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Discussion
Attention facilitation for negative images differed between the participant groups;
participants with a history of MDD showed similar reaction times for negative and neutral trials,
while participants without a history of MDD were faster to respond during neutral compared to
negative trials. These findings suggest that participants without a history of MDD avoided
orienting attention to negative images, while participants with a history of MDD showed
attention bias or an inability to suppress preferential orienting to negative images.
The difference in attention for negative images between the participant groups despite
euthymic mood supports the hypothesis that cognitive bias is a trait characteristic of depression
vulnerability rather than a consequence of negative mood. Beck’s cognitive model and recent
studies in individuals with other risk factors for depression (Joormann and Gotlib, 2007; Zhong
et al., 2012) suggest that cognitive biases may be present even before MDD onset and contribute
to increased risk for mood and anxiety disorders. There were no group differences in attention
preferences in this study, however previous studies indicate that attentional bias is modulated by
psychosocial stress (Roelofs et al., 2007; Brüne et al., 2013; Sanchez et al., 2013). Stress
proximal to EDP performance may reveal greater difference in attention bias between women
with and without MDD history. Attentional bias for negative information that remains during
depression remission may indicate a susceptibility to the depressogenic effects of negative events
and stressors.
In contrast to well accepted findings of bias for positive emotional information in never
depressed individuals (Joormann and Gotlib, 2007; Sears et al., 2011; Sanchez et al., 2013; Isaac
et al., 2014), this study found that both groups showed attention facilitation away from positive
images. This study used shorter presentation durations and more complex visual stimuli than
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previous studies that found positivity bias in never depressed participants. It may be that
attentional avoidance of negative and positive images in never depressed participants represents
an effect of arousal rather than valence. Both negative and positive images are higher in arousal
ratings than neutral images in the IAPS. Additionally, because of the short stimuli presentation
durations, participants may have adopted a strategy of avoiding highly arousing images in an
attempt to avoid negative images. Electrophysiological studies have shown that voluntarily
directing attention away from emotional distractors results in decreased amplitudes in signals
that represents emotional attention (Cesarei et al., 2009; MacNamara and Hajcak, 2009) and
affects reaction time especially for highly arousing images regardless of valence (Wiens and
Syrjänen, 2013). Participants in the current study may have avoided directing attention to highly
arousing images. However, participants with a history of MDD had equivalent reaction times
during neutral and negative trials suggesting that they were less able to direct attention away
from the negative images than from positive images.
Participants with a history of MDD also showed greater limbic and visual region activity
for emotionally valenced images than participants without a history of MDD. In all participants
left amygdala activity was correlated with attention facilitation for negative images, but not for
positive images. These results suggest that there is a stronger relation between amygdala activity
and attention for negative information than positive information. The amygdala has direct
bidirectional projections to early visual areas and likely enhances attention to emotional
information through feedback mechanisms to visual regions (Pourtois et al., 2013). Resting
functional connectivity analyses in the current study indicated stronger connectivity between left
amygdala and areas important for the integration of visual perception and attention (Cavanna and
Trimble, 2006) in participants with a history of MDD. Attention networks in individuals with a
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history of MDD may be predisposed to attentional gain for negative emotional information
through amygdala feedback to visual regions.
The results of this study should be interpreted with consideration to the limitations of the
relatively small sample size for the MDD Hx+ group and the unbalanced sample size between
the two groups. However the depression history of participants in this study was fairly
homogenous with no participants having highly recurrent depressive episodes. Additionally, this
study only included postmenopausal women as participants, which limits the interpretation of
these results for young women and men. Although sex differences in attention bias in depression
have not been previously examined, prior studies suggest sex differences in neural activity for
emotional processing that may interact with gonadal hormone levels (Kret and De Gelder, 2012).
Future studies should examine whether the association of depression history and cognitive bias
differs by sex or hormonal status.
Cognitive models predict that enhanced amygdala sensitivity and attentional processing
of negative information increases depression risk by supporting negative cognitive schemas.
Greater attention to negative information may contribute to the perception that negative
information is more salient or predictive than neutral or positive information, and modulate the
depressogenic effects of life events and stressors. The current findings of negative attention
facilitation in correlation with amygdala activity and resting connectivity in attention networks
provide evidence that differences in activity and functional connectivity in limbic and attentional
networks may provide a neurobiological basis for continued cognitive bias in remitted depressed
individuals.
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Table 1: Participant Screening

MDD Group
MDD Hx - (n = 21)

MDD Hx + (n = 12)

Mean
60.64

Standard Deviation
6.81

Mean
62.42

Standard Deviation
5.79

p value
0.45

Dementia Rating Scale

141.45

2.52

137.00

14.32

0.16

WASI IQ

118.10

10.17

115.55

12.36

0.54

Global Deterioration Scale

1.73

.46

1.75

.45

0.89

Brief Cognitive Rating Scale

9.36

1.14

9.83

1.34

0.29

Mini Mental State Exam

29.09

1.06

29.58

.67

0.16

NEO - Neuroticism

12.05

5.45

15.75

6.63

0.09

NEO - Extraversion

32.82

3.97

31.75

6.63

0.56

NEO - Openness

31.18

5.98

32.33

9.08

0.66

NEO - Agreeableness

38.77

5.00

38.33

5.05

0.81

NEO - Conscientiousness

36.32

5.57

35.33

8.21

0.68

Beck Depression Inventory

2.91

3.21

2.17

2.62

0.50

Beck Anxiety Inventory

2.68

2.95

3.08

3.26

0.72

Age
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Table 2: Subjective Measures

MDD Group
MDD Hx– (n = 21)

MDD Hx+ (n = 12)

Trait Anxiety

Mean
25.23

Standard Deviation
6.36

Mean
24.17

Standard Deviation
5.56

p value
0.63

State Anxiety

26.91

6.83

28.75

5.38

0.43

Pre SACL - Stress

1.29

2.19

.83

1.34

0.45

Pre SACL - Arousal

10.43

1.83

9.25

3.55

0.22

-13.14

13.10

-10.50

14.83

0.60

Post SACL - Stress

1.95

3.91

1.08

1.51

0.47

Post SACL - Arousal

7.36

3.76

6.67

3.58

0.60

Post POMS - Total Mood Disturbance

-9.32

17.10

-1.75

16.34

0.22

VAS - Involved

81.68

22.70

83.42

14.72

0.81

VAS - Stressful

19.77

22.16

22.42

25.17

0.75

VAS - New

75.86

27.12

68.58

40.07

0.53

VAS - Uncontrollable

26.41

33.00

23.92

23.02

0.82

VAS - Unpredictable

52.00

33.82

40.08

29.06

0.31

VAS - Anticipate

12.05

16.33

13.17

10.97

0.83

Pre POMS - Total Mood Disturbance
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Figure 1- EDP Performance and Brain Activity: A) MDD HX- group (n=21) showed greater reaction
time for both negative and positive images than neutral images during the EDP. The MDD Hx+ (n=12)
group did not show a reaction time difference between negative and neutral images. The difference in
reaction time between neutral and negative images was significantly greater in the MDD Hx- group
compared to the MDD Hx+ group (t (34) =2.78, p < 0.01). B) Amygdala activity during the EDP was
greater in the MDD HX+ during both negative positive images than the MDD Hx- group (corr p < 0.001).
Error bars: +/- 1 SD.
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Figure 2- EDP Brain Activity
Negative images - neutral images: MDD HX+ > -MDD HX- (corr p < 0.001). MDD Hx+ group
had greater activity in the left amygdala and right hippocampal complex during negative images
than the MDD Hx- group.
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Figure 3 - Functional Connectivity with Left Amygdala:
Greater resting functional connectivity between left amygdala and right hippocampal complex and
precuneus in MDD HX+ compared to MDD HX- (corr p< 0.001).
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CHAPTER 4: CONCLUSIONS AND FUTURE DIRECTIONS
Review of Findings
The main findings of this dissertation provide information about the role of estradiol in
the response to psychosocial stress, and amygdala activity and connectivity in attentional
facilitation in women with remitted MDD. The findings of Chapter 2 demonstrate that estradiol
levels in different menstrual phases modulate the neural and mood responses to psychosocial
stress such that young women show greater hippocampal deactivation and negative mood to
psychosocial stress during low estradiol phases of the menstrual cycle, while women in high
estradiol phases appear to be protected against these effects of stress. Examining cognitive bias
during MDD remission in Chapter 3 indicated that postmenopausal women with remitted MDD
show enhanced amygdala activity for all emotional image types and attentional facilitation for
negative images despite being euthymic. In both remitted and never depressed women amygdala
activity for negative images was directly correlated with attention facilitation for negative and
positive images. Resting functional connectivity analysis using the amygdala as a seed region
demonstrated greater functional connectivity between the left amygdala and right hippocampal
complex and visual regions in women with remitted MDD. Additionally, amygdala-hippocampal
connectivity was directly correlated with both amygdala activity for all image types and attention
facilitation for negative images. Data presented in Appendix A and discussed below indicate that
amygdala-hippocampal functional connectivity was reduced following estradiol treatment only
in women with remitted MDD and that estradiol treatment had interactive effects with MDD
history on mood response to psychosocial stress such that women with remitted MDD benefitted
from estradiol treatment while women with no history of MDD were negatively impacted.
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Discussion
The core symptoms of MDD represent dysfunction in systems that are necessary for
maintaining euthymic mood and regulating endocrine and emotional responses to negative
information and stress. One conceptualization of these systems is the dorsal and ventral divisions
proposed by Phillips and others (Mayberg, 1997; Phillips et al., 2003, 2008; Price and Drevets,
2012). The ventral system is comprised of brain regions including the amygdala that are involved
in early and automatic information processing, which allows for the evaluation of emotional
information and quick activation of autonomic and endocrine responses. The dorsal division
includes the hippocampus and frontal regions that integrate current information with associations
from memory and components of cognitive control (goal maintenance, decision making). These
processes serve to place current information within the context of past experiences and future
plans and regulate ventral activity. Gold’s model of stress response incorporates the dorsal and
ventral divide and demonstrates the importance of maintaining a healthy balance between the
systems for adaptive stress responding (Gold, 2015).
The hypothesis that dysregulated stress responding is integral to major depression is
supported by consistent findings of endocrine abnormalities in MDD (Gold et al., 1986; Young
et al., 1994, 2000) and the commonality of stressful life events as depression antecedents (Caspi
et al., 2003; Kendler et al., 1999, 2000). Integrated brain systems for stress responding and
emotional cognition provide a mechanism whereby enhanced ventral activity may result in
altered cognitive schemas. Unregulated ventral activity results in suppressed function (Conrad et
al., 1996; deQuervain et al., 1998; Diamond et al., 1999) and altered structural integrity
(Magariños et al., 1996; Watanabe et al., 1992; Woolley et al., 1990) in dorsal regions and may
thus perpetuate long-term enhanced emotional reactivity. Such an altered system may become
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predisposed to ventral system processes and establish cognitive bias for negative emotional
information, especially when efficient use of cognitive resources is necessary as during
psychosocial stress.
During normal stress responding dorsal system activity is reduced and ventral activity is
released from dorsal inhibition (Arnsten, 2009; Gold, 2015; Simpson et al., 2001). This shift in
brain activity initiates autonomic and endocrine responses to the stressor and results in dysphoric
mood (Gold, 2015; Phelps and LeDoux, 2005). The brain activity patterns in the presently
reported study (Chapter 2) confirm that a similar shift in activity is seen during the stress
condition of the MIST; activity is reduced in dorsal regions of the frontal and parietal cortex as
well as hippocampus. These findings also replicate those of the task developers (Pruessner et al.,
2008), and confirm that a similar activation pattern is seen in young women as mixed-sex
studies.
The findings reported in this dissertation support a role for estrogen in maintaining dorsal
function during psychosocial stress in young women. Around ovulation, when estradiol levels
are high, hippocampal activity was greater during psychosocial stress than in the early follicular
phase when estradiol levels are low. These results accord with estrogen’s known effects on
hippocampal function and support of hippocampally-mediated cognition. Reduced hippocampal
activity during stress in the low estradiol phase may suggests that normal fluctuations in ovarian
hormones across the menstrual cycle establish states when the dorsal system exerts less control
over ventral activity. During these phases women may be more susceptible to the depressogenic
effects of stressful events. Indeed, in the presented study, negative mood or “distress” was
greater following the MIST in women during the low estradiol phase and was related to both low
estradiol and hippocampal deactivation during the stress condition. Similar to Phillips model,
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Pruessner and colleagues posit that hippocampal activity towards evaluation of threat stimuli and
automatic regulation of ventral activity is a default and ongoing function (Dedovic et al., 2009;
Pruessner et al., 2008). Deactivation of the hippocampus releases ventral activity during the
stress response and allows for activation of endocrine and autonomic responses (Dedovic et al.,
2009; Jacobson and Sapolsky, 1991; Sapolsky et al., 1984). The hippocampus may act as a
gatekeeper for stress responding such that ventral activity must exceed a threshold to reduce
hippocampal activity and activate subsequent stress response pathways.
In healthy women the effects of estrogen on hippocampal regulation of stress responding
may be subtle and acute, however for women with additional vulnerabilities or preexisting
ventral-dorsal dysregulation, loss of estrogen support of dorsal function may contribute to the
risk for depression following stressful events. A recent study examining the effect of emergency
contraception following sexual assault found that six months after the assault women who
received contraception that contained estradiol had less post-traumatic stress symptoms than
women who received either contraception containing both estradiol and progesterone or no
contraception (Ferree et al., 2012). These findings support the hypothesis that estradiol levels
proximal to traumatic or stressful events may impact long term mood and memory for the event.
The presented findings similarly demonstrate that high estradiol reduces the negative mood
response following stressful events, likely through supporting hippocampal function and
restraining ventral system involvement.
The study presented in Chapter 2 did not include women with current or past mood
disorder. However preliminary data from a recent study (Appendix A) indicates that stress
responsivity and estrogen effects may differ by depression history. Postmenopausal women with
a past history of MDD had more negative mood or “distress” following the MIST than women
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with no history of MDD (Appendix A). However, 3 months of estradiol treatment appears to
reverse the effect of MDD history on mood response, such that estradiol treatment combined
with a history of MDD was associated with a less negative mood response to the MIST than
estradiol treatment in women without past MDD. Interestingly, in women with no history of
MDD estradiol treatment was associated with a more negative mood response to the MIST.
While this is the opposite effect as seen in young women (Chapter 2), this result agrees with
previous findings in older women. Newhouse and colleagues previously found that estrogen
treatment was associated with higher negative mood scores on the POMS following the Trier
stress task in healthy postmenopausal women (Newhouse et al., 2008). Although the Trier task
shares stressful components with the MIST (performance and social evaluative threat), it is not
conducted in the MRI environment suggesting that estrogen has a general effect on the
psychosocial stress response that is not specific to the type of stressor or the imaging
environment.
The study presented in Chapter 2 and previous work in young women (Andreano and
Cahill, 2010; Davydov et al., 2005; Goldstein et al., 2005) demonstrate that estrogen has
beneficial effects on emotional processing and mood, however there may be a shift in these
effects at menopause or with age such that estrogen has no or negative effect on mood following
stress. Enhanced negative emotional response to psychosocial stress in euthymic women with a
history of MDD may indicate ongoing vulnerability to depressive symptoms even during
remission. However, depression history appears to alter the effects of estrogen, such that women
who are vulnerable to depression may remain sensitive to the beneficial effect of estrogen
following menopause.
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For many MDD is a recurrent disorder. Cognitive models of MDD point to high
recurrence rates as an indication that cognitive alterations remain during remission and confer
continued vulnerability for depressive episodes (Beck, 2005; Hasselbalch et al., 2011). Bias in
allocating cognitive resources such as attention and memory towards negative information may
result in negative information appearing more salient than neutral or positive information thus
reinforcing negative schemas. The findings in Chapter 3 demonstrate that euthymic
postmenopausal women with remitted MDD show both greater amygdala activity and attention
to negative information than women with no history of MDD.
Women with no MDD history showed attentional facilitation for neutral images in
contrast to previous findings in free viewing tasks that healthy individuals generally show
attention bias for positive information(Cotton et al., 2015; Isaac et al., 2014; Joormann and
Gotlib, 2007; Sanchez et al., 2013; Sears et al., 2011). Because of the limited image presentation
duration, the EDP task simulates a situation in which processing and evaluation of emotional
information must occur rapidly. Under these conditions women with no history of MDD appear
to avoid attentional allocation to highly arousing information, thereby avoiding attending to all
emotionally valenced images compared to neutral images.
Performance on the EDP task suggests that women with past MDD show similar
avoidance of positive images as women without such history, attend more to negative images but
show no difference in attention between negative and neutral images. It may be that women with
a history of MDD are not able to avoid attending to negative information, or alternatively, that
they perceive neutral images as negative (as has been found in MDD (Gollan et al., 2008;
Leppänen et al., 2004) ) and thus attend equivocally to negative and neutral images. Greater
amygdala activity for all image types during the EDP in women with MDD history than without
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such history suggests that automatic ventral system processing of emotional information differs
between these groups even during remission and euthymia. In addition, amygdala activity was
positively correlated with attentional facilitation on the EDP indicating that altered ventral-dorsal
function and interactions has consequences for cognitive processes and bias that remains despite
remission.
The study presented in Chapter 3 found that amygdala-hippocampal functional
connectivity was greater in women with past MDD than in women with no history of MDD and
was correlated with attentional bias for negative images. The functional significance of increased
amygdala-hippocampal resting connectivity is unclear; better correlated amygdala and
hippocampal activity in women with past MDD may represent greater amygdala involvement in
hippocampal activity. If this is the case one may expect greater connectivity to be related to
better memory for negative information, which was not evident in the preliminary data
(Appendix A). Alternatively, greater amygdala-hippocampal resting connectivity may indicate
compensatory hippocampal control of enhanced amygdala activity in MDD. Amygdala activity
during emotional images and amygdala connectivity to attention and visual processing areas
were greater in women with MDD history (Chapter 3) suggesting that attentional bias for
negative images may be related to enhanced amygdala activity and ventral-driven gain in
attention and visual processes. The women in the current study were euthymic and remitted from
MDD but still showed greater amygdala activity for emotional images and greater amygdalahippocampal functional connectivity than women with no history of MDD; remission from MDD
may thus be accompanied by increased hippocampal regulation of amygdala activity. This
hypothesis accords with previous studies which have shown that amygdala-hippocampal
connectivity in healthy individuals is inversely correlated with cortisol response during
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psychosocial stress (Vaisvaser et al., 2013) and with faster recovery from experimental HPA axis
disruption (Kiem et al., 2013). Although greater amygdala-hippocampal functional connectivity
may be associated with MDD remission, tasks such as the EDP may drive amygdala activity
such that hippocampal regulation is overcome as indicated by greater amygdala activity in
women with remitted MDD and related attentional bias.
Preliminary results presented in Appendix A demonstrate that 3 months of estradiol
treatment reduced amygdala-hippocampal functional connectivity specifically in women with
MDD history such that there was no significant difference in connectivity between women with
and without a history of MDD following treatment. Whether the effect of estrogen on functional
connectivity is accompanied by changes in cognitive bias was not investigated in this
dissertation. However, the presented positive effect of estrogen on mood response to
psychosocial stress in women with a history of MDD in combination with reduced amygdalahippocampal connectivity may indicate that estrogen normalizes ventral activity and reduces
negative mood.
MDD vulnerability appears to involve aberrant interactions between ventral affective
processing pathways and dorsal regulatory and cognitive association pathways. Enhanced ventral
activity or reduced dorsal regulation may result in altered cognitive processing of emotional
information that biases attention and memory for negative information. The findings of the
studies included in this dissertation suggest a role for estrogen in modulating emotional
processing networks with effects on mood following psychosocial stress and cognitive
processing of emotional information and support the integration of neural system dysregulation
and cognitive models of MDD in women.
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Ovarian hormones have long been proposed to have a role in the sex difference in MDD,
however the mechanisms through which ovarian hormones affect depression vulnerability have
been unclear. The study presented in Appendix A suggests that estrogen enhances dorsal system
function and differentially modulates mood responses to psychosocial stress in postmenopausal
women with and without a history of MDD. Similarly, Chapter 2 demonstrates that in healthy
young women, estrogen fluctuations across the menstrual cycle affect the reduction in dorsal
activity that characterizes the central stress response. The effect of low estrogen on the mood
response to stress may be related to the negative mood commonly experienced prior to
menstruation and create periods of increased risk for depressive symptoms in vulnerable women.
Enhanced ventral activity is a common component in stress response dysregulation
(Gold, 2015) and dorsal-ventral dysregulation models of MDD (Phillips et al., 2003; Price and
Drevets, 2012) and has a central role in cognitive models as a driver of aberrant allocation of
attention and memory for negative information (Beck, 2005; Pourtois et al., 2013). The relation
between amygdala activity and attention bias for negative images found in Chapter 3 leads to the
hypothesis that enhanced automatic ventral processing of negative emotional information may be
a risk for MDD or recurrence. The findings presented in Chapter 3 indicate that amygdalahippocampal functional integration is stronger in women with past depressive episodes.
However, it is unclear whether this enhanced functional connectivity represents aberrant
amygdala involvement in hippocampal function that remains in remission and may drive
cognitive bias towards negative information, or whether it indicates a compensatory mechanism
for restoring dorsal regulation of ventral activity the may be related to successful remission.
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Limitations and Future Directions
The results of this dissertation should be interpreted with consideration of a number of
limitations. While all participants scored in the non-clinical range for mood symptoms at the
study visit, the sample sizes precluded examination of factors that may affect the findings
presented in Chapter 3 and the Appendix A, such as current depressive symptoms, number of
depressive episodes, length of illness, and treatment history. However, participants in Chapter 3
with past MDD represented a fairly homogenous MDD history with no highly recurrent or
treatment resistant depressive episodes. None of the participants reported history of anxiety
disorder and there were no group differences in trait or state anxiety, however because of the
high comorbidity of depression and anxiety disorders further characterization of anxiety
symptoms and history may be useful in determining the separate effects of depression and
anxiety. The results presented in the Appendix A should be interpreted as preliminary findings as
the group sizes were unbalanced and it is therefore difficult to ascertain the significance of
findings concerning all participant groups.
Future work should examine the interactions between estrogen and mood disorder in
young women and include participants with current illness to determine whether the beneficial
effect of estrogen on mood response to psychosocial stress seen in older women with MDD
history extends of young women and active mood disorder. The investigation of young women
presented in this dissertation was designed to minimize the effects of progesterone, however
pharmacological manipulation of ovarian hormones in young women may be useful in further
characterizing the separate effects of estrogen and progesterone.
This dissertation did not investigate the roles of neurotransmitter systems in stress
responding or emotional processing and thus cannot provide information about these potential
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mechanisms of estrogen’s effects. However, the findings support hippocampal function as a
promising target of further investigation. Examining neurotransmitter systems that impact
hippocampal function (such as the cholinergic system) may be of particular interest in future
studies of estrogen’s effect on mood, stress response, and attention in relation to MDD. Similarly
the effects of estrogen on cognitive bias should be further examined; the present study (Chapter 3
and Appendix A) did not investigate attentional bias following estradiol treatment and found no
evidence of memory bias, but did find an estradiol effect on amygdala-hippocampal functional
connectivity which suggest that estrogen may alter the functional relationship between brain
regions involved in cognitive processing of emotional information. Further, the addition of eye
tracking during the EDP task may aide in distinguishing between attentional facilitation and
avoidance.
Conclusions
The findings presented in this dissertation suggest that fluctuations of estrogen across the
menstrual cycle and at other reproductive events may contribute to negative mood alterations
through effects on brain systems integral to emotional evaluation and response with potential
cognitive consequences. Estrogen may thus protect against the depressogenic effects of stressful
life events in women. For women with current or past MDD, estrogen supplementation in young
women or replacement in older women may be a successful strategy for preventing recurrence
following stressful events. The association between negative mood response to psychosocial
stress and ovarian hormone fluctuation in women supports stronger consideration of MDD in
women as a reproductive phase-associated mood disorder and of hormone therapy as an
adjunctive treatment similar to the standard ovarian hormone therapy treatment of premenstrual
dysphoric disorder, post-partum depression, and polycystic ovarian syndrome. The findings in
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this dissertation indicate that cognitive bias for negative information remains during remission in
women and that estrogen affects brain networks involved in the cognitive processing of such
emotional information.
This work should be expanded to investigate the effects of menstrual cycle phase and
estradiol level on psychosocial stress response in women who are currently experiencing
depressive episodes or other mood and anxiety disorders such as post-traumatic stress disorder.
Additionally, whether estradiol treatment or menstrual phase affects attention facilitation for
negative images in women with current or past mood disorder should be examined. Determining
the efficacy of cognitive bias modification in reducing depressive symptoms and perhaps
reducing recurrence risk requires further investigation. However, ovarian hormone therapy may
be a potential augmentative strategy in women by supporting new learning and modulate ventraldorsal interactions integral to successful cognitive training approaches.

154

References for Chapter 4
Andreano, J., and Cahill, L. (2010). Menstrual cycle modulation of medial temporal activity
evoked by negative emotion. Neuroimage 53, 1286–1293.
Arnsten, A.F. (2009). Stress signalling pathways that impair prefrontal cortex structure and
function. Nature Reviews Neuroscience 10, 410–422.
Beck, A.T. (2005). The current state of cognitive therapy: a 40-year retrospective. JAMA
Psychiatry 62, 953–959.
Caspi, A., Sugden, K., Moffitt, T.E., Taylor, A., Craig, I.W., Harrington, H., McClay, J., Mill, J.,
Martin, J., Braithwaite, A., et al. (2003). Influence of life stress on depression:
moderation by a polymorphism in the 5-HTT gene. Science 301, 386–389.
Conrad, C.D., Galea, L.A., Kuroda, Y., and McEwen, B.S. (1996). Chronic stress impairs rat
spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment.
Behavioral Neuroscience 110, 1321–1334.
Cotton, S., Luberto, C.M., Sears, R.W., Strawn, J.R., Stahl, L., Wasson, R.S., Blom, T.J., and
Delbello, M.P. (2015). Mindfulness-based cognitive therapy for youth with anxiety
disorders at risk for bipolar disorder: a pilot trial. Early Intervention in Psychiatry.
Davydov, D., Shapiro, D., Goldstein, I., and Chicz-DeMet, A. (2005). Moods in everyday
situations: effects of menstrual cycle, work, and stress hormones. Journal of
Psychosomatic Research 58, 343–349.

155

Dedovic, K., Duchesne, A., Andrews, J., Engert, V., and Pruessner, J.C. (2009). The brain and
the stress axis: the neural correlates of cortisol regulation in response to stress.
NeuroImage 47, 864–871.
deQuervain, D.J., Roozendaal, B., and McGaugh, J.L. (1998). Stress and glucocorticoids impair
retrieval of long-term spatial memory. Nature 394, 787–790.
Diamond, D.M., Park, C.R., Heman, K.L., and Rose, G.M. (1999). Exposing rats to a predator
impairs spatial working memory in the radial arm water maze. Hippocampus 9, 542–552.
Ferree, N.K., Wheeler, M., and Cahill, L. (2012). The influence of emergency contraception on
post-traumatic stress symptoms following sexual assault. Journal of Forensic Nursing 8,
122–130.
Gold, P.W. (2015). The organization of the stress system and its dysregulation in depressive
illness. Molecular Psychiatry 20, 32–47.
Gold, P.W., Loriaux, D.L., Roy, A., Kling, M.A., Calabrese, J.R., Kellner, C.H., Nieman, L.K.,
Post, R.M., Pickar, D., and Gallucci, W. (1986). Responses to corticotropin-releasing
hormone in the hypercortisolism of depression and Cushing’s disease. Pathophysiologic
and diagnostic implications. The New England Journal of Medicine 314, 1329–1335.
Goldstein, J.M., Jerram, M., Poldrack, R., Ahern, T., Kennedy, D.N., Seidman, L.J., and Makris,
N. (2005). Hormonal cycle modulates arousal circuitry in women using functional
magnetic resonance imaging. The Journal of Neuroscience 25, 9309–9316.

156

Gollan, J.K., Pane, H.T., McCloskey, M.S., and Coccaro, E.F. (2008). Identifying differences in
biased affective information processing in major depression. Psychiatric Research 159,
18–24.
Hasselbalch, B., Knorr, U., and Kessing, L. (2010). Cognitive impairment in the remitted state of
unipolar depressive disorder: a systematic review. Journal of Affective Disorders 134,
20–31.
Isaac, L., Vrijsen, J.N., Rinck, M., Speckens, A., and Becker, E.S. (2014). Shorter gaze duration
for happy faces in current but not remitted depression: evidence from eye movements.
Psychiatry Research 218, 79–86.
Jacobson, L., and Sapolsky, R. (1991). The role of the hippocampus in feedback regulation of the
hypothalamic-pituitary-adrenocortical axis. Endocrine Review 12, 118–134.
Joormann, J., and Gotlib, I.H. (2007). Selective attention to emotional faces following recovery
from depression. Journal of Abnormal Psychology 116, 80–85.
Kendler, K.S., Karkowski, L.M., and Prescott, C.A. (1999). Causal relationship between stressful
life events and the onset of major depression. The American Journal of Psychiatry 156,
837–841.
Kendler, K.S., Thornton, L.M., and Gardner, C.O. (2000). Stressful life events and previous
episodes in the etiology of major depression in women: an evaluation of the “kindling”
hypothesis. The American Journal of Psychiatry 157, 1243–1251.

157

Kiem, S.A., Andrade, K.C., Spoormaker, V.I., Holsboer, F., Czisch, M., and Sämann, P.G.
(2013). Resting state functional MRI connectivity predicts hypothalamus-pituitary-axis
status in healthy males. Psychoneuroendocrinology 38, 1338–1348.
Leppänen, J.K., Milders, M., Bell, J.S., Terriere, E., and Hietanen, J.K. (2004). Depression
biases the recognition of emotionally neutral faces. Psychiatry Research 128, 123–133.
Magariños, A.M., McEwen, B.S., Flügge, G., and Fuchs, E. (1996). Chronic psychosocial stress
causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate
tree shrews. The Journal of Neuroscience 16, 3534–3540.
Mayberg, H.S. (1997). Limbic-cortical dysregulation: a proposed model of depression. The
Journal of Neuropsychiatry and Clinical Neurosciences 9, 471–481.
Newhouse, P.A., Dumas, J., Hancur-Bucci, C., Naylor, M., Sites, C.K., Benkelfat, C., and
Young, S.N. (2008). Estrogen administration negatively alters mood following
monoaminergic depletion and psychosocial stress in postmenopausal women.
Neuropsychopharmacology 33, 1514–1527.
Phelps, E.A., and LeDoux, J.E. (2005). Contributions of the amygdala to emotion processing:
from animal models to human behavior. Neuron 48, 175–187.
Phillips, M.L., Drevets, W.C., Rauch, S.L., and Lane, R. (2003). Neurobiology of emotion
perception II: Implications for major psychiatric disorders. Biological Psychiatry 54,
515–528.

158

Phillips, M.L., Ladouceur, C.D., and Drevets, W.C. (2008). A neural model of voluntary and
automatic emotion regulation: implications for understanding the pathophysiology and
neurodevelopment of bipolar disorder. Molecular Psychiatry 13, 829, 833–857.
Pourtois, G., Schettino, A., and Vuilleumier, P. (2013). Brain mechanisms for emotional
influences on perception and attention: what is magic and what is not. Biological
Psychology 92, 492–512.
Price, J.L., and Drevets, W.C. (2012). Neural circuits underlying the pathophysiology of mood
disorders. Trends in Cognitive Sciences 16, 61–71.
Pruessner, J.C., Dedovic, K., Khalili-Mahani, N., Engert, V., Pruessner, M., Buss, C., Renwick,
R., Dagher, A., Meaney, M.J., and Lupien, S. (2008). Deactivation of the limbic system
during acute psychosocial stress: evidence from positron emission tomography and
functional magnetic resonance imaging studies. Biological Psychiatry 63, 234–240.
Sanchez, A., Vazquez, C., Marker, C., LeMoult, J., and Joormann, J. (2013). Attentional
disengagement predicts stress recovery in depression: an eye-tracking study. Journal of
Abnormal Psychology 122, 303–313.
Sapolsky, R.M., Krey, L.C., and McEwen, B.S. (1984). Glucocorticoid-sensitive hippocampal
neurons are involved in terminating the adrenocortical stress response. Proceedings of the
National Academy of Sciences 81, 6174–6177.
Sears, C., Newman, K., Ference, J., and Thomas, C. (2011). Attention to Emotional Images in
Previously Depressed Individuals: An Eye-Tracking Study. Cognitive Therapy and
Research 35, 517–528.

159

Simpson, J.R., Drevets, W.C., Snyder, A.Z., Gusnard, D.A., and Raichle, M.E. (2001). Emotioninduced changes in human medial prefrontal cortex: II. During anticipatory anxiety.
Proceedings of the National Academy of Sciences 98, 688–693.
Vaisvaser, S., Lin, T., Admon, R., Podlipsky, I., Greenman, Y., Stern, N., Fruchter, E., Wald, I.,
Pine, D.S., Tarrasch, R., et al. (2013). Neural traces of stress: cortisol related sustained
enhancement of amygdala-hippocampal functional connectivity. Frontiers in Human
Neuroscience 7, 313.
Watanabe, Y., Gould, E., and McEwen, B.S. (1992). Stress induces atrophy of apical dendrites of
hippocampal CA3 pyramidal neurons. Brain Research 588, 341–345.
Woolley, C.S., Gould, E., and McEwen, B.S. (1990). Exposure to excess glucocorticoids alters
dendritic morphology of adult hippocampal pyramidal neurons. Brain Research 531,
225–231.
Young, E.A., Haskett, R.F., Grunhaus, L., Pande, A., Weinberg, V.M., Watson, S.J., and Akil, H.
(1994). Increased evening activation of the hypothalamic-pituitary-adrenal axis in
depressed patients. Archives of General Psychiatry 51, 701–707.
Young, E.A., Lopez, J.F., Murphy-Weinberg, V., Watson, S.J., and Akil, H. (2000). Hormonal
evidence for altered responsiveness to social stress in major depression.
Neuropsychopharmacology 23, 411–418.

160

COMPREHENSIVE BIBLIOGRAPHY
Adli, M., Bauer, M., and Rush, A.J. (2006). Algorithms and collaborative-care systems for
depression: are they effective and why? A systematic review. Biological Psychiatry 59,
1029–1038.
Andreano, J., and Cahill, L. (2010). Menstrual cycle modulation of medial temporal activity
evoked by negative emotion. Neuroimage 53, 1286–1293.
Altemus, M. (2006). Sex differences in depression and anxiety disorders: potential biological
determinants. Hormones and Behavior 50, 534–538.
American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders
(5th ed.) (Washington, DC: American Psychiatric Association).
Archer, D.F., Sturdee, D.W., Baber, R., de Villiers, T.J., Pines, A., Freedman, R.R., Gompel, A.,
Hickey, M., Hunter, M.S., Lobo, R.A., et al. (2011). Menopausal hot flushes and night
sweats: where are we now? Climacteric 14, 515–528.
Armstrong, T., and Olatunji, B.O. (2013). Eye tracking of attention in the affective disorders: a
meta-analytic review and synthesis. Clinical Psychology Review 32, 704–723.
Arnone, D., McKie, S., Elliott, R., Thomas, E.J., Downey, D., Juhasz, G., Williams, S.R.,
Deakin, J.F., and Anderson, I.M. (2012). Increased amygdala responses to sad but not
fearful faces in major depression: relation to mood state and pharmacological treatment.
The American Journal of Psychiatry 169, 841–850.
Arnsten, A.F. (2009). Stress signalling pathways that impair prefrontal cortex structure and
function. Nature Reviews Neuroscience 10, 410–422.

161

Baca-Garcia, E., Diaz-Sastre, C., Ceverino, A., Resa, E., Oquendo, M., Saiz-Ruiz, J., and Leon,
J. (2004). Premenstrual symptoms and luteal suicide attempts. European Archives of
Psychiatry and Clinical Neuroscience 254, 326–329.
Beck AT, Haigh EA. (2014). Advances in cognitive theory and therapy: the generic cognitive
model. Clinical Psychology 10:1–24.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. (1961). An inventory for measuring
depression. Archives of General Psychiatry 4:561–71.
Beck AT. (2005). The current state of cognitive therapy: a 40-year retrospective. JAMA
Psychiatry 62:953–959.
Beck, A., Ward, C., Mendelson, M., Mock, J., and Erbaugh, J. (1961). An inventory for
measuring depression. Archives of General Psychiatry 4, 53–63.
Berman, K.F., Schmidt, P.J., Rubinow, D.R., Danaceau, M.A., Van Horn, J.D., Esposito, G.,
Ostrem, J.L., and Weinberger, D.R. (1997). Modulation of cognition-specific cortical
activity by gonadal steroids: a positron-emission tomography study in women.
Proceedings of the National Academy of Sciences 94, 8836–8841.
Berthoz, S., Armony, J., Blair, R., and Dolan, R. (2002). An fMRI study of intentional and
unintentional (embarrassing) violations of social norms. Brain 125, 1696–1708.
Bishop, S.J., Duncan, J., and Lawrence, A.D. (2004). State anxiety modulation of the amygdala
response to unattended threat-related stimuli. The Journal of Neuroscience 24, 10364–
10368.

162

Booij, L., Van der Does, A.J., and Riedel, W.J. (2003). Monoamine depletion in psychiatric and
healthy populations: review. Molecular Psychiatry 8, 951–973.
Booij, L., Van der Does, W., Benkelfat, C., Bremner, J.D., Cowen, P.J., Fava, M., Gillin, C.,
Leyton, M., Moore, P., Smith, K.A., et al. (2002). Predictors of mood response to acute
tryptophan depletion. A reanalysis. Neuropsychopharmacology 27, 852–861.
Borrow, A.P., and Cameron, N.M. (2014). Estrogenic mediation of serotonergic and
neurotrophic systems: implications for female mood disorders. Progress in NeuroPsychopharmacology & Biological Psychiatry 54, 13–25.
Bove, R, Secor, E, Chibnik, L.B., and Barnes, L.L. (2014). Age at surgical menopause influences
cognitive decline and Alzheimer pathology in older women. Neurology 82, 222–229.
Bradley, M.M., and Lang, P.J. (1999) Affective norms for English words (ANEW): Instruction
manual and affective ratings. The Center for Research in Psychophysiology, University
of Florida.
Brett M, Anton JL, Valabregue R, Poline JB. (2002). Region of interest analysis using the
MarsBar toolbox for SPM 99. Neuroimage 16:S497.
Bromberger, J.T., Schott, L.L., Kravitz, H.M., Sowers, M., Avis, N.E., Gold, E.B., Randolph,
J.F., and Matthews, K.A. (2010). Longitudinal change in reproductive hormones and
depressive symptoms across the menopausal transition: results from the Study of
Women’s Health Across the Nation (SWAN). Archives of General Psychiatry 67, 598–
607.

163

Bromet, E., Andrade, L., Hwang, I., Sampson, N., Alonso, J., Girolamo, G., Graaf, R.,
Demyttenaere, K., Hu, C., Iwata, N., et al. (2011). Cross-national epidemiology of DSMIV major depressive episode. BMC Medicine 9, 90.
Brundtland, G.H. (2001). From the World Health Organization. Mental health: new
understanding, new hope. JAMA 286, 2391.
Brüne M, Nadolny N, Güntürkün O, Wolf OT. (2013). Stress induces a functional asymmetry in
an emotional attention task. Cognition & Emotion 27:558–66.
Bryant, R.A., Felmingham, K.L., Silove, D., Creamer, M., O’Donnell, M., and McFarlane, A.C.
(2011). The association between menstrual cycle and traumatic memories. Journal of
Affective Disorders 131, 398–401.
Burke, H.M., Fernald, L.C., Gertler, P.J., and Adler, N.E. (2005). Depressive symptoms are
associated with blunted cortisol stress responses in very low-income women.
Psychosomatic Medicine 67, 211–216.
Burt, C.E., Cohen, L.H., and Bjorck, J.P. (1988). Perceived family environment as a moderator
of young adolescents’ life stress adjustment. American Journal of Community
Psychology 16, 101–122.
Caetano SC, Hatch JP, Brambilla P, Sassi RB, Nicoletti M, Mallinger AG, Frank E, Kupfer DJ,
Keshavan MS, Soares JC. (2004). Anatomical MRI study of hippocampus and amygdala
in patients with current and remitted major depression. Psychiatry Research 132:141–7.

164

Canli, T., Desmond, J.E., Zhao, Z., and Gabrieli, J.D. (2002). Sex differences in the neural basis
of emotional memories. Proceedings of the National Academy of Sciences 99, 10789–
10794.
Carney, R.M., and Freedland, K.E. (2003). Depression, mortality, and medical morbidity in
patients with coronary heart disease. Biological Psychiatry 54, 241–247.
Caspi, A., Sugden, K., Moffitt, T.E., Taylor, A., Craig, I.W., Harrington, H., McClay, J., Mill, J.,
Martin, J., Braithwaite, A., et al. (2003). Influence of life stress on depression:
moderation by a polymorphism in the 5-HTT gene. Science 301, 386–389.
Cavanna AE, Trimble MR. (2006). The precuneus: a review of its functional anatomy and
behavioural correlates. Brain A Journal of Neurology 129:564–83.
Cesarei A, Codispoti M, Schupp H. (2009). Peripheral vision and preferential emotion
processing. Neuroreport 20:1439–1443.
Chatterton, R., Mateo, E., Hou, N., Rademaker, A., Acharya, S., Jordan, V., and Morrow, M.
(2005). Characteristics of salivary profiles of oestradiol and progesterone in
premenopausal women. Journal of Endocrinology 186, 77–84.
Chen, P., Kales, H.C., Weintraub, D., Blow, F.C., Jiang, L., and Mellow, A.M. (2007).
Antidepressant treatment of veterans with Parkinson’s disease and depression: analysis of
a national sample. Journal of Geriatric Psychiatry and Neurology 20, 161–165.
Chrousos, G.P., and Gold, P.W. (1992). The concepts of stress and stress system disorders.
Overview of physical and behavioral homeostasis. JAMA 267, 1244–1252.

165

Chun, M.M., and Turk-Browne, N.B. (2007). Interactions between attention and memory.
Current Opinion in Neurobiology 17, 177–184.
Cohen, L.S., Soares, C.N., Poitras, J.R., Prouty, J., Alexander, A.B., and Shifren, J.L. (2003).
Short-term use of estradiol for depression in perimenopausal and postmenopausal
women: a preliminary report. The American Journal of Psychiatry 160, 1519–1522.
Colla, M., Kronenberg, G., Deuschle, M., Meichel, K., Hagen, T., Bohrer, M., and Heuser, I.
(2007). Hippocampal volume reduction and HPA-system activity in major depression.
Journal of Psychiatric Research 41, 553–560.
Colzato, L.S., Hertsig, G., van den Wildenberg, W.P., and Hommel, B. (2010). Estrogen
modulates inhibitory control in healthy human females: evidence from the stop-signal
paradigm. Neuroscience 167, 709–715.
Colzato, L.S., Pratt, J., and Hommel, B. (2012). Estrogen modulates inhibition of return in
healthy human females. Neuropsychologia 50, 98–103.
Compton, J., Travis, M.J., Norbury, R., Erlandsson, K., van Amelsvoort, T., Daly, E.,
Waddington, W., Matthiasson, P., Eersels, J.L., Whitehead, M., et al. (2008). Long-term
estrogen therapy and 5-HT (2A) receptor binding in postmenopausal women; a single
photon emission tomography (SPET) study. Hormones and Behavior 53, 61–68.
Conrad, C.D., Galea, L.A., Kuroda, Y., and McEwen, B.S. (1996). Chronic stress impairs rat
spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment.
Behavioral Neuroscience 110, 1321–1334.

166

Cornwell, B.R., Alvarez, R.P., Lissek, S., Kaplan, R., Ernst, M., and Grillon, C. (2011). Anxiety
overrides the blocking effects of high perceptual load on amygdala reactivity to threatrelated distractors. Neuropsychologia 49, 1363–1368.
Costa, P., and McCrae, R. (2000). Overview: innovations in assessment using the revised NEO
personality inventory. Assessment 7, 325–327.
Cotton, S., Luberto, C.M., Sears, R.W., Strawn, J.R., Stahl, L., Wasson, R.S., Blom, T.J., and
Delbello, M.P. (2015). Mindfulness-based cognitive therapy for youth with anxiety
disorders at risk for bipolar disorder: a pilot trial. Early Intervention in Psychiatry.
Craig, M.C., and Murphy, D.G. (2007). Estrogen: effects on normal brain function and
neuropsychiatric disorders. Climacteric 10, 97–104.
Damasio, AR, Grabowski, TJ, and Bechara, A (2000). Subcortical and cortical brain activity
during the feeling of self-generated emotions. Nature 10, 1049-56.
Davydov, D., Shapiro, D., Goldstein, I., and Chicz-DeMet, A. (2005). Moods in everyday
situations: effects of menstrual cycle, work, and stress hormones. Journal of
Psychosomatic Research 58, 343–349.
De Quervain, D.J., Roozendaal, B., Nitsch, R.M., McGaugh, J.L., and Hock, C. (2000). Acute
cortisone administration impairs retrieval of long-term declarative memory in humans.
Nature Neuroscience 3, 313–314.
Dedovic, K., Duchesne, A., Andrews, J., Engert, V., and Pruessner, J.C. (2009). The brain and
the stress axis: the neural correlates of cortisol regulation in response to stress.
NeuroImage 47, 864–871.

167

Delgado, P.L., Charney, D.S., Price, L.H., Landis, H., and Heninger, G.R. (1989).
Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy
subjects. Life Sciences 45, 2323–2332.
Dent, J., and Teasdale, J.D. (1988). Negative cognition and the persistence of depression. Journal
of Abnormal Psychology 97, 29–34.
deQuervain, D.J., Roozendaal, B., and McGaugh, J.L. (1998). Stress and glucocorticoids impair
retrieval of long-term spatial memory. Nature 394, 787–790.
Derijk, R., and Sternberg, E.M. (1994). Corticosteroid Action and Neuroendocrine‐Immune
Interactions. Annals of the New York Academy of Science 746, 33–41.
Derntl, B, Windischberger, C, and Robinson, S (2008). Facial emotion recognition and amygdala
activation are associated with menstrual cycle phase. Psychoneuroendocrinology 32,
704–723.
Diamond, D.M., Park, C.R., Heman, K.L., and Rose, G.M. (1999). Exposing rats to a predator
impairs spatial working memory in the radial arm water maze. Hippocampus 9, 542–552.
Disner, S.G., Beevers, C.G., Haigh, E.A., and Beck, A.T. (2011). Neural mechanisms of the
cognitive model of depression. Nature Reviews Neuroscience 12, 467–477.
Drevets, W.C. (2003). Neuroimaging abnormalities in the amygdala in mood disorders. Annals
of the New York Academy of Sciences 985, 420–444.
Drevets, W.C., Price, J.L., and Furey, M.L. (2008). Brain structural and functional abnormalities
in mood disorders: implications for neurocircuitry models of depression. Brain Structure
and Function 213, 93–118.

168

Drevets, W.C., Price, J.L., Bardgett, M.E., Reich, T., Todd, R.D., and Raichle, M.E. (2002).
Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype
and plasma cortisol levels. Pharmacology, Biochemistry, and Behavior 71, 431–447.
Drevets, W.C., Price, J.L., Simpson, J.R., Todd, R.D., Reich, T., Vannier, M., and Raichle, M.E.
(1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824–
827.
Duman, R.S., and Li, N. (2012). A neurotrophic hypothesis of depression: role of synaptogenesis
in the actions of NMDA receptor antagonists. Philosophical Transactions of the Royal
Society of London. Series B, Biological Sciences 367, 2475–2484.
Dumas, J., Hancur-Bucci, C., Naylor, M., Sites, C., and Newhouse, P. (2006). Estrogen treatment
effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal
women. Neuropsychopharmacology 31, 2065–2078.
Dumas, J., Hancur-Bucci, C., Naylor, M., Sites, C., and Newhouse, P. (2008). Estradiol interacts
with the cholinergic system to affect verbal memory in postmenopausal women: evidence
for the critical period hypothesis. Hormones and Behavior 53, 159–169.
Dumas, J., Kutz, A.M., Naylor, M.R., Johnson, J.V., and Newhouse, P.A. (2012). Estradiol
treatment altered anticholinergic-related brain activation during working memory in
postmenopausal women. Neuroimage 60, 1394–1403.
Duque A, Vázquez C. (2015). Double attention bias for positive and negative emotional faces in
clinical depression: evidence from an eye-tracking study. Journal of Behavior Therapy
and Experimental Psychiatry 46:107–14.

169

Egeth, H.E., and Yantis, S. (1997). Visual attention: control, representation, and time course.
Annual Review of Psychology 48, 269–297.
Ellenbogen, M.A., Young, S.N., Dean, P., Palmour, R.M., and Benkelfat, C. (1996). Mood
response to acute tryptophan depletion in healthy volunteers: sex differences and
temporal stability. Neuropsychopharmacology 15, 465–474.
Epperson, C.N., Amin, Z., Ruparel, K., Gur, R., and Loughead, J. (2012). Interactive effects of
estrogen and serotonin on brain activation during working memory and affective
processing in menopausal women. Psychoneuroendocrinology 37, 372–382.
Erk, S., Mikschl, A., Stier, S., Ciaramidaro, A., Gapp, V., Weber, B., and Walter, H. (2010).
Acute and Sustained Effects of Cognitive Emotion Regulation in Major Depression. The
Journal of Neuroscience 30, 15726–15734.
Ertman, N., Andreano, J.M., and Cahill, L. (2012). Progesterone at encoding predicts subsequent
emotional memory. Learning & Memory 18, 759–763.
Etgen, A.M., and Karkanias, G.B. (1994). Estrogen regulation of noradrenergic signaling in the
hypothalamus. Psychoneuroendocrinology 19, 603–610.
Fader, A.J., Hendricson, A.W., and Dohanich, G.P. (1998). Estrogen improves performance of
reinforced T-maze alternation and prevents the amnestic effects of scopolamine
administered systemically or intrahippocampally. Neurobiology of Learning and Memory
69, 225–240.

170

Fader, A.J., Johnson, P.E., and Dohanich, G.P. (1999). Estrogen improves working but not
reference memory and prevents amnestic effects of scopolamine of a radial-arm maze.
Pharmacology, Biochemistry, and Behavior 62, 711–717.
Farrag, A.F., Khedr, E.M., Abdel-Aleem, H., and Rageh, T.A. (2002). Effect of surgical
menopause on cognitive functions. Dementia and Geriatric Cognitive Disorders 13, 193–
198.
Feldman, S., and Weidenfeld, J. (1999). Glucocorticoid receptor antagonists in the hippocampus
modify the negative feedback following neural stimuli. Brain Research 821, 33–37.
Ferree, and Cahill (2009). Post-event spontaneous intrusive recollections and strength of memory
for emotional events in men and women. Consciousness and Cognition 18,126-34.
Ferree, Kamat, and Cahill (2011). Influences of menstrual cycle position and sex hormone levels
on spontaneous intrusive recollections following emotional stimuli. Consciousness and
Cognition 20:4, 1154–1162.
Ferree, N.K., Wheeler, M., and Cahill, L. (2012). The influence of emergency contraception on
post-traumatic stress symptoms following sexual assault. Journal of Forensic Nursing 8,
122–130.
Fink, G., Sumner, B., Rosie, R., Grace, O., and Quinn, J. (1995). Estrogen control of central
neurotransmission: Effect on mood, mental state, and memory. Cellular and Molecular
Neurobiology 16, 325–344.

171

Fink, G., Sumner, B.E., McQueen, J.K., Wilson, H., and Rosie, R. (1998). Sex steroid control of
mood, mental state and memory. Clinical and Experimental Pharmacology & Physiology
25, 764–775.
Folstein MF, Folstein SE, McHugh PR. (1975). “Mini-mental state”. A practical method for
grading the cognitive state of patients for the clinician. Journal of Psychiatric Research
12:189–98.
Frank, E., Anderson, B., Reynolds, C.F., Ritenour, A., and Kupfer, D.J. (1994). Life events and
the research diagnostic criteria endogenous subtype. A confirmation of the distinction
using the Bedford College methods. Archives of General Psychiatry 51, 519–524.
Freeman, E.W., Sammel, M.D., Boorman, D.W., and Zhang, R. (2014). Longitudinal pattern of
depressive symptoms around natural menopause. JAMA Psychiatry 71, 36–43.
Fuxe, K., Härfstrand, A., Agnati, L.F., Yu, Z.Y., Cintra, A., Wikström, A.C., Okret, S., Cantoni,
E., and Gustafsson, J.A. (1985). Immunocytochemical studies on the localization of
glucocorticoid receptor immunoreactive nerve cells in the lower brain stem and spinal
cord of the male rat using a monoclonal antibody against rat liver glucocorticoid receptor.
Neuroscience Letters 60, 1–6.
Gaddy M, Ingram R. (2014). A meta-analytic review of mood-congruent implicit memory in
depressed mood. Clinical Psychology Review 34:402416.
Genazzani, A.R., Bernardi, F., Pluchino, N., Begliuomini, S., Lenzi, E., Casarosa, E., and Luisi,
M. (2005). Endocrinology of menopausal transition and its brain implications. CNS
Spectrums 10, 449–457.

172

George, MS, Ketter, TA, Parekh, PI, and Herscovitch, P (1996). Gender differences in regional
cerebral blood flow during transient self-induced sadness or happiness. Biological
Psychiatry 1, 859-71.
Gibbs, R.B. (2000a). Effects of gonadal hormone replacement on measures of basal forebrain
cholinergic function. Neuroscience 101, 931–938.
Gibbs, R.B. (2000b). Estrogen replacement enhances acquisition of a spatial memory task and
reduces deficits associated with hippocampal muscarinic receptor inhibition. Hormones
and Behavior 36, 222–233.
Gibbs, R.B. (2002). Basal forebrain cholinergic neurons are necessary for estrogen to enhance
acquisition of a delayed matching-to-position T-maze task. Hormones and Behavior 42,
245–257.
Gibbs, R.B. (2007). Estradiol enhances DMP acquisition via a mechanism not mediated by
turning strategy but which requires intact basal forebrain cholinergic projections.
Hormones and Behavior 52, 352–359.
Gibbs, R.B. (2010). Estrogen therapy and cognition: a review of the cholinergic hypothesis.
Endocrine Reviews 31, 224–253.
Gillies, G., and McArthur, S. (2010). Estrogen Actions in the Brain and the Basis for Differential
Action in Men and Women: A Case for Sex-Specific Medicines. Pharmacological
Reviews 62, 155-98.

173

Glue, P., Donovan, M., Kolluri, S., and Emir, B. (2010). Meta-analysis of relapse prevention
antidepressant trials in depressive disorders. Australian and New Zealand Journal of
Psychiatry 44, 697–705.
Gold, P.W. (2015). The organization of the stress system and its dysregulation in depressive
illness. Molecular Psychiatry 20, 32–47.
Gold, P.W., Loriaux, D.L., Roy, A., Kling, M.A., Calabrese, J.R., Kellner, C.H., Nieman, L.K.,
Post, R.M., Pickar, D., and Gallucci, W. (1986). Responses to corticotropin-releasing
hormone in the hypercortisolism of depression and Cushing’s disease. Pathophysiologic
and diagnostic implications. The New England Journal of Medicine 314, 1329–1335.
Goldstein, J.M., Jerram, M., Poldrack, R., Ahern, T., Kennedy, D.N., Seidman, L.J., and Makris,
N. (2005). Hormonal cycle modulates arousal circuitry in women using functional
magnetic resonance imaging. The Journal of Neuroscience 25, 9309–9316.
Gollan, J.K., Pane, H.T., McCloskey, M.S., and Coccaro, E.F. (2008). Identifying differences in
biased affective information processing in major depression. Psychiatric Research 159,
18–24.
Gonda, X., Telek, T., Juhász, G., Lazary, J., Vargha, A., and Bagdy, G. (2008). Patterns of mood
changes throughout the reproductive cycle in healthy women without premenstrual
dysphoric disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry 32,
1782–1788.
Gotlib, I., and Joormann, J. (2010). Cognition and Depression: Current Status and Future
Directions. Clinical Psychology 6, 285–312.

174

Gotlib, I.H., Krasnoperova, E., Yue, D.N., and Joormann, J. (2004). Attentional biases for
negative interpersonal stimuli in clinical depression. Journal of Abnormal Psychology
113, 121–135.
Greendale, G.A., Reboussin, B.A., Hogan, P., Barnabei, V.M., Shumaker, S., Johnson, S., and
Barrett-Connor, E. (1998). Symptom relief and side effects of postmenopausal hormones:
results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstetrics and
Gynecology 92, 982–988.
Greene, G.L., Gilna, P., Waterfield, M., Baker, A., Hort, Y., and Shine, J. (1986). Sequence and
expression of human estrogen receptor complementary DNA. Science 231, 1150–1154.
Grothe, M.J., Heinsen, H., Amaro, E., Grinberg, L.T., and Teipel, S.J. (2015). Cognitive
Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild
Cognitive Impairment. Cerebral Cortex 48, 413-421.
Haddad, A., Williams, M., McTavish, S., and Harmer, C. (2009). Low-dose tryptophan depletion
in recovered depressed women induces impairments in autobiographical memory
specificity. Psychopharmacology 207, 499-508.
Halbreich, U., Lumley, L.A., Palter, S., Manning, C., Gengo, F., and Joe, S.H. (1995a). Possible
acceleration of age effects on cognition following menopause. Journal of Psychiatric
Research 29, 153–163.
Halbreich, U., Rojansky, N., Palter, S., Tworek, H., Hissin, P., and Wang, K. (1995b). Estrogen
augments serotonergic activity in postmenopausal women. Biological Psychiatry 37,
434–441.

175

Hall, G., Witelson, SF, Szechtman, H, and Nahmias, C (2004). Sex differences in functional
activation patterns revealed by increased emotion processing demands. Neuroreport 9,
219-23.
Hallion L, Ruscio A. (2011). A meta-analysis of the effect of cognitive bias modification on
anxiety and depression. Psychological Bulletin 137:940–58.
Hammen, C. (1991). Generation of stress in the course of unipolar depression. Journal of
Abnormal Psychology 100, 555–561.
Hampson, E., and Morley, E.E. (2013). Estradiol concentrations and working memory
performance in women of reproductive age. Psychoneuroendocrinology 38.
Hampson, E., Anders, S., and Mullin, L. (2006). A female advantage in the recognition of
emotional facial expressions: Test of an evolutionary hypothesis. Evolution and Human
Behavior 27, 401–416.
Hankin, B.L., Mermelstein, R., and Roesch, L. (2007). Sex differences in adolescent depression:
stress exposure and reactivity models. Child Development 78, 279–295.
Hardeveld, F., Spijker, J., and Graaf, D.R. (2010). Prevalence and predictors of recurrence of
major depressive disorder in the adult population. Acta Psychiatrica Scandinavica 122,
184–191.
Harsh, V., Meltzer-Brody, S., Rubinow, D.R., and Schmidt, P.J. (2009). Reproductive aging, sex
steroids, and mood disorders. Harvard Review of Psychiatry 17, 87–102.

176

Hasselbalch, B., Knorr, U., and Kessing, L. (2010). Cognitive impairment in the remitted state of
unipolar depressive disorder: a systematic review. Journal of Affective Disorders 134,
20–31.
Hayward, G., Goodwin, G.M., Cowen, P.J., and Harmer, C.J. (2005). Low-dose tryptophan
depletion in recovered depressed patients induces changes in cognitive processing
without depressive symptoms. Biological Psychiatry 57, 517–524.
Herman, J.P., Adams, D., and Prewitt, C. (1995). Regulatory changes in neuroendocrine stressintegrative circuitry produced by a variable stress paradigm. Neuroendocrinology 61,
180–190.
Herman, J.P., and Cullinan, W.E. (1997). Neurocircuitry of stress: central control of the
hypothalamo-pituitary-adrenocortical axis. Trends in Neurosciences 20, 78–84.
Hogervorst, E., and Bandelow, S. (2010). Sex steroids to maintain cognitive function in women
after the menopause: a meta-analyses of treatment trials. Maturitas 66, 56–71.
Holsboer, F., Von Bardeleben, U., Gerken, A., Stalla, G.K., and Müller, O.A. (1984). Blunted
corticotropin and normal cortisol response to human corticotropin-releasing factor in
depression. The New England Journal of Medicine 311, 1127.
Holtmann, J., Herbort, M.C., and Wüstenberg, T. (2013). Trait anxiety modulates fronto-limbic
processing of emotional interference in borderline personality disorder. Frontiers in
Human Neuroscience 7.
Huettel, S. A., Song, A. W., and McCarthy, G. (2009). Functional magnetic resonance imaging.
Sunderland, Mass: Sinauer Associates.

177

Inagaki, T., Gautreaux, C., and Luine, V. (2010). Acute estrogen treatment facilitates
recognition memory consolidation and alters monoamine levels in memory-related brain
areas. Hormones and Behavior 58, 415–426.
Iraizoz, I., Guijarro, J.L., Gonzalo, L.M., and de Lacalle, S. (1999). Neuropathological changes
in the nucleus basalis correlate with clinical measures of dementia. Acta
Neuropathologica 98, 186–196.
Isaac, L., Vrijsen, J.N., Rinck, M., Speckens, A., and Becker, E.S. (2014). Shorter gaze duration
for happy faces in current but not remitted depression: evidence from eye movements.
Psychiatry Research 218, 79–86.
Jaako-Movits, K., Zharkovsky, T., Pedersen, M., and Zharkovsky, A. (2006). Decreased
hippocampal neurogenesis following olfactory bulbectomy is reversed by repeated
citalopram administration. Cellular and Molecular Neurobiology 26, 1559–1570.
Jacobson, L., and Sapolsky, R. (1991). The role of the hippocampus in feedback regulation of the
hypothalamic-pituitary-adrenocortical axis. Endocrine Review 12, 118–134.
Jankord, R., and Herman, J.P. (2008). Limbic regulation of hypothalamo-pituitary-adrenocortical
function during acute and chronic stress. Annals of the New York Academy of Sciences
1148, 64–73.
Jiang, W., Krishnan, R.R., and O’Connor, C.M. (2002). Depression and heart disease: evidence
of a link, and its therapeutic implications. CNS Drugs 16, 111–127.
Joffe, H., Hall, J.E., Gruber, S., Sarmiento, I.A., Cohen, L.S., Yurgelun-Todd, D., and Martin,
K.A. (2006). Estrogen therapy selectively enhances prefrontal cognitive processes: a

178

randomized, double-blind, placebo-controlled study with functional magnetic resonance
imaging in perimenopausal and recently postmenopausal women. Menopause 13, 411–
422.
Johnson, E.O., Kamilaris, T.C., Chrousos, G.P., and Gold, P.W. (1992). Mechanisms of stress: a
dynamic overview of hormonal and behavioral homeostasis. Neuroscience and
Biobehavioral Reviews 16, 115–130.
Joormann, J., and Gotlib, I.H. (2007). Selective attention to emotional faces following recovery
from depression. Journal of Abnormal Psychology 116, 80–85.
Joynt, K.E., Whellan, D.J., and O’Connor, C.M. (2003). Depression and cardiovascular disease:
mechanisms of interaction. Biological Psychiatry 54, 248–261.
Kajantie, E., and Phillips, D. (2006). The effects of sex and hormonal status on the physiological
response to acute psychosocial stress. Psychoneuroendocrinology 31, 151–178.
Keller MB, Berndt ER. (2002). Depression treatment: a lifelong commitment?
Psychopharmacology Bulletin 36:133–41.
Kelly, M.J., and Levin, E.R. (2001). Rapid actions of plasma membrane estrogen receptors.
Trends in Endocrinology and Metabolism 12, 152–156.
Kelly, M.J., Qiu, J., and Rønnekleiv, O.K. (2003). Estrogen modulation of G-protein-coupled
receptor activation of potassium channels in the central nervous system. Annals of the
New York Academy of Sciences 1007, 6–16.

179

Kendler, K.S., Karkowski, L.M., and Prescott, C.A. (1999). Causal relationship between stressful
life events and the onset of major depression. The American Journal of Psychiatry 156,
837–841.
Kendler, K.S., Thornton, L.M., and Gardner, C.O. (2000). Stressful life events and previous
episodes in the etiology of major depression in women: an evaluation of the “kindling”
hypothesis. The American Journal of Psychiatry 157, 1243–1251.
Kessler, R., and Ustun, T. (2004). The World Mental Health (WMH) Survey Initiative Version
of the World Health Organization (WHO) Composite International Diagnostic Interview
(CIDI). International Journal of Methods in Psychiatric Research 13, 93–121.
Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., Rush, J.A.,
Walters, E.E., and Wang, P.S. (2003). The Epidemiology of Major Depressive Disorder:
Results From the National Comorbidity Survey Replication (NCS-R). JAMA 289, 3095–
3105.
Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R., and Walters, E.E. (2005a).
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National
Comorbidity Survey Replication. Archives of General Psychiatry 62, 593–602.
Kessler, R.C., Chiu, W.T., Demler, O., Merikangas, K.R., and Walters, E.E. (2005b). Prevalence,
severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity
Survey Replication. Archives of General Psychiatry 62, 617–627.
Kessler, R.C., McGonagle, K.A., Nelson, C.B., Hughes, M., Swartz, M., and Blazer, D.G.
(1994). Sex and depression in the National Comorbidity Survey. II: Cohort effects.
Journal of Affective Disorders 30, 15–26.
180

Kiem, S.A., Andrade, K.C., Spoormaker, V.I., Holsboer, F., Czisch, M., and Sämann, P.G.
(2013). Resting state functional MRI connectivity predicts hypothalamus-pituitary-axis
status in healthy males. Psychoneuroendocrinology 38, 1338–1348.
Kimonis ER, Frick PJ, Fazekas H, Loney BR. (2006). Psychopathy, aggression, and the
processing of emotional stimuli in non-referred girls and boys. Behavioral Sciences & the
Law 24:21–37.
King, M.G., Burrows, G.D., and Stanley, G.V. (1983). Measurement of stress and arousal:
Validation of the stress/arousal adjective checklist. British Journal of Psychology 74,
473–479.
Kirschbaum, C., Kudielka, B.M., Gaab, J., Schommer, N.C., and Hellhammer, D.H. (1999).
Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the
hypothalamus-pituitary-adrenal axis. Psychosomatic Medicine 61, 154–162.
Kirschbaum, C., Wüst, S., and Hellhammer, D. (1992). Consistent sex differences in cortisol
responses to psychological stress. Psychosomatic Medicine 54, 648–657.
Kitraki, E., Karandrea, D., and Kittas, C. (1999). Long-lasting effects of stress on glucocorticoid
receptor gene expression in the rat brain. Neuroendocrinology 69, 331–338.
Kret, M., and De Gelder, B. (2012). A review on sex differences in processing emotional signals.
Neuropsychologia 50, 1211–1221.
Kudielka BM, Buske-Kirschbaum A, Hellhammer DH, Kirschbaum C. (2004). HPA axis
responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and
children: impact of age and gender. Psychoneuroendocrinology 29:83–98.

181

Kugaya, A., Epperson, C.N., Zoghbi, S., van Dyck, C.H., Hou, Y., Fujita, M., Staley, J.K., Garg,
P.K., Seibyl, J.P., and Innis, R.B. (2003). Increase in prefrontal cortex serotonin 2A
receptors following estrogen treatment in postmenopausal women. The American Journal
of Psychiatry 160, 1522–1524.
Kuiper, G.G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J.A. (1996). Cloning
of a novel receptor expressed in rat prostate and ovary. Proceedings of the National
Academy of Sciences 93, 5925–5930.
Lang PJ, Bradley MM, Cuthbert BN. (1999). International affective picture system (IAPS):
Technical manual and affective ratings.
Lee, R.S., Hermens, D.F., Porter, M.A., and Redoblado-Hodge, M.A. (2012). A meta-analysis of
cognitive deficits in first-episode Major Depressive Disorder. Journal of Affective
Disorders 140, 113–124.
Leppänen, J.K., Milders, M., Bell, J.S., Terriere, E., and Hietanen, J.K. (2004). Depression
biases the recognition of emotionally neutral faces. Psychiatry Research 128, 123–133.
Liu, R.T., and Alloy, L.B. (2010). Stress generation in depression: A systematic review of the
empirical literature and recommendations for future study. Clinical Psychology Review
30, 582–593.
Love, T., Smith, Y.R., Persad, C.C., Tkaczyk, A., and Zubieta, J.K. (2010). Short-term hormone
treatment modulates emotion response circuitry in postmenopausal women. Fertility and
Sterility 93, 1929–1937.

182

Luine, V., and Rodriguez, M. (1994). Effects of estradiol on radial arm maze performance of
young and aged rats. Behavioral and Neural Biology 62, 230–236.
Luine, V.N. (1985). Estradiol increases choline acetyltransferase activity in specific basal
forebrain nuclei and projection areas of female rats. Experimental Neurology 89, 484–
490.
Luine, V.N. (2014). Estradiol and cognitive function: Past, present and future. Hormones and
Behavior 66, 602-618.
Lupien, S.J., Evans, A., Lord, C., Miles, J., Pruessner, M., Pike, B., and Pruessner, J.C. (2007).
Hippocampal volume is as variable in young as in older adults: implications for the
notion of hippocampal atrophy in humans. NeuroImage 34, 479–485.
Lupien, S.J., Fiocco, A., Wan, N., Maheu, F., Lord, C., Schramek, T., and Tu, M.T. (2005).
Stress hormones and human memory function across the lifespan.
Psychoneuroendocrinology 30, 225–242.
Lupien, S.J., McEwen, B.S., Gunnar, M.R., and Heim, C. (2009). Effects of stress throughout the
lifespan on the brain, behaviour and cognition. Nature Reviews Neuroscience 10, 434–
445.
Lupien, S.J., Wilkinson, C.W., Brière, S., Ng Ying Kin, N.M., Meaney, M.J., and Nair, N.P.
(2002). Acute modulation of aged human memory by pharmacological manipulation of
glucocorticoids. The Journal of Clinical Endocrinology and Metabolism 87, 3798–3807.
MacNamara A, Hajcak G. (2009). Anxiety and spatial attention moderate the electrocortical
response to aversive pictures. Neuropsychopharmacology 47:2975–2980.

183

Magariños, A.M., and McEwen, B.S. (1995). Stress-induced atrophy of apical dendrites of
hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory
amino acid receptors. Neuroscience 69, 89–98.
Magariños, A.M., McEwen, B.S., Flügge, G., and Fuchs, E. (1996). Chronic psychosocial stress
causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate
tree shrews. The Journal of Neuroscience 16, 3534–3540.
Maki, P.M. (2005). A systematic review of clinical trials of hormone therapy on cognitive
function: effects of age at initiation and progestin use. Annals of the New York Academy
of Sciences 1052, 182–197.
Maki, P.M., and Dumas, J. (2009). Mechanisms of action of estrogen in the brain: insights from
human neuroimaging and psychopharmacologic studies. Seminars in Reproductive
Medicine 27, 250–259.
Maki, P.M., and Resnick, S.M. (2000). Longitudinal effects of estrogen replacement therapy on
PET cerebral blood flow and cognition. Neurobiology of Aging 21, 373–383.
Maldjian, J., Laurienti, P., Kraft, R., and Burdette, J. (2003). An automated method for
neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets.
NeuroImage 19, 1233–1239.
Mayberg, H.S. (1997). Limbic-cortical dysregulation: a proposed model of depression. The
Journal of Neuropsychiatry and Clinical Neurosciences 9, 471–481.

184

McEwen, B.S., Akama, K.T., and Spencer-Segal, J.L. (2012). Estrogen effects on the brain:
actions beyond the hypothalamus via novel mechanisms. Behavioral Neuroscience 126,
4–16.
McEwen, B.S., Gould, E., Orchinik, M., Weiland, N.G., and Woolley, C.S. (1995). Oestrogens
and the structural and functional plasticity of neurons: implications for memory, ageing
and neurodegenerative processes. Ciba Foundation Symposium 191 - Non-Reproductive
Actions of Sex Steroids 191, 52–66; discussion 66–73.
McEwen, B.S., Tanapat, P., and Weiland, N.G. (1999). Inhibition of dendritic spine induction on
hippocampal CA1 pyramidal neurons by a nonsteroidal estrogen antagonist in female
rats. Endocrinology 140, 1044–1047.
McGaugh, J.L. (2004). The amygdala modulates the consolidation of memories of emotionally
arousing experiences. Annual Review of Neuroscience 27, 1–28.
McHugo, M., Olatunji, B.O., and Zald, D.H. (2013). The emotional attentional blink: what we
know so far. Frontiers in Human Neuroscience 7.
McKinnon, M.C., Yucel, K., Nazarov, A., and MacQueen, G.M. (2009). A meta-analysis
examining clinical predictors of hippocampal volume in patients with major depressive
disorder. Journal of Psychiatry & Neuroscience 34, 41–54.
McNair, D., Lorr, M., and Droppleman, L. (1989). Profile of mood states (POMS). The Journal
of Nervous and Mental Disease 167, 612–614.

185

Mendelsohn, D., Riedel, W.J., and Sambeth, A. (2009). Effects of acute tryptophan depletion on
memory, attention and executive functions: a systematic review. Neuroscience and
Biobehavioral Reviews 33, 926–952.
Merchenthaler, I., Lane, M., Numan, S., and Dellovade, T. (2004). Distribution of estrogen
receptor alpha and beta in the mouse central nervous system: in vivo autoradiographic
and immunocytochemical analyses. Journal of Comparative Neurology 473, 270–291.
Merten, J. (2005). Culture, gender and the recognition of the basic emotions. Psychologia 48,
306–316.
Merz, C., Tabbert, K., Schweckendiek, J., Klucken, T., Vaitl, D., Stark, R., and Wolf, O. (2012).
Neuronal correlates of extinction learning are modulated by sex hormones. Social
Cognitive and Affective Neuroscience 7, 819–830.
Mezulis, A.H., Funasaki, K.S., Charbonneau, A.M., and Hyde, J. (2010). Gender differences in
the cognitive vulnerability-stress model of depression in the transition to adolescence.
Cognitive Therapy and Research 34, 501–513.
Milad, Goldstein, Orr, and Wedig (2006). Fear conditioning and extinction: influence of sex and
menstrual cycle in healthy humans. Behavioral Neuroscience 120, 1196-203.
Milad, M.R., Zeidan, M.A., Contero, A., Pitman, R.K., Klibanski, A., Rauch, S.L., and
Goldstein, J.M. (2010). The influence of gonadal hormones on conditioned fear
extinction in healthy humans. Neuroscience 168, 652–658.

186

Miller, G.E., Stetler, C.A., Carney, R.M., Freedland, K.E., and Banks, W.A. (2002). Clinical
depression and inflammatory risk markers for coronary heart disease. The American
Journal of Cardiology 90, 1279–1283.
Ming, G.L., and Song, H. (2011). Adult neurogenesis in the mammalian brain: significant
answers and significant questions. Neuron 70, 687–702.
Mohanty, A., and Sussman, T.J. (2013). Top-down modulation of attention by emotion. Frontiers
in Human Neuroscience 7, 102.
Monroe, S.M., and Harkness, K.L. (2005). Life stress, the “kindling” hypothesis, and the
recurrence of depression: considerations from a life stress perspective. Psychological
Review 112, 417–445.
Montagne, B., Kessels, R.P., Frigerio, E., de Haan, E.H., and Perrett, D.I. (2005). Sex differences
in the perception of affective facial expressions: do men really lack emotional sensitivity?
Cognitive Processing 6, 136–141.
Moore, R.Y., and Bloom, F.E. (1979). Central catecholamine neuron systems: anatomy and
physiology of the norepinephrine and epinephrine systems. Annual Review of
Neuroscience 2, 113–168.
Moos, R. (1968). The development of a menstrual distress questionnaire. Psychological
Medicine 30, 853–867.
Moreno, F.A., McGahuey, C.A., Freeman, M.P., and Delgado, P.L. (2006). Sex differences in
depressive response during monoamine depletions in remitted depressive subjects. The
Journal of Clinical Psychiatry 67, 1618–1623.

187

Morrison, M.F., Kallan, M.J., Ten Have, T., Katz, I., Tweedy, K., and Battistini, M. (2004). Lack
of efficacy of estradiol for depression in postmenopausal women: a randomized,
controlled trial. Biological Psychiatry 55, 406–412.
Moulton, C.D., Pickup, J.C., and Ismail, K. (2015). The link between depression and diabetes:
the search for shared mechanisms. The Lancet. Diabetes & Endocrinology 3, 461–471.
Munck, A., and Guyre, P.M. (1991). Glucocorticoids and immune function.
Psychoneuroimmunology 2, 447–474.
Murray, C., Atkinson, C., Bhalla, K., Birbeck, G., Burstein, R., Chou, D., Dellavalle, R., Danaei,
G., Ezzati, M., Fahimi, A., et al. (2013). The State of US Health, 1990-2010: Burden of
Diseases, Injuries, and Risk Factors. JAMA 310, 591–606.
Nappi, RE, Sinforiani, E, Mauri, M, and Bono, G (1999). Memory functioning at menopause:
impact of age in ovariectomized women. Gynecologic and Obstetric Investigation 47, 2936.
Nemeroff, C.B., Owens, M.J., Bissette, G., Andorn, A.C., and Stanley, M. (1988). Reduced
corticotropin releasing factor binding sites in the frontal cortex of suicide victims.
Archives of General Psychiatry 45, 577–579.
Nemeroff, C.B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C.D.,
Loosen, P.T., and Vale, W. (1985). Elevated concentrations of CSF corticotropinreleasing factor-like immunoreactivity in depressed patients. Science 226, 1342–1344.

188

Neumeister A, Wood S, Bonne O, Nugent AC, Luckenbaugh DA, Young T, Bain EE, Charney
DS, Drevets WC. (2005). Reduced hippocampal volume in unmedicated, remitted
patients with major depression versus control subjects. Biological Psychiatry 57:935–7.
Newcomer, J.W., Craft, S., Askins, K., Hershey, T., Bardgett, M.E., Csernansky, J.G., Gagliardi,
A.E., and Vogler, G. (1998). Glucocorticoid interactions with memory function in
schizophrenia. Psychoneuroendocrinology 23, 65–72.
Newcomer, J.W., Craft, S., Hershey, T., Askins, K., and Bardgett, M.E. (1994). Glucocorticoidinduced impairment in declarative memory performance in adult humans. The Journal of
Neuroscience 14, 2047–2053.
Newcomer, J.W., Selke, G., Melson, A.K., Hershey, T., Craft, S., Richards, K., and Alderson,
A.L. (1999). Decreased memory performance in healthy humans induced by stress-level
cortisol treatment. Archives of General Psychiatry 56, 527–533.
Newhouse, P., and Albert, K. (2015). Estrogen, Stress, and Depression: A Neurocognitive
Model. JAMA Psychiatry 72, 727–729.
Newhouse, P., and Dumas, J. (2015). Estrogen-cholinergic interactions: Implications for
cognitive aging. Hormones and Behavior. Advance online publication. doi:
10.1016/j.yhbeh.2015.06.022.
Newhouse, P.A., Dumas, J., Hancur-Bucci, C., Naylor, M., Sites, C.K., Benkelfat, C., and
Young, S.N. (2008). Estrogen administration negatively alters mood following
monoaminergic depletion and psychosocial stress in postmenopausal women.
Neuropsychopharmacology 33, 1514–1527.

189

Nielsen, S.E., Ahmed, I., and Cahill, L. (2013). Sex and menstrual cycle phase at encoding
influence emotional memory for gist and detail. Neurobiology of Learning and Memory
106, 56–65.
Nikkheslat, N., Zunszain, P.A., Horowitz, M.A., Barbosa, I.G., Parker, J.A., Myint, A.M.,
Schwarz, M.J., Tylee, A.T., Carvalho, L.A., and Pariante, C.M. (2015). Insufficient
glucocorticoid signaling and elevated inflammation in coronary heart disease patients
with comorbid depression. Brain, Behavior, and Immunity 48, 8–18.
O’Malley, C.A., Hautamaki, R.D., Kelley, M., and Meyer, E.M. (1987). Effects of ovariectomy
and estradiol benzoate on high affinity choline uptake, ACh synthesis, and release from
rat cerebral cortical synaptosomes. Brain Research 403, 389–392.
O’Toole, S.M., and Rubin, R.T. (1995). Neuroendocrine aspects of primary endogenous
depression--XIV. Gonadotropin secretion in female patients and their matched controls.
Psychoneuroendocrinology 20, 603–612.
Oestergaard, S., and Møldrup, C. (2011). Improving outcomes for patients with depression by
enhancing antidepressant therapy with non-pharmacological interventions: a systematic
review of reviews. Public Health 125, 357–367.
Ooishi, Y., Mukai, H., Hojo, Y., Murakami, G., Hasegawa, Y., Shindo, T., Morrison, J.H.,
Kimoto, T., and Kawato, S. (2012). Estradiol rapidly rescues synaptic transmission from
corticosterone-induced suppression via synaptic/extranuclear steroid receptors in the
hippocampus. Cerebral Cortex 22, 926–936.
Ostlund, H., Keller, E., and Hurd, Y. (2003). Estrogen receptor gene expression in relation to
neuropsychiatric disorders. Annals of the New York Academy of Sciences 1007, 54–63.
190

Patel, P.D., Lopez, J.F., Lyons, D.M., Burke, S., Wallace, M., and Schatzberg, A.F. (2000).
Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey
brain. Journal of Psychiatric Research 34, 383–392.
Pearson, R., and Lewis, M.B. (2005). Fear recognition across the menstrual cycle. Hormones and
Behavior 47, 267–271.
Peers, P.V., Simons, J.S., and Lawrence, A.D. (2013). Prefrontal control of attention to threat.
Frontiers in Human Neuroscience 7, 24.
Phelps, E.A., and LeDoux, J.E. (2005). Contributions of the amygdala to emotion processing:
from animal models to human behavior. Neuron 48, 175–187.
Phillips, M.L., Drevets, W.C., Rauch, S.L., and Lane, R. (2003). Neurobiology of emotion
perception II: Implications for major psychiatric disorders. Biological Psychiatry 54,
515–528.
Phillips, M.L., Ladouceur, C.D., and Drevets, W.C. (2008). A neural model of voluntary and
automatic emotion regulation: implications for understanding the pathophysiology and
neurodevelopment of bipolar disorder. Molecular Psychiatry 13, 829, 833–857.
Phillips, S.M., and Sherwin, B.B. (1992). Effects of estrogen on memory function in surgically
menopausal women. Psychoneuroendocrinology 17, 485–495.
Piefke, M, Weiss, PH, and Markowitsch, HJ (2005). Gender differences in the functional
neuroanatomy of emotional episodic autobiographical memory. Human Brain 4, 313-24.

191

Pourtois G, Schettino A, Vuilleumier P. (2013). Brain mechanisms for emotional influences on
perception and attention: what is magic and what is not. Biological Psychology 92:492–
512.
Price, J.L., and Drevets, W.C. (2012). Neural circuits underlying the pathophysiology of mood
disorders. Trends in Cognitive Sciences 16, 61–71.
Pruessner, J.C., Dedovic, K., Khalili-Mahani, N., Engert, V., Pruessner, M., Buss, C., Renwick,
R., Dagher, A., Meaney, M.J., and Lupien, S. (2008). Deactivation of the limbic system
during acute psychosocial stress: evidence from positron emission tomography and
functional magnetic resonance imaging studies. Biological Psychiatry 63, 234–240.
Raedt, R., and Koster, E. (2010). Understanding vulnerability for depression from a cognitive
neuroscience perspective: A reappraisal of attentional factors and a new conceptual
framework. Cognitive, Affective, & Behavioral Neuroscience 10, 50–70.
Rasgon, N.L., Altshuler, L.L., and Fairbanks, L. (2001). Estrogen-replacement therapy for
depression. The American Journal of Psychiatry 158, 1738.
Reich, T., and Winokur, G. (1970). Postpartum psychoses in patients with manic depressive
disease. The Journal of Nervous and Mental Disease 151, 60–68.
Reisberg B, Ferris SH, Leon MJ de, Crook T. (1982). The global deterioration scale for
assessment of primary degenerative dementia. American Journal of Psychiatry 139:1136–
1139.
Reisberg B, Ferris SH. (1988). Brief Cognitive Rating Scale (BCRS). Psychopharmacology
Bulletin 24:629–36.

192

Resnick, S.M., Maki, P.M., Golski, S., Kraut, M.A., and Zonderman, A.B. (1998). Effects of
estrogen replacement therapy on PET cerebral blood flow and neuropsychological
performance. Hormones and Behavior 34, 171–182.
Reul, J.M., and de Kloet, E.R. (1985). Two receptor systems for corticosterone in rat brain:
microdistribution and differential occupation. Endocrinology 117, 2505–2511.
Roca, C.A., Schmidt, P.J., Deuster, P.A., Danaceau, M.A., Altemus, M., Putnam, K., Chrousos,
G.P., Nieman, L.K., and Rubinow, D.R. (2005). Sex-related differences in stimulated
hypothalamic-pituitary-adrenal axis during induced gonadal suppression. The Journal of
Clinical Endocrinology and Metabolism 90, 4224–4231.
Rocca, WA, Bower, JH, and Maraganore, DM (2008). Increased risk of cognitive impairment or
dementia in women who underwent oophorectomy before menopause. Neurology 69,
1074-83.
Roelofs K, Bakvis P, Hermans EJ, Pelt J van, Honk J van. (2007). Tthe effects of social stress
and cortisol responses on the preconscious selective attention to social threat. Biological
Psychology 75:1–7.
Roiser, J.P., Levy, J., Fromm, S.J., Wang, H., Hasler, G., Sahakian, B.J., and Drevets, W.C.
(2008). The effect of acute tryptophan depletion on the neural correlates of emotional
processing in healthy volunteers. Neuropsychopharmacology 33, 1992–2006.
Rosenberg, L., and Park, S. (2002). Verbal and spatial functions across the menstrual cycle in
healthy young women. Psychoneuroendocrinology 27, 835–841.

193

Rubinow, D.R., and Schmidt, P.J. (1995). The neuroendocrinology of menstrual cycle mood
disorders. Annals of the New York Academy of Sciences 771, 648–659.
Rubinow, D.R., and Schmidt, P.J. (2006). Gonadal steroid regulation of mood: the lessons of
premenstrual syndrome. Frontiers in Neuroendocrinology 27, 210–216.
Ruhé, H.G., Mason, N.S., and Schene, A.H. (2007). Mood is indirectly related to serotonin,
norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion
studies. Molecular Psychiatry 12, 331–359.
Sanchez, A., Vazquez, C., Marker, C., LeMoult, J., and Joormann, J. (2013). Attentional
disengagement predicts stress recovery in depression: an eye-tracking study. Journal of
Abnormal Psychology 122, 303–313.
Santesso DL, Steele KT, Bogdan R, Holmes AJ, Deveney CM, Meites TM, Pizzagalli DA.
(2008). Enhanced negative feedback responses in remitted depression. Neuroreport
19:1045–8.
Sapolsky, Krey, and McEwen (1986). The Neuroendocrinology of Stress and Aging: The
Glucocorticoid Cascade Hypothesis. Endocrine Reviews 7, 284301.
Sapolsky, R.M., Krey, L.C., and McEwen, B.S. (1984). Glucocorticoid-sensitive hippocampal
neurons are involved in terminating the adrenocortical stress response. Proceedings of the
National Academy of Sciences 81, 6174–6177.
Sarter, M, and Bruno, JP (1997). Cognitive functions of cortical acetylcholine: toward a unifying
hypothesis. Brain Research Reviews 23, 28-46.

194

Sarter, M, Bruno, J.P., and Givens, B (2003). Attentional functions of cortical cholinergic inputs:
what does it mean for learning and memory? Neurobiology of Learning and Memory 8,
245–256.
Saunders, K., and Hawton, K. (2006). Suicidal behaviour and the menstrual cycle. Psychological
Medicine 36, 901–912.
Savitz, J.B., and Drevets, W.C. (2009). Imaging phenotypes of major depressive disorder:
genetic correlates. Neuroscience 164, 300–330.
Schildkraut, J.J. (1973). Neuropharmacology of the affective disorders. Annual Review of
Pharmacology 13, 427–454.
Schildkraut, J.J., Schanberg, S.M., Kopin, I.J., and Durell, J. (1969). Affective disorders and
norepinephrine pharmacology. International Psychiatry Clinics 6, 83–141.
Schiller, C.E., Meltzer-Brody, S., and Rubinow, D.R. (2015). The role of reproductive hormones
in postpartum depression. CNS Spectrums 20, 48–59.
Schliebs, R., and Arendt, T. (2006). The significance of the cholinergic system in the brain
during aging and in Alzheimer’s disease. Journal of Neural Transmission 113, 1625–
1644.
Schmidt KS, Mattis PJ, Adams J, Nestor P. (2005). Test-retest reliability of the dementia rating
scale-2: alternate form. Dementia and Geriatric Cognitive Disorders 20:42–4.
Schmidt, P.J., and Rubinow, D.R. (2010). Sex hormones and mood in the perimenopause. Annals
of the New York Academy of Sciences 1179, 70–85.

195

Schmidt, P.J., Nieman, L., Danaceau, M.A., Tobin, M.B., Roca, C.A., Murphy, J.H., and
Rubinow, D.R. (2000). Estrogen replacement in perimenopause-related depression: a
preliminary report. American Journal of Obstetrics and Gynecology 183, 414–420.
Schmidt, P.J., Nieman, L.K., Danaceau, M.A., Adams, L.F., and Rubinow, D.R. (1998).
Differential behavioral effects of gonadal steroids in women with and in those without
premenstrual syndrome. The New England Journal of Medicine 338, 209–216.
Sears, C., Newman, K., Ference, J., and Thomas, C. (2011). Attention to Emotional Images in
Previously Depressed Individuals: An Eye-Tracking Study. Cognitive Therapy and
Research 35, 517–528.
Shackman, A.J., Maxwell, J.S., McMenamin, B.W., Greischar, L.L., and Davidson, R.J. (2011).
Stress potentiates early and attenuates late stages of visual processing. The Journal of
Neuroscience 31, 1156–1161.
Shaywitz, S.E., Shaywitz, B.A., Pugh, K.R., Fulbright, R.K., Skudlarski, P., Mencl, W.E.,
Constable, R.T., Naftolin, F., Palter, S.F., Marchione, K.E., et al. (1999). Effect of
estrogen on brain activation patterns in postmenopausal women during working memory
tasks. JAMA 281, 1197–1202.
Sheline, Wang, Gado, Csernansky, and Vannier (1996). Hippocampal atrophy in recurrent major
depression. Proceedings of the National Academy of Sciences 93, 3908-3913.
Sheline, Y. (2000). 3D MRI studies of neuroanatomic changes in unipolar major depression: the
role of stress and medical comorbidity. Biological Psychiatry 15, 791–8000.

196

Sherwin, B.B. (1988). Affective changes with estrogen and androgen replacement therapy in
surgically menopausal women. Journal of Affective Disorders 14, 177–187.
Sherwin, B.B., and Gelfand, M.M. (1985). Sex steroids and affect in the surgical menopause: a
double-blind, cross-over study. Psychoneuroendocrinology 10, 325–335.
Sherwin, B.B., and Henry, J.F. (2008). Brain aging modulates the neuroprotective effects of
estrogen on selective aspects of cognition in women: a critical review. Frontiers in
Neuroendocrinology 29, 88–113.
Simpson, J.R., Drevets, W.C., Snyder, A.Z., Gusnard, D.A., and Raichle, M.E. (2001). Emotioninduced changes in human medial prefrontal cortex: II. During anticipatory anxiety.
Proceedings of the National Academy of Sciences 98, 688–693.
Snyder, j S., Soumier, A., Brewer, M., Pickel, J., and Cameron, H.A. (2011). Adult hippocampal
neurogenesis buffers stress responses and depressive behaviour. Nature 476, 458–461.
Soares, C.N., Almeida, O.P., Joffe, H., and Cohen, L.S. (2001). Efficacy of estradiol for the
treatment of depressive disorders in perimenopausal women: a double-blind, randomized,
placebo-controlled trial. Archives of General Psychiatry 58, 529–534.
Solomon DA, Keller MB, Leon AC, Mueller TI, Shea MT, Warshaw M, Maser JD, Coryell W,
Endicott J. (1997). Recovery from major depression. A 10-year prospective follow-up
across multiple episodes. JAMA Psychiatry 54:1001–6.
Song X, Dong Z, Long X, Li S, Zuo X, Zhu C, He Y, Yan C, Zang Y. (2011). REST: a toolkit
for resting-state functional magnetic resonance imaging data processing. PLOS One 6.

197

Spielberger CD. (2010). State Trait Anxiety Inventory. Corsini Encyclopedia of Psychology.
Hoboken, NJ: Wiley.
Spitzer, R.L., Williams, J.B., Gibbon, M., and First, M.B. (1992). The Structured Clinical
Interview for DSM-III-R (SCID). I: History, rationale, and description. Archives of
General Psychiatry 49, 624–629.
Stahl, S.M. (1998). Basic psychopharmacology of antidepressants, part 2: Estrogen as an adjunct
to antidepressant treatment. The Journal of Clinical Psychiatry 59, 15–24.
Stahl, S.M. (2001). Effects of estrogen on the central nervous system. The Journal of Clinical
Psychiatry 62, 317–318.
Steiner, M., Dunn, E., and Born, L. (2003). Hormones and mood: from menarche to menopause
and beyond. Journal of Affective Disorders 74, 67–83.
Sternberg, E.M., Chrousos, G.P., Wilder, R.L., and Gold, P.W. (1992). The stress response and
the regulation of inflammatory disease. Annals of Internal Medicine 117, 854–866.
Stokes, P.E. (1995). The potential role of excessive cortisol induced by HPA hyperfunction in
the pathogenesis of depression. European Neuropsychopharmacology 5 Suppl, 77–82.
Stollstorff, M., Munakata, Y., Jensen, A.P., Guild, R.M., Smolker, H.R., Devaney, J.M., and
Banich, M.T. (2013). Individual differences in emotion-cognition interactions: emotional
valence interacts with serotonin transporter genotype to influence brain systems involved
in emotional reactivity and cognitive control. Frontiers in Human Neuroscience 7.
Stroud, L.R., Salovey, P., and Epel, E.S. (2002). Sex differences in stress responses: social
rejection versus achievement stress. Biological Psychiatry 52, 318–327.

198

Substance Abuse and Mental Health Services Administration, (2013). Results from the 2012
National Survey on Drug Use and Health: Summary of National Findings, NSDUH
Series H-48, HHS Publication No. (SMA) 14-4863.
Sumner, B.E., and Fink, G. (1993). Effects of acute estradiol on 5-hydroxytryptamine and
dopamine receptor subtype mRNA expression in female rat brain. Molecular and Cellular
Neurosciences 4, 83–92.
Sumner, B.E., and Fink, G. (1995). Estrogen increases the density of 5-hydroxytryptamine (2A)
receptors in cerebral cortex and nucleus accumbens in the female rat. The Journal of
Steroid Biochemistry and Molecular Biology 54, 15–20.
Sumner, B.E., and Fink, G. (1997). The density of 5-hydoxytryptamine2A receptors in forebrain
is increased at pro-oestrus in intact female rats. Neuroscience Letters 234, 7–10.
Sumner, B.E., and Fink, G. (1998). Testosterone as well as estrogen increases serotonin2A
receptor mRNA and binding site densities in the male rat brain. Brain Research.
Molecular Brain Research 59, 205–214.
Sundström Poromaa, I., and Gingnell, M. (2014). Menstrual cycle influence on cognitive
function and emotion processing-from a reproductive perspective. Frontiers in
Neuroscience 8, 380.
Suslow, T., Junghanns, K., and Arolt, V. (2001). Detection of facial expressions of emotions in
depression. Perceptual and Motor Skills 92, 857–868.
Thompson, A.E., and Voyer, D. (2014). Sex differences in the ability to recognise non-verbal
displays of emotion: a meta-analysis. Cognition & Emotion 28, 1164–1195.

199

Toren, P., Dor, J., Rehavi, M., and Weizman, A. (1996). Hypothalamic-pituitary-ovarian axis
and mood. Biological Psychiatry 40, 1051–1055.
Trivedi, M.H., Rush, J.A., Wisniewski, S.R., Nierenberg, A.A., Warden, D., Ritz, L., Norquist,
G., Howland, R.H., Lebowitz, B., and McGrath, P.J. (2006). Evaluation of outcomes with
citalopram for depression using measurement-based care in STAR* D: implications for
clinical practice. American Journal of Psychiatry 163, 28–40.
Vadakkadath Meethal, S., and Atwood, C.S. (2005). The role of hypothalamic-pituitary-gonadal
hormones in the normal structure and functioning of the brain. Cellular and Molecular
Life Sciences 62, 257–270.
Vaisvaser, S., Lin, T., Admon, R., Podlipsky, I., Greenman, Y., Stern, N., Fruchter, E., Wald, I.,
Pine, D.S., Tarrasch, R., et al. (2013). Neural traces of stress: cortisol related sustained
enhancement of amygdala-hippocampal functional connectivity. Frontiers in Human
Neuroscience 7, 313.
Vamvakopoulos, N.V. (1995). Sexual dimorphism of stress response and immune/ inflammatory
reaction: the corticotropin releasing hormone perspective. Mediators of Inflammation 4,
163–174.
Van der Veen, F.M., Evers, E.A., van Deursen, J.A., Deutz, N.E., Backes, W.H., and Schmitt,
J.A. (2006). Acute tryptophan depletion reduces activation in the right hippocampus
during encoding in an episodic memory task. Neuroimage 31, 1188–1196.
Van Marle, H.J., Hermans, E.J., Qin, S., and Fernández, G. (2009). From specificity to
sensitivity: how acute stress affects amygdala processing of biologically salient stimuli.
Biological Psychiatry 66, 649–655.
200

Videbech, P., and Ravnkilde, B. (2004). Hippocampal volume and depression: a meta-analysis of
MRI studies. The American Journal of Psychiatry 161, 1957–1966.
Vogel, E.K., and Luck, S.J. (2000). The visual N1 component as an index of a discrimination
process. Psychophysiology 37, 190–203.
Wang, J., Korczykowski, M., Rao, H., Fan, Y., Pluta, J., Gur, R.C., McEwen, B.S., and Detre,
J.A. (2007). Gender difference in neural response to psychological stress. Social
Cognitive and Affective Neuroscience 2, 227–239.
Watanabe, Y., Gould, E., and McEwen, B.S. (1992). Stress induces atrophy of apical dendrites of
hippocampal CA3 pyramidal neurons. Brain Research 588, 341–345.
Wechsler D. (1996). Wechsler Abbreviated Scale of Intelligence. The Psychological
Corporation.
Weiss, E., Longhurst, J., and Mazure, C. (1999). Childhood sexual abuse as a risk factor for
depression in women: psychosocial and neurobiological correlates. American Journal of
Psychiatry 156, 816–828.
Whitehouse, P.J., Price, D.L., Struble, R.G., and Clark, A.W. (1982). Alzheimer’s disease and
senile dementia: loss of neurons in the basal forebrain. Science 215, 1237–1239.
Whitfield-Gabrieli S, Nieto-Castanon A. (2011). Conn: a functional connectivity toolbox for
correlated and anticorrelated brain networks. Brain Connectivity 2:125–41.
Whittle, S., Yücel, M., Yap, M.B., and Allen, N.B. (2011). Sex differences in the neural
correlates of emotion: evidence from neuroimaging. Biological Psychology 87, 319–333.

201

Widerlöv, E., Bissette, G., and Nemeroff, C.B. (1988). Monoamine metabolites, corticotropin
releasing factor and somatostatin as CSF markers in depressed patients. Journal of
Affective Disorders 14, 99–107.
Wiens S, Syrjänen E. (2013). Directed attention reduces processing of emotional distracters
irrespective of valence and arousal level. Biological Psychiatry 94:44–54.
Woolley, C.S. (1998). Estrogen-mediated structural and functional synaptic plasticity in the
female rat hippocampus. Hormones and Behavior 34, 140–148.
Woolley, C.S. (1999). Effects of estrogen in the CNS. Current Opinion in Neurobiology 9, 349–
354.
Woolley, C.S. (2000). Effects of oestradiol on hippocampal circuitry. Novartis Foundation
Symposium 230, 173–180.
Woolley, C.S., and McEwen, B.S. (1992). Estradiol mediates fluctuation in hippocampal synapse
density during the estrous cycle in the adult rat. The Journal of Neuroscience 12, 2549–
2554.
Woolley, C.S., Gould, E., and McEwen, B.S. (1990). Exposure to excess glucocorticoids alters
dendritic morphology of adult hippocampal pyramidal neurons. Brain Research 531,
225–231.
Woolley, C.S., Weiland, N.G., McEwen, B.S., and Schwartzkroin, P.A. (1997). Estradiol
increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptormediated synaptic input: correlation with dendritic spine density. The Journal of
Neuroscience 17, 1848–1859.

202

Young, E., and Korszun, A. (2002). The hypothalamic–pituitary–gonadal axis in mood disorders.
Endocrinology and Metabolism Clinics of North America 31, 6378.
Young, E., and Korszun, A. (2010). Sex, trauma, stress hormones and depression. Molecular
Psychiatry 15, 23–28.
Young, E., and Ribeiro, S. (2006). Sex differences in the ACTH response to 24H metyrapone in
depression. Brain Research 1126, 148–155.
Young, E.A., Haskett, R.F., Grunhaus, L., Pande, A., Weinberg, V.M., Watson, S.J., and Akil, H.
(1994). Increased evening activation of the hypothalamic-pituitary-adrenal axis in
depressed patients. Archives of General Psychiatry 51, 701–707.
Young, E.A., Lopez, J.F., Murphy-Weinberg, V., Watson, S.J., and Akil, H. (2000). Hormonal
evidence for altered responsiveness to social stress in major depression.
Neuropsychopharmacology 23, 411–418.
Young, E.A., Midgley, A.R., Carlson, N.E., and Brown, M.B. (2000). Alteration in the
hypothalamic-pituitary-ovarian axis in depressed women. Archives of General Psychiatry
57, 1157–1162.
Young, S.N. (2013). The effect of raising and lowering tryptophan levels on human mood and
social behaviour. Philosophical Transactions of the Royal Society of London. Series B,
Biological Sciences 368.
Young, S.N., and Leyton, M. (2002). The role of serotonin in human mood and social
interaction. Insight from altered tryptophan levels. Pharmacology, Biochemistry, and
Behavior 71, 857–865.

203

Zeidan, M., Igoe, S., Linnman, C., Vitalo, A., Levine, J., Klibanski, A., Goldstein, J., and Milad,
M. (2011). Estradiol modulates medial prefrontal cortex and amygdala activity during
fear extinction in women and female rats. Biological Psychiatry 70, 920–927.
Zhong M, Wang X, Xiao J, Yi J, Zhu X, Liao J, Wang W, Yao S. (2012). Amygdala
hyperactivation and prefrontal hypoactivation in subjects with cognitive vulnerability to
depression. Biological Psychiatry 88:233–42.

204

APPENDIX A: PRELIMINARY DATA

205

Methods
Two groups of postmenopausal women were recruited, with and without a personal
history of MDD. Of each MDD history group a portion of women received three months of
open-label estradiol (E2) and a portion received no treatment. Mood response to psychosocial
stress was assessed during a laboratory psychosocial stress task. We hypothesized that E2
treatment would be associated with less negative mood response to the stress task only in women
with a previous history of MDD. Recognition memory for emotionally-valenced words was
tested after the stress task. We hypothesized that E2 treatment would decrease recognition
memory for negative words following the stress task. Women who received E2 treatment
completed both a baseline visit before treatment and a study day visit following treatment. The
effects of E2 treatment on amygdala-hippocampal functional connectivity was analyzed using
resting state scans from the baseline and study day visits. We hypothesized that E2 treatment
would reduce amygdala-hippocampal connectivity specifically in women with MDD history
(Figure 1).
Participants
Fifty three postmenopausal women between the ages of 45-75 were enrolled in this study.
None of the participants were taking ovarian hormones and were at least one year without such
treatment. Participants were recruited through mass mailing letters, fliers at clinical offices,
Research Match, and email announcements to Vanderbilt faculty and staff. This study was
approved by the Vanderbilt University Institutional Review Board and informed consent was
obtained from all participants.
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Participants were assigned to open-label oral E2 for 3 months (1mg per day for the first
month, and 2mg per day for the second and third months) or to no treatment. Generally, women
who were willing and medically able to take estradiol were placed in the E2+ group, while
women who were not willing or had medical contraindications to estradiol were placed in the
E2- group. One participant’s data was excluded from analysis as an outlier in MRI signal change,
so that a total of 52 participants’ data are included in the data reported here. There were four
participant groups: 1) women who received estradiol treatment with no history of MDD
(E2+/MDD Hx- , n = 17; 2) women who received estradiol treatment with a history of MDD
(E2+/MDD Hx+, n = 10); 3) women who did not receive estradiol treatment with no history of
MDD (E2-/MDD Hx-, n = 20); 4) women who did not receive estradiol treatment with a history
of MDD (E2-/MDD Hx+, n = 5).
Cognitive Screening
All participants were cognitively assessed using: the Wechsler Abbreviated Scale of
Intelligence (WASI) (Wechsler, 1996), the Mini Mental State Exam (MMSE) (Folstein et al.,
1975), Brief Cognitive Rating Scale (Reisberg and Ferris, 1988), and the Mattis Dementia Rating
Scale (Schmidt et al., 2005) to establish a Global Deterioration Scale score (GDS) (Reisberg et
al., 1988). Participants were required to have a GDS score of 1-2 and a MMSE score of greater
than 26. No participant scored below 123 on the Mattis scale or below 90 on the WASI;
participants were of average or above intelligence with no evidence of dementia or mild
cognitive impairment.
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MDD History Screening
Participants were screened for current and past depression, mania and dysthymia using
the partial Structured Clinical Interview for DSM-IV-TR (SCID) (Spitzer et al., 1992). No
participants met criteria for a history of premenstrual dysphoric disorder on the Composite
International Diagnostic Interview for premenstrual dysphoric disorder (CICI-PMDD).
Criteria for never depressed participants were: no current or past episodes that met SCID
criteria for MDD, dysthymia, or mania, a current score less than 7 on the Beck Depression
Inventory (BDI), and a score less than 15 on Beck Anxiety Inventory (BAI) (Beck et al., 1961).
Criteria for prior history of MDD were: at least one episode, in the last ten years that met
criteria for MDD on the SCID, no MDD episodes in the last year, current BDI score less than 7,
and current BAI less than 15 (Santesso et al., 2008).
Participants in the estradiol treatment group completed an additional study day prior to
estradiol treatment, the results of that baseline day are presented in Chapter 3, however resting
functional connectivity comparison between the baseline and study day for the estradiol
treatment group will be presented below.
Stress Task
We employed the Montreal Imaging Stress Task (MIST) for psychosocial stress
induction (Pruessner et al., 2008). The MIST produces moderate psychosocial stress through a
combination of motivated performance and social-evaluative threat. We presented the MIST as
an arithmetic task in the MRI scanner, and instructed participants that they should achieve an 8090% correct performance for their data to be usable in the context of this experiment.
Unbeknownst to the subjects, the MIST contains an algorithm producing script that
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automatically adjusts the difficulty of the math tasks to the aptitude of the participant, this way
maintaining a low performance rate (between 40-50%) by changing either the problem difficulty
or the allotted time. A “control” condition, in which the participants solve arithmetic problems
with no time limit and no performance limit, serves as a contrast to control for brain activity
changes induced by arithmetic task demands (visual stimuli, motor response, and mental
arithmetic). Social evaluative threat comes from scripted experimenter interaction; the
experimenters enter the MRI room between runs and inform the participants that they are not
doing well enough and that they need to improve their performance for the experiment to be
successful.
In this study, participants completed three runs of the MIST. After the first run,
experimenter 1 entered the scanner room and provided the scripted feedback and asked the
participant to complete a second run of the task. After the second run the experimenter 1 entered
the scanner room and told the participant that the experimenter 2 (“doctor”) would like to speak
with them about their performance, at which point the experimenter 2 entered the scanner room
and provided the scripted feedback and asked the participant to complete a third run of the task.
This protocol was designed to maintain both performance and social evaluative threat throughout
the MIST and to prevent participants from habituating to the performance challenge or giving up
on completing the task. Specifically the interaction of the participants and the experimenters was
structured to generate psychosocial stress. To habituate the participants to the scanning
environment and decrease scanner-related stress at the study day, participants entered an MRI
simulator during the screening visit; in the MRI simulator, participants watched a nature video
while being exposed to the MRI environment (simulated MRI sounds, head coil, and being
placed in the MRI bore) and the stimulus presentation system.
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The MIST was presented in a block design; each condition was presented twice per 3
runs (“stress”: 100 seconds, “control”: 50 seconds, “rest”: 30 seconds). Participants practiced the
MIST task (control trials only) in the MRI simulator, before the MRI session.
Imaging Parameters
Participants were scanned on a Philips 3.0 Tesla Achieva scanner, with an 8 channel head
coil. All participants received the following MR sequences:
1) Sagittal T1-weighted 3D Turbo Field Echo Sensitivity Encoding (TFE SENSE) sequence
perpendicular to the anterior commissure (AC) -posterior commissure (PC) line, repetition time
(TR) of 9.9 ms, echo time (TE) of 4.6 ms, a flip angle of 8°, number signal averages (NSA) 1.0,
a field of view (FOV) of 256 mm, a 256 × 256 matrix, and 1.0 mm slice thickness with no gap
for 140 contiguous slices.
2) T2- weighted Gradient and Spin Echo (GRASE) sequence parallel to the AC-PC line, TR
2470 ms, TE 80 ms, NSA 3.0, FOV of 230 mm, 0.7 mm slice thickness with 5.0 mm gap for 28
slices
3) Echoplanar Blood Oxygenation Level Dependent (EpiBOLD) functional resting-state scan
with transverse orientation, TR 1500 ms, TE 35 ms, flip angle 90°, 1 NSA for FOV 240 mm,
80X80 matrix, and 5.0 mm slice thickness with no gap, for 24 slices.
4) Three EpiBOLD functional sequences during the 3 runs of the MIST with transverse
orientation, TR 2500 ms, TE 35 ms, flip angle 90°, 1 NSA for, FOV 240, 240X128 matrix, and
4.0 mm slice thickness with no gap, with ascending interleaved acquisition, for 35 contiguous
slices (task-related fMRI data will not be presented).
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Functional Connectivity Analysis
Participants who received estradiol treatment completed resting scans (eyes open with
fixation point) before task scans during the MRI session at both the baseline (pre estradiol) and
study day (post estradiol). Images from the resting scan were preprocessed in SPM8 including:
realignment of the functional runs and correction for bulk-head motion, coregistration of
functional and anatomical images for each participant, segmentation of the anatomical image,
and normalization of the anatomical and functional images to the standard MNI template.
Each subject’s normalized structural and functional images and T1W tissue maps were
used as input into CONN. The resulting BOLD time series were band-pass filtered (0.01-0.1Hz)
to further reduce noise and increase sensitivity. The output matrices of SPM movement were
entered into Conn as first-level covariates; the mean BOLD time series from each region-ofinterest was entered as a predictor in a multiple regression general linear model at each voxel.
To evaluate whether estradiol treatment affected the difference in amygdala-hippocampal
functional connectivity between MDD history groups (presented in Chapter 3) a mask created
from the significant hippocampal cluster in Chapter 3 was used as an ROI in a 2nd level resting
state functional connectivity analysis with the left amygdala as a seed region (anatomical ROI
from the human AAL atlas defined in WFU PickAtlas42). Cluster threshold correction was used
to control for multiple comparisons within the hippocampal ROI (from voxel wise p = 0.05) to
corrected p < 0.001 with k = 7 (corrected voxel-wise p < 0.001) (from alpha simulation in REST
toolbox for SPM (Song et al., 2011)). Independent t tests were run to compare mean correlations
between activity time series in the left amygdala seed and right hippocampal ROI between
groups for baseline, study day, and change values between the E2+/ MDD Hx- and E2+/MDD
Hx+ groups.
211

Subjective Measures
Before the MIST, participants completed self-rated measures including: the State – Trait
Anxiety Inventory (STAI) (Spielberger, 2010), the Stress Arousal Checklist (SACL) (King et al.,
1983), and the Profile of Mood States (POMS) (McNair et al., 1989). Following the EDP,
participants completed a second SACL and POMS, and a visual analogue scale (VAS) for task
perception including: the extent of their personal involvement, how stressful, new,
uncontrollable, and unpredictable the task was, and whether they anticipated negative
consequences. These measures have been previously used to assess the stressfulness of
laboratory tasks and procedures (Kirschbaum et al., 1999; Kudielka et al., 2004). A 2X2 (E2
treatment X MDD Hx) multivariate ANOVA, with alpha = 0.05 was run for all self-rated
measures, and for difference score on the SACL and POMS (pre to post MIST). Change in
SACL-Stress score was termed “Distress” for analysis. Independent T test with alpha = 0.05
were run for groups comparisons for measures that had significant effects of the interactions E2
X MDD Hx.
Emotional Words Memory Task
At the study day participants completed an emotional episodic memory task that
consisted of an encoding (before the MIST) and recognition phase (after the MIST). During the
encoding phase, subjects were presented with 30 words for study (10 neutral, 10 positive, and 10
negative). The study words were taken from the Affective Norms for English Words (ANEW)
list (Bradley and Lang, 1999), which provides a set of normative emotional ratings, including
valence and arousal, for a large number of words in the English language. Words used were of
medium frequency of occurrence, and high concreteness. During the encoding task, subjects
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were instructed to read the words out loud, to ensure that they read each word, and to try to
remember the words for later testing.
During the recognition phase, subjects were presented with a combination of the 30
words that were presented during the encoding phase, and 30 new words that were not presented
during the encoding task. Subjects were instructed to press a button to indicate whether the word
was an old word that they had seen previously or a new word they had not seen prior to the fMRI
session. The new words were matched on valence, frequency, and concreteness to the studied
words. Measures of sensitivity and response bias were obtained from the behavioral performance
of this task. Performance on the emotional memory task was calculated by d’, a measure of
sensitivity in detecting hits and false alarms, response bias was calculated as C, a measure of bias
to respond to a binary choice either towards “yes” (liberal bias) or “no” (conservative bias).
Similar protocols have been used to study that effects of cortisol administration and acute
laboratory stress on emotional memory encoding and consolidation (Buchanan and Lovallo,
2001; Kuhlmann and Wolf, 2006; Kuhlmann et al., 2005; Roozendaal, 2002; Roozendaal et al.,
2008).

Results
Functional Connectivity
A resting functional connectivity analysis for the left amygdala seed with the
hippocampal ROI created from the significant cluster in the results of Chapter 3 was completed
only for participants who received estradiol treatment and thus had both a baseline pre estradiol
treatment resting scan and a study day post estradiol treatment resting scan. Comparison of
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functional connectivity at the baseline visit showed greater connectivity between the left
amygdala and right hippocampus in the MDD Hx+ group compared to the MDD Hx- group
( t(26) = 4.68 , p < 0.01), confirming the results in Chapter 3 in this subset of participants. There
was no significant difference in left amygdala-right hippocampal functional connectivity
between MDD Hx+ group and MDD HX-group at the study day following estradiol treatment (t
(26) = -0.26, p = 0.80). Comparison of change in functional connectivity between left amygdala
and right hippocampus (estradiol effect) showed a significant difference between groups (t (26) =
2.50, p = 0.02). Paired t test showed that the MDD Hx+ group had a significant decrease in left
amygdala right hippocampal function connectivity from baseline to study day (t(10) = 3.09, p =
0.01), while the MDD Hx- group had no significant change (t(16) = -0.50, p = 0.62).
Subjective Measures
In a 2X2 (E2 treatment X MDD Hx) multivariate ANOVA, there was a main effect of E2
treatment for a number of pre MIST measures with the E2+ groups having significantly lower
scores : STAI – state, BDI, BAI, Pre POMS-Depression (Table 1). There was an effect of the
interaction E2 X MDD Hx for VAS- Unpredictable (F (1) = 8.45, p = 0.01) and change in
SACL-Stress “Distress” (F (1) = 8.00, p = 0.01). In independent T-tests for group comparisons
there was a trend (t (25) = 1.37, p = 0.06) for greater VAS-Unpredictable score in the
E2+/MDD+ group (M = 85.80, SD = 19.22) compared to the E2+/MDD Hx- group (M = 65.12,
SD = 30.10); there were no significant differences in VAS-unpredictable for all other group
comparisons. There was a significant difference in “distress” in the group comparisons: 1) The
E2+/ MDD Hx- group had greater (t(25) = 2.80, p = 0.01) “distress” than the E2+/MDD Hx+
group; 2) The E2+/MDD Hx- group also had greater (t(35) = 2.15, p = 0.04) “distress” than the
E2-/MDD Hx- group; 3) The E2-/MDD Hx – group had greater (t(35) = -1.47, p = 0.16)
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“distress” than the E2-/MDD Hx+ group (Table 2). In women who did not receive estradiol,
women with MDD history had a more negative mood response to the MIST than women without
MDD history. However, in women who received estradiol treatment this was reversed; women
with MDD history had a less negative mood response than women without MDD history.
Emotional Words Memory Task
In a 2X2 (E2 treatment X MDD Hx) ANOVA of emotional words memory task
performance there were no main effects of E2 or MDD history, and no significant interaction
between E2 treatment and MDD history ( Table 2 and Table 3).
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